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Global Abstract 
 
Obesity is a serious public health crisis and recent estimates of its incidence are the 
highest in United States history, with 35% and 17% of American adults and children 
affected, respectively. The clinical definition of adult obesity is operationalized as a body 
mass index (BMI) greater than 30 kg/m2. Although the prevalence of common obesity 
has increased dramatically over the past 30 years–largely thought to be due to changes in 
the environment, such as high calorie diets and sedentary lifestyles—twin and family 
studies have shown consistently that relative body weight is under considerable genetic 
influence in both children and adults, with heritability estimates ranging from 40% to 
90%. Elucidating the genetic and environmental liability to relative body weight is an 
important public health endeavor. To further our understanding of the genetics of BMI 
and common complex obesity, several studies are described that integrate clinical, twin, 
and genome-wide association (GWAS) methodology in the context of genetic risk scores, 
clinical risk prediction, development across adolescence into adulthood, and comorbidity 
with depression symptoms and smoking behavior. First, in two cross-sectional genetic 
association studies, the utility of genetic risk sum scores (GRSS) were assessed, which 
summarize the total number of risk alleles, as an alternative form of replication and for 
potential clinical utility for obesity risk prediction. Next, since there has been only 
limited research on when during development BMI-associated variants begin influencing 
BMI, a longitudinal twin study was utilized to assess the effects of adult-validated BMI-
SNPs across adolescence into adulthood. In addition, obesity is comorbid with numerous 
medical conditions including cardiovascular disease, insulin-resistance and some forms 
of cancer, as well as, various psychiatric disorders including eating disorders, mood 
disorders, and substance use. The next series of studies aimed to understand phenotypic 
and genetic associations between BMI/obesity and binge eating disorder (BED), 
depression symptoms and smoking behavior. Using a clinical sample of overweight and 
obese women with and without BED, the relationship of BED, food intake and 
internalizing symptoms of depression and anxiety was examined. Next, twin study 
methodology was used to investigate if shared genetic and/or environmental liability was 
responsible for phenotypic associations found between BMI, depression symptoms, and 
impulsivity. Finally, a genetic association study aimed at investigating whether genetic 
variants were associated with multiple behaviors, body composition and smoking 
behavior, or were trait-specific is presented. By utilizing several samples and 
methodologies and by pursuing methods development, a comprehensive approach is 
presented that is hoped to represent a more powerful evidence-based strategy to 
understanding the genetic and environmental determinants of BMI and common complex 
obesity, along with associated depression symptoms and smoking behavior. 
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Chapter 1:  General Introduction 
 
THE OBESITY EPIDEMIC 
 
Prevalence 
 
Obesity is a growing public health crisis that is increasingly global in scope (1). Its 
prevalence among adult Americans has increased dramatically over the last fifty years. 
As reported by the Centers for Disease Control and Prevention, obesity rates increased 
from 5% in 1959 to 15% in 1980, and recent estimates of 35% in 2010 are the highest in 
United States history (2). These estimates reflect a five-fold increase in obesity since 
1959. Similarly, rates of obesity in childhood have increased significantly over the past 
30 years, from 5% in 1980 to 17% in 2010 (2). Furthermore, the US is not alone in this 
epidemic, as the World Health Organization reports similar child and adult obesity trends 
for many other nations (1). 
 
Defining obesity 
 
Obesity is defined as an excess of body adiposity. Historically, body weight has been 
used as a proxy measure of adiposity. Until the 1970s, obesity was defined on the basis of 
reference tables of “ideal body weight” determined by the life insurance industry from 
associations with mortality (1). However, this was replaced in the 1980s by body mass 
index (BMI), a height-adjusted measure of weight calculated as the ratio of weight in 
kilograms by height in meters squared (kg/m2). The current clinical definition of adult 
obesity is a BMI greater than 30 kg/m2. BMI may be further partitioned into clinical 
categories corresponding to BMI ranges of underweight <18, normal 18-25, overweight 
25-30 and obese class I 30-35, class II 35-40, and class III 40+ kg/m2 (US Dietary 
Guidelines). In children, the criteria for classification as overweight and obese are based 
on the 85th and 95th percentiles of BMI for sex and age in relation to a reference 
population (3). Additionally, research has demonstrated that BMI is correlated with other, 
more direct measures of body fat including underwater weighing and dual energy X-ray 
absorptiometry (DEXA) (4-6). However, the limitations of BMI have been realized and 
factors such as age, sex, ethnicity, and muscle mass can affect the association between 
BMI and body fat (7-10). BMI nonetheless remains a widely used, simple, inexpensive, 
and noninvasive proxy measure of body fat that can be calculated with reasonable 
accuracy. 
 
Mortality and morbidity 
 
With increasing BMI there is a curvilinear rise in mortality (11, 12). In obese groups, this 
rise in mortality is thought to be due to the numerous adverse medical conditions 
associated with high levels of body fat. In adults, obesity is associated with increased risk 
of cardiovascular disease (13), type II diabetes (14, 15), some forms of cancer (16) and is 
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comorbid with multiple psychiatric disorders (17-21). Similarly, childhood obesity is 
associated with both immediate and long-term health consequences including increases in 
blood pressure, cholesterol and insulin resistance, as well as social and psychological 
problems (22-25). Furthermore, research has demonstrated that obese children are more 
likely to become obese adults (26-30), adding to the necessity of effective prevention and 
treatment efforts. 
 
Determinants of obesity 
 
Obesity is the result of positive energy balance, that is, excess caloric intake relative to 
energy expenditure. Although energy balance may appear straightforward, its relationship 
with obesity is complex and involves both genetic and environmental determinants. With 
respect to the doubling of obesity rates in the past 30 years, it is arguable that while our 
genomes have remained stable, environmental changes are attributable to this rise. 
Examples of such environmental factors include increases in restaurant and fast-food 
dining, and consumption of sweetened beverages (12, 31). For example, the reported 
number of fast food restaurants has increased from an estimated 600 in 1958 to over 
222,000 in 2010 (1). Additionally, data on energy expenditure suggest that physical 
activity has declined but that the magnitude of this change is small and could not alone 
account for the dramatic increase in rates of obesity (32). Tracking of energy intake and 
expenditure is difficult and complicated by inaccuracies in reporting (33). Further 
research and developments in methodology are needed to clarify the relative contribution 
of dietary intake and energy expenditure to obesity over the life course. Although 
nutritional intake and physical activity affect relative body weight, twin and family 
studies have consistently shown a significant genetic contribution to body composition 
with heritability estimates of 40 to 70% (34-36). These results suggest that a considerable 
fraction of the variance in BMI is due to genetic effects. Therefore, the obesity epidemic 
likely reflects multiple interactions between lifestyle and genetic factors. More research is 
needed to unravel the interactions between these factors, and especially, identify critical 
time points of susceptibility. 
 
THE GENETICS OF OBESITY 
 
Three broad categories of obesity etiology have been described: monogenic, syndromic 
and common complex obesity. Dysfunction or loss of a single or few genes is both 
necessary and sufficient to cause monogenic or syndromic obesity and the typical onset is 
early in childhood. Common complex obesity is thought to be the result of the interplay 
between many genes, each of relatively small effect, along with influences of the 
environment. Research suggests that less than 5% of obesity cases are caused by 
monogenic or syndromic inheritance (37). Given that our focus herein is on common 
complex obesity, only a brief review of monogenic and syndromic obesity are provided. 
More detailed descriptions of rarer forms of obesity may be found in Mutch & Clement, 
Hinney et al., and Beales (38-40), as well as in the Online Mendelian Inheritance in Man 
database (http://www.ncbi.nlm.nih.gov/omim).  
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Monogenic obesity 
 
Monogenic obesity, also known as non-syndromic obesity, is defined as obesity caused 
from a rare mutation of a single gene. There have been over 200 reported cases of 
monogenic obesity, implicating a total of 11 genes (38, 40). The most common mutations 
causing monogenic obesity are in the melanocortin-4-receptor gene (MC4R) on 
chromosome 18q22 and account for 6% of monogenic obesity (41, 42). Association with 
MC4R in humans was first reported in 1998 after screening of extremely obese 
individuals and their families identified frameshift mutations co-segregating in an 
autosomal dominant fashion (43, 44). The leptin receptor gene (LEPR) on chromosome 
1p31 has been found to account for 3% of monogenic obesity cases (45) and yielded its 
first reported association in humans in 1998 following the presentation of severely obese 
siblings with extremely high levels of serum leptin (46). In fact, many of the transcripts 
of genes associated with monogenic obesity have been shown to have a role in the 
hypothalamic leptin-melanocortin system, which include the following genes: leptin 
(LEP), pro-opiomelanocortin (POMC), prohormone convertase 1 (PC1), brain-derived 
neurotrophic factor (BDNF) and its receptor neurotrophic tyrosine kinase receptor type 2 
(NTRK2) and single-minded homolog 1 (SIM1) (37, 38, 40, 47-50) . 
 
Syndromic obesity 
 
There are approximately 30 Mendelian disorders that include obesity as a clinical feature 
but are distinguished by additional presenting attributes including intellectual disabilities, 
dysmorphic features and developmental abnormalities (38, 40, 49, 50). These disorders 
are termed syndromic obesity and are the consequence of specific genetic defects or 
chromosomal abnormalities that disrupt contiguous gene(s). Because multiple genes may 
be disrupted, the particular causes of obesity often remain elusive. The most common 
forms of syndromic obesity disorders identified to date are Prader-Willi syndrome 
(PWS), Bardet-Biedl syndrome, and Alström syndrome. Of these, PWS has the greatest 
incidence, occurring in 1 in 25,000 births and, in addition to obesity, is characterized by 
hyperphagia, intellectual disabilities, and hypogonadism. Most cases of PWS are caused 
by deletion of the paternal copy of the imprinted small nuclear ribonucleoprotein 
polypeptide N gene (SNRPN) and potentially other genes within the 15q11-q13 region. 
The full catalogue of syndromes may be found in the Online Mendelian Inheritance in 
Man database (http://www.ncbi.nlm.nih.gov/omim). 
 
Polygenic inheritance 
 
Although the prevalence of common obesity has increased dramatically over the past 30 
years–largely thought to be due to changes in the environment, such as high calorie diets 
and sedentary lifestyles—twin and family studies have shown consistently that relative 
body weight is under considerable genetic influence in both children and adults, with 
heritability estimates ranging from 40% to 90% (35, 51-54). Additionally, twin study 
meta-analyses which examined BMI from birth to adulthood have revealed that the 
contribution of genetic effects are low at birth but increase over time, with upwards of 
50% of the phenotypic variance due to genetic effects after the first year of life (54, 55). 
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Furthermore, twin studies have demonstrated significant sex effects on BMI, with greater 
phenotypic variance in females and significant sex-specific genetic factors also reported 
(51, 54, 56-60). Given the large heritability estimates reported for BMI, molecular 
genetic approaches represent a useful tool with which to examine underlying mechanisms 
and genetic susceptibility to obesity. To date, a number of approaches have been utilized 
to identify BMI/obesity-associated genes including candidate gene, linkage and 
association studies. 
Studies of candidate genes known to cause severe obesity in experimental animals 
have implicated several genes in human obesity (40). In the mid-1990s, Zhang et al., 
discovered that a mutation in the gene encoding the leptin protein was responsible for the 
severe obesity phenotype in the ob/ob mouse (61). Shortly thereafter, the first human 
mutations were reported in a pair of severely obese cousins, who were found to carry a 
frameshift mutation in the LEP gene on chromosome 7q32 (62). Mutations in the LEP 
gene are largely associated with monogenic obesity and ~1% of extreme early onset 
obesity cases carry LEP mutations (40). However, variants in LEP have not demonstrated 
association with BMI in the general population (63). Although hundreds of genes have 
been proposed as obesity candidate genes, few have yielded convincing association 
findings for BMI liability or obesity susceptibility and include common variants in MC4R 
and BDNF (63-67).  
Genome-wide linkage studies provided an alternative method for identifying 
BMI/obesity-susceptibility genes. By examining rates of recombination between 
polymorphic markers among affected siblings, linkage analysis has the potential to 
localize a co-segregating genetic effect to a particular genetic locus. Unlike candidate 
gene studies, linkage studies do not rely on an a priori hypothesis, but rather aim to 
identify previously unknown genetic loci to potentially lead to new insights regarding the 
biology. Numerous linkage scans have been performed, identifying more than 300 
chromosomal loci demonstrating linkage with BMI/obesity (48, 68). However, like 
candidate gene approaches, linkage studies have been plagued by non-replication of 
positive findings (68, 69). For instance, a meta-analysis of 37 studies boasting a 
combined sample size of 10,000 families failed to identify any locus robustly linked to 
BMI or obesity (68). As such, linkage analysis has not proved to be a powerful method 
for identifying genetic loci with small effects, as would be expected for BMI and 
common complex obesity. 
By the mid-2000s, the fruits of the Human Genome Project and International 
HapMap Project (70), coupled with the rapid development of high-density high-
throughput genotyping arrays, set the stage for a new era of complex disease mapping by 
genome-wide association studies (GWAS). GWAS is premised on the expectation that, 
by capturing the majority of common human variation across the genome, individual 
associations might be identified without a priori expectation of a given locus’s 
involvement in disease etiology. Common variation, in the context of GWAS, is taken 
commonly to mean point mutations, or single nucleotide polymorphisms (SNPs) with 
minor allele frequencies (MAF) >1-5%. An advantage of GWAS over linkage studies is 
its extendibility to population-based designs, allowing for potentially larger sample sizes 
and increased power to detect variants with smaller effect-sizes (71). The GWAS 
approach has successfully identified polymorphisms that contribute to disease risk for 
numerous complex traits and diseases (72). Though, in some ways the field of obesity 
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stumbled into the GWAS era. In 2007, a GWAS of type II diabetes by the Welcome Trust 
Case Control Consortium identified the first association with BMI. A SNP in the fat mass 
and obesity-associated (FTO) gene was found to be significantly associated with type II 
diabetes.  However, when the analyses were adjusted for BMI, the strength of this 
association was diminished, indicating that the effect of FTO on type II diabetes was 
through its association with BMI. Since 2007, several subsequent GWAS of successively 
larger size have been performed for BMI and obesity-related traits (67). In 2009, two 
large-scale BMI meta-analyses by Thorleifsson et al. and Willer et al. yielded 13 genetic 
loci reaching genome-wide significance, including the previously implicated variants in 
or near FTO and MC4R (see Chapter 2 for a complete list). A subsequent mega-analysis 
by Speliotes et al. (2010) incorporated a two-stage approach in which a GWAS was 
performed on 249,796 individuals from 46 studies in the first stage, followed by a second 
stage in which association was performed in an additional 125,931 individuals from 42 
studies. This study confirmed 32 SNPs unequivocally associated with BMI (see Chapter 
3 for a complete list). These variants, although highly associated with BMI, have small 
individual effects ranging 0.06 to 0.39 kg/m2 change in BMI per risk allele and in 
aggregate account for a limited proportion of the phenotypic variance (~1.45%) (63). 
Current GWAS designs are limited to detecting trait or disease associations with 
common variation in accordance with the common disease-common variant (CDCV) 
hypothesis (73). For BMI, the aforementioned 32 common SNPs account for ~1.45% of 
the phenotypic variance, leaving a substantial fraction of the heritability in BMI 
unaccounted for. As for other complex traits and diseases, this “missing heritability” has 
lead to efforts to identify rare variants contributing to common disease. Given the 
heritability of BMI and the observation that common SNPs only account for a portion of 
the expected phenotypic variance, it is conceivable that additional classes of genetic 
variants such as rarer and/or structural variation or epigenetic mechanisms influence body 
composition. A growing number of rare copy number variants (CNV) have demonstrated 
association with BMI and obesity (a catalogue of CNVs appears in Chapter 3) (74-82). In 
addition, for many of the BMI/obesity-associated loci, it has yet to be determined if they 
represent the causative locus or if they are merely correlated with the causative variant. 
Fine mapping efforts by large-scale exome and genome sequencing efforts are needed to 
identify the true causal variants. Indeed, such studies are underway and include the 
UK10K project, a whole-genome sequencing study of 4,000 individuals and exome 
sequencing of an additional 6,000 individuals, including 2,000 with extreme obesity 
phenotypes (83). 
In summary, despite an arguably changing environment, twin and family studies 
support the significant role of genes in contributing to relative body weight and obesity 
across the lifespan. However, as described in the preceding sections, most genes that 
contribute to relative body weight and obesity are of largely unknown function and have 
limited utility for risk prediction. This is further complicated by the fact that most studies 
to date have been on samples of primarily European descent and cross-sectional in nature. 
Additional research is needed in diverse human populations and it remains unknown 
when in development the identified genetic effects become important for predicting BMI.   
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OBESITY AND PSYCHIATRIC COMORBIDITY 
 
Obesity is comorbid with numerous medical conditions including a variety of psychiatric 
disorders and traits. Obesity has been associated with eating disorders, mood disorders, 
substance use as well as personality disorders (84-86). For example, the National 
Epidemiological Survey on Alcohol and Related Conditions (NESARC), a study of over 
40,000 American adults, reports significant increased odds for many psychiatric disorders 
among them include: lifetime prevalence of any anxiety disorder (OR = 1.4-2.3), lifetime 
prevalence of alcohol dependence (OR = 1.1-1.6), and prevalence of antisocial 
personality disorder (OR = 1.1-3.3) (86). Below appears a synopsis of three psychiatric 
disorders and their association with obesity that are of particular relevance to this thesis. 
 
Binge eating disorder 
 
Binge eating disorder (BED) is under consideration for inclusion in the Diagnostic and 
Statistical Manual of Mental Disorders, fifth edition (DSM-V). BED is currently defined 
by the DSM-IV as a provisional eating disorder diagnosis characterized by recurrent 
episodes of binge eating without weight control compensatory behavior and includes: (1) 
“eating, in a discrete period of time (e.g., within any 2-hour period), an amount of food 
that is definitely larger than what most people would eat during a similar period of time 
and under similar circumstances,” and (2) “a sense of lack of control over eating during 
the episode”. Additionally, individuals with BED must experience distress about their 
binge eating and endorse three of the following symptoms: (1) eating more rapidly than 
normal, (2) eating until uncomfortably full, (3) eating large amounts when not hungry, (4) 
eating alone because of embarrassment, and (5) feeling disgusted, depressed or guilty 
about overeating (87). Although obesity is not a requirement for a BED diagnosis, 
research indicates that approximately 70% of those meeting criteria for BED are obese 
(21). While the prevalence of BED in community samples ranges from 2-5%, 
approximately 30% of obese individuals seeking weight control treatment meet criteria 
for BED (88, 89). The recurrent overeating that characterizes BED, along with the 
absence of compensatory behaviors exhibited by those with bulimia nervosa (BN), is 
most likely responsible for the high frequency of obesity in this group. 
 
Major depressive disorder and depression symptoms 
 
According to the DSM-IV, major depressive disorder (MDD) is characterized by a 
depressed mood most of the day nearly everyday for at least a two-week period and/or 
diminished interest or pleasure in all or almost all activities. Additional criteria include 
endorsement of at least three of the following symptoms: (1) significant weight loss or 
weight gain, (2) insomnia or hypersomnia, (3) psychomotor agitation or retardation, (4) 
loss of energy, (5) feelings of worthlessness or excessive guilt, (6) diminished ability to 
concentrate and (7) recurrent thoughts of death or suicide (87). As reported by the 2006 
National Comorbidity Survey Replication, the lifetime history estimates of MDD are 
12.7% in men and 21.3% in women (90). However, within obese populations, reported 
lifetime prevalence rates of depression have been shown to be elevated upwards of 32% 
(20). In addition, Strine et al. found that adults with a current or lifetime diagnosis of 
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depression were significantly more likely to engage in unhealthy behaviors such as 
physical inactivity and to be obese (20). Furthermore, longitudinal phenotypic studies 
have found a reciprocal association between obesity and depression, suggesting that 
elevated BMI may increase depression and vice versa (91, 92). Cross-sectional studies of 
BMI and depression symptoms have reported positive (93-97), negative (primarily in 
males) (98, 99) and no association (100-102) between these traits. However, a population 
based study from the Netherlands found a quadratic (U-shaped) association of BMI and 
depression indicating those with the lowest and the highest relative body weight were 
more likely to present with depression. In light of current DSM-IV MDD criteria, which 
include items related to increase and decrease in appetite, weight and energy expenditure, 
it is feasible that BMI may be associated with greater levels of depression in both 
underweight and obese individuals (103). Further research is needed to clarify the nature 
of the association between body weight and depression. 
 
Nicotine dependence and smoking behavior 
 
Nicotine dependence (ND) is characterized by tolerance and withdrawal symptoms in 
relation to tobacco use. ND can occur with cigarette smoking, smokeless tobacco use, 
cigar or pipe use. According to the DSM-IV, ND is diagnosed by clinically significant 
impairment or distress from the presence of any three of the following seven criteria 
occurring at any time in the same 12-month period: (1) tolerance, (2) withdrawal, (3) 
taking the substance in larger amounts than intended, (4) persistent desire or unsuccessful 
efforts to cut down on the substance, (5) spending a great deal of time obtaining or 
recovering from the effects of the substance, (6) giving up important recreational, social, 
or occupational activities as a result of the substance, and (7) continued use of the 
substance despite physical or psychological problems caused by the substance. There are 
a number of questionnaires that are used to assess ND and the most widely used are the 
eight-item Fagerström Tolerance Questionnaire (FTQ), the six-item Fagerstöm Test for 
Nicotine Dependence (FTND), which is a shortened version of the FTQ, excluding items 
on nicotine yield of cigarettes and inhalation, and the two-item Heaviness of Smoking 
Index (HSI), a shorter version of the same test only including items on time to first 
cigarette after waking and number of cigarettes per day (104, 105). In 2010, according to 
the Centers for Disease Control and Prevention, the estimate of American adults reported 
as current smokers was 19.3% (106-108). Cross-sectional studies of smoking behavior 
typically support a negative relationship between current smoking and BMI (109-111), 
which may be due, in part, to effects of nicotine on energy homeostasis (112-116). 
Furthermore, smoking cessation is often followed by weight-gain (113, 117, 118). In 
contrast, however, a positive association is supported by the observation that within 
smoking cohorts, heavy smokers tend to be of increased body weight compared to light 
smokers (119-121). Additionally, smoking has been associated with accumulation of 
visceral fat and increased waist circumference (122-124). Phenotypic associations 
between smoking and body composition suggest a complex relationship and the causes of 
these associations remain incompletely understood. 
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SPECIFIC AIMS 
 
Survey of limitations 
 
GWAS has proven a fruitful approach for identifying polymorphisms that 
contribute to disease risk for numerous complex traits and diseases (72).  However, this 
method has been met with important limitations, especially as applied to psychiatric 
disorders. A number of potential factors have been proposed that may reduce the power 
of this methodology in general, as well as for the field of common complex obesity 
specifically.  
To date, large-scale GWAS meta-analyses have confirmed 32 SNPs associated 
with BMI which, although highly associated, have small individual effects ranging 0.06 
to 0.39 kg/m2 change in BMI per risk allele. Therefore, replication attempts have limited 
power to achieve genome-wide significance, even with thousands of subjects (125). 
Moreover, in aggregate these BMI-associated SNPs account for a fraction of the 
phenotypic variance (~1.45%) (63), and thus have limited utility for risk prediction (67), 
suggesting that other classes of genetic variants may be important.  
Also, given that the large-scale meta-analyses of BMI were performed on samples 
of primarily European descent, these findings may not be easily generalizable to other 
ancestry groups. From a public health perspective, this is particularly problematic since 
research indicates that there exist health disparities between racial groups, including 
increased obesity prevalence in African- and Hispanic-Americans (126). The 
aforementioned BMI-associated SNPs were identified from cross-sectional adults 
samples, which does not address at what point during development these variants 
influence BMI. The identification of specific “windows” of risk is essential for 
understanding development as well as informing prevention and intervention efforts.   
Furthermore, relative body weight has been associated with numerous other 
medical conditions and traits. This may impact the power of gene identification efforts, 
especially if control groups are not adequately screened for correlated traits or such 
correlations are not accounted for in statistical methodology. There is a paucity of 
literature reporting on the potential common genetic liability between obesity and 
comorbid traits. Without consideration of genetically correlated traits, genome-wide 
studies of complex disease may be limited in their power to detect etiologically relevant 
variation.  
In summary, the present survey of limitations of gene-identification efforts for 
common complex obesity has identified the following issues: replication of variants with 
small effects, utility of risk prediction, generalizability to multiple racial groups and 
across the lifespan and affects of comorbidity. This thesis delves into many of these 
limitations and attempts to address these issues through five specific aims. 
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Specific aims 
 
The purpose of this research was to develop methods to better delineate the genetics of 
common complex obesity and the corresponding associations with depression symptoms 
and smoking behavior through the following five aims: 
 
1. Examine phenotypic associations between BMI, depression and smoking behavior 
in clinical and epidemiological samples. Identify putative mediators and 
moderators of the BMI-depression link and explore sample structures via 
symptom profiles. 
 
2. Apply multivariate twin methodology to BMI, depression and nicotine-use 
phenotypes in order to test for shared genetic and environmental liability of 
multiple traits and stability over time. 
 
3. Catalogue common polygenic variation associated with body composition. 
 
4. Test genetic variants catalogued for association in multiple cohorts and traits to 
provide evidence of replication, assess clinical utility and potentially discover 
variants influencing multiple traits. 
 
5. Methods development in each of the preceding areas, presented throughout. 
 
Thesis outline 
 
In the following chapters, several studies will be described that integrate both GWAS and 
twin study methodology to further our understanding of the genetics of BMI and common 
complex obesity in the context of genetic risk scores, clinical risk prediction, 
development across adolescence into adulthood, and comorbidity with depression 
symptoms and smoking behavior. In the first chapter, the obesity epidemic and the 
associated mortality and morbidity, and a highlight of the genetics of obesity and BMI 
are reported in order to provide the necessary background.  
In the subsequent two chapters, genetic risk sum scores (GRSS), which 
summarize the total number of risk alleles and test the aggregate risk, as an alternative 
form of replication and assess clinical utility for obesity risk prediction are performed. 
Specifically, in Chapter 2, genetic variants were catalogued from two-large scale meta-
analyses of BMI in order to test a GRSS constructed by the count method in a sample of 
European-Americans and African-Americans from the Molecular Genetics of 
Schizophrenia Controls (MGS-C). In Chapter 3, to extend GRSS methodology, scores 
were constructed from proxy versus imputed SNPs and count versus weighted methods 
were compared. In addition to BMI-validated SNPs, previously implicated common and 
rare CNVs were identified from the literature and were tested for association with BMI 
and obesity. An integrated model of common and rare variation was tested for association 
with BMI and subsequently assessed for clinical utility in a sample of European-
Americans and African-Americans from the Study of Addiction: Genes and Environment 
(SAGE).  
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Since there has been limited research on when during development BMI-
associated variants begin to influence BMI, Chapter 4, utilizes a longitudinal twin study 
to assess the effects of adult-validated BMI-SNPs across adolescence into adulthood. To 
our knowledge, this is the first study of BMI to incorporate GRSS methodology in the 
context of variance decomposition. Furthermore, only limited models have been applied 
to examine the genetic and environmental architecture of BMI across adolescence into 
adulthood. Therefore, this study tested models to quantify the relative proportion of 
genetic and environmental factors that persist across time versus those that are time 
specific in the Virginia Twin Study of Adolescent Behavioral Development (ABD).  
Obesity is comorbid with numerous medical conditions as well as a various 
psychiatric disorders including eating disorders, mood disorders, and substance use (84-
86). In Chapters 5 through 8, phenotypic and genetic associations between BMI/obesity 
and binge eating disorder (BED), depression symptoms and smoking behavior are 
examined in several different types of samples. In Chapters 5 and 6, the University of 
Minnesota Study of Binge Eating Disorder (UofMN), which is a clinical sample of 
overweight and obese women with and without BED, is used to examine the relationship 
of BED, food intake and internalizing symptoms of depression and anxiety. Additionally, 
tracking of energy intake and expenditure is difficult and complicated by inaccuracies in 
reporting (33). An improved understanding of the accuracy of self-reported food intake is 
central to diagnosis of eating disorders, monitoring response to treatment and obesity 
management. Therefore, in Chapter 5, energy intake and energy expenditure were 
assessed by multiple methods to potential identify differences in food intake, metabolism 
and accuracy of self-reported food intake in obese women with and without BED. In 
Chapter 6, the UofMN sample was used to examine models by which BED, internalizing 
behaviors of depression and anxiety influence food intake in overweight/obese women. 
Greater understanding of the mechanisms underlying the associations between mood, 
binge eating and food intake will facilitate the development of more effective prevention 
and treatment strategies for both BED and obesity. 
Despite numerous phenotypic associations between BMI, depression symptoms, 
and smoking behavior, there is a paucity of reports investigating genetic and 
environmental associations between them. To better understand the underlying common 
genetic architecture, it is essential that the complex nature of the observed associations 
between these traits be assessed. Accordingly, Chapters 7 and 8 investigate associations 
between BMI, depression symptoms and smoking behavior by two different types of 
genetically informed samples: twin studies and GWAS. In Chapter 7, twin study 
methodology is used to investigate if shared genetic and/or environmental liability is 
responsible for phenotypic associations found between relative body weight, depression 
symptoms, and impulsivity in the Virginia 30,000 Twin Study (VA30k). Furthermore, 
most studies do not examine common versus specific genetic effects. In Chapter 8, 
genetic variants individually associated with BMI or smoking behavior were catalogued 
and tested for association in The Health Aging and Body Composition Study (HABC) in 
order to investigate whether genetic variants were associated with multiple behaviors or 
were trait-specific. Without consideration of genetically correlated traits, genome-wide 
studies of complex disease may be limited in their power to detect etiologically relevant 
variation. 
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Finally, Chapter 9 provides a global discussion of this thesis by summarizing key 
findings from each study, discussing limitations of the research presented, and providing 
extensions for future research.  By utilizing several samples and methodologies and by 
pursuing methods development, a comprehensive approach is presented that is hoped to 
represent a more powerful evidence-based strategy to understanding the genetic and 
environmental determinants of BMI and common complex obesity, along with the 
associated depression symptoms and smoking behavior. 
 
COHORTS 
 
In order to implement the aims of this dissertation, several data types were utilized 
including clinical studies, population-based twin samples and samples genotyped for the 
study of common diseases. Table 1 lists each study along with the corresponding sample 
and the chapter in which it appears. 
 
I. Molecular Genetics of Schizophrenia Controls (MGS-C) 
 
The MGS-C is a cross-sectional sample of 2,653 European-Americans and 
973 African-Americans. Participants were considered for “control” status if 
they denied all of the following psychosis screening questions: treatment for 
or diagnosis of schizophrenia or schizoaffective disorder; treatment for or 
diagnosis of bipolar disorder or manic-depression; treatment for or diagnosis 
of psychotic symptoms such as auditory hallucinations or persecutory 
delusions. Participants completed an online questionnaire, which included 
items on height and current weight. Venipuncture for DNA extraction and 
establishment of lymphoblastoid cell lines was completed at Rutgers 
University Cell and DNA Repository. DNA samples were genotyped using 
the Affymetrix 6.0 array at the Broad Institute.  
 
II. Study of Addiction: Genes and Environment (SAGE)  
 
Complete data on height, weight, alcohol dependence, nicotine dependence, 
genotypes and copy number variants were available for 1850 European-
American and 498 African-American SAGE participants. The SAGE sample 
was drawn from three contributing projects: the Collaborative Study on the 
Genetics of Alcoholism (COGA), the Collaborative Study on the Genetics of 
Nicotine Dependence (COGEND) and the Family Study of Cocaine 
Dependence (FSCD). Body composition variables were not available for the 
FSCD sample, thus not included in the analyses described herein.  Study 
variables were assessed by interview using versions of the Semi-Structured 
Assessment for the Genetics of Alcoholism. Body mass index (BMI) was 
calculated from self-reported height and weight. Samples were genotyped on 
the Illumina Human 1M beadchip at the Center for Inherited Diseases 
Research at Johns Hopkins University. 
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III. Virginia Twin Study of Adolescent Behavioral Development (ABD) 
 
ABD is a longitudinal population-based twin study of adolescent 
psychopathology. ABD twin participants twins aged 8 to 17 were recruited 
through Virginia schools and were followed-up every 18 months for up to four 
waves of data collection (n = 2,794). In total, there were 913 participants from 
639 families (291 twin pairs, 348 singletons) that were also genotyped on the 
Illumina Human 660 array. BMI was calculated from measured weight and 
height. 
 
IV. University of Minnesota Study of Binge Eating Disorder (UofMN) 
 
Thirty-four women participated in this study examining metabolic measures, 
including 17 meeting clinical criteria for binge eating disorder and 17 
overweight/obese controls with no history of any binge eating or eating 
disorder behaviors. Food intake was assessed from a laboratory eating 
episode, 24-hour dietary recall interviews and food diaries. Energy 
expenditure was assessed by the doubly labeled water technique, basal 
metabolic rate and the thermic effect of food. Furthermore, participants 
completed a variety of questionnaires including the Beck depression and 
anxiety inventories. 
 
V. The Virginia 30,000 Twin Study (VA30k) 
 
The VA30k sample is a large population-based twin study. Ascertainment for 
the VA30k sample was through two sources, a volunteer twin sample solicited 
through the American Association of Retired Persons and the Virginia Twin 
Registry. BMI data was available for n=14,457 adult twins. Participants 
completed the Health and Lifestyle Questionnaire, which included abbreviated 
versions of the Symptoms Checklist and the Eysenck Personality 
Questionnaire and smoking history. 
 
VI. The Health Aging and Body Composition Study (HABC) 
 
The HABC study is a prospective community based sample of body 
composition changes over time in elderly adults and included 1663 European-
American and 1139 African-American participants. Participants were 
recruited in 1997-1998 from Pittsburgh, PA, and Memphis, TN metropolitan 
area residents who were Medicare eligible and between the ages of 69 and 80 
years. BMI was calculated from laboratory measured height and weight 
during initial evaluation. Physical activity was estimated from a structured 
interview of 27 questions. Computerized tomography was used to determine 
abdominal visceral adiposity density. Smoking habits and race were self-
reported via telephone interview. Genotyping was performed by the Center for 
Inherited Disease Research using the Illumina Human 1M-Duo BeadChip 
system. 
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Table 1: Summary of dissertation studies 
 
 
Chapter Study Sample Design Phenotype Aim 
2 Genetic risk sum score comprised of common polygenic variation is associated with body mass index MGS-C 
Cross-sectional, 
GWAS BMI, obesity 3, 4, 5 
3 
Association of common and rare variation influencing 
body mass index: A combined single nucleotide 
polymorphism and copy number variation analysis 
SAGE Cross-sectional, GWAS, CNV BMI, obesity 3, 4, 5 
4 
Association of common polygenic variation with body 
mass index across adolescent development: A 
longitudinal twin study 
ABD Longitudinal, twin, GWAS BMI 2, 4, 5 
5 
Comparisons of energy intake and energy expenditure 
in overweight and obese women with and without 
binge eating disorder 
U of MN Clinical BED, obesity 1, 5 
6 
Binge eating disorder mediates links between 
symptoms of depression, anxiety, and energy intake in 
overweight and obese women 
U of MN Clinical 
BED, obesity, 
depression 
symptoms 
1, 5 
7 
Genetic and environmental associations between body 
mass index, depression symptoms and impulsivity in a 
population-based sample of twins: VA30k 
VA30k Cross-sectional, twin 
BMI, depression 
symptoms, 
impulsivity 
1, 2 
8 
On the genetic and environmental relationship of body 
mass index, smoking initiation and nicotine 
dependence in a population-based sample of twins 
VA30k Cross-sectional, twin 
BMI, smoking 
behavior 1, 2 
8 Evidence of shared polygenic risk among smoking behaviors and body composition HABC 
Cross-sectional, 
GWAS 
BMI, obesity, 
smoking behavior 1, 3, 4 
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Chapter 2:  Genetic risk sum score comprised of common 
polygenic variation is associated with body mass index 
 
 
Adapted from: Peterson RE, Maes HH, Holmans P, Sanders AR, Levinson DF, Shi J, Kendler 
KS, Gejman PV, Webb BT. Genetic risk sum score comprised of common polygenic variation is 
associated with body mass index. Human Genetics. 2011 Feb;129(2):221-30.  
 
ABSTRACT 
 
Genome-wide association studies (GWAS) of body mass index (BMI) using large 
samples have yielded approximately a dozen robustly associated variants and implicated 
additional loci. Individually these variants have small effects and in aggregate explain a 
small proportion of the variance. As a result, replication attempts have limited power to 
achieve genome-wide significance, even with several thousand subjects. Since there is 
strong prior evidence for genetic influence on BMI for specific variants, alternative 
approaches to replication can be applied. Instead of testing individual loci sequentially, a 
genetic risk sum score (GRSS) summarizing the total number of risk alleles can be tested. 
In the current study, GRSS comprised of 56 top variants catalogued from two large meta-
analyses was tested for association with BMI in the Molecular Genetics of Schizophrenia 
controls (2,653 European-Americans, 973 African-Americans). After accounting for 
covariates known to influence BMI (ancestry, sex, age), GRSS was highly associated 
with BMI (p-value = 3.19x10-6) although explained a limited amount of the variance 
(0.66%). However, area under receiver operator criteria curve (AUC) estimates indicated 
that the GRSS and covariates significantly predicted overweight and obesity 
classification with maximum discriminative ability for predicting class III obesity 
(AUC=0.697). The relative contributions of the individual loci to GRSS were examined 
post hoc and the results were not due to a few highly significant variants, but rather the 
result of numerous variants of small effect. This study provides evidence of the utility of 
a GRSS as an alternative approach to replication of common polygenic variation in 
complex traits. 
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INTRODUCTION 
 
Obesity is a general medical condition, defined clinically by a body mass index (BMI) 
greater than 30 kg/m2 and is associated with increased risk of cardiovascular disease, type 
II diabetes, cancer and poor quality of life (12, 127, 128). The National Center for Health 
Statistics reports over 33% of American adults are obese with another 33% meeting 
criteria for being overweight (127, 129). Although increase in energy intake with reduced 
physical activity contributes to the increase in obesity, genetic factors have consistently 
been demonstrated to influence individual differences in BMI, with twin and family 
studies estimating heritabilities of ~0.70 (35, 36).  
Genome-wide association studies (GWAS) have successfully identified 
polymorphisms that contribute to disease risk for numerous complex traits and diseases 
(72). GWAS for BMI and obesity using sample sizes in the tens of thousands have 
yielded many putative risk variants of individually small effect. The first common single 
nucleotide polymorphisms (SNPs) associated with BMI and common obesity were in the 
fat mass and obesity-associated (FTO) gene and near melanocortin 4 receptor (MC4R) 
and have been widely replicated (66, 130-135). Additionally, two large-scale BMI meta-
analyses, Thorleifsson et al. (2009) and Willer et al. (2009), yielded 13 genetic loci 
reaching genome-wide significance, including the previously implicated variants in or 
near FTO and MC4R. These variants were highly significant but had modest effects with 
0.06-0.4 kg/m2 per allele change in BMI and modest obesity (BMI>30 kg/m2) odds ratios 
ranging 1.03-1.3. Although many loci are expected to contribute to a complex trait like 
BMI, the large number implied by the current result was unexpected to many (136, 137). 
Despite the large sample size (n>30,000), Willer et al. (2009) estimated 5-10% power to 
detect genome-wide significant variants with effect sizes of 0.06-0.1 BMI units per allele. 
Therefore, it is likely that many variants influencing BMI did not reach genome-wide 
significance in these meta-analyses.  
Replication attempts using studies unselected for BMI have limited power to 
achieve genome-wide significance, even with thousands of subjects (125). Since there is 
strong a priori evidence for genome-wide significant and suggestive variants from the 
large meta-analyses, alternative approaches to replication can be applied. Instead of 
testing individual loci sequentially, a genetic risk sum score (GRSS) summarizing the 
total number of risk alleles can be constructed and tested. The aggregate risk should be 
significant if a sufficient proportion of the variants have real effects. GRSS have been 
used to test the total impact of associated variants on complex traits and disease. For 
example, Aulchenko et al. (2009) used 54 variants in a GRSS which accounted for ~4% 
of the phenotypic variance in height. Risk scores incorporating 18-20 genome-wide 
significant variants have been shown to be associated and predictive of type II diabetes, 
though algorithms including family history and additional risk factors perform better 
(138, 139). GRSS have also been applied to BMI and obesity in populations of European 
and Chinese descent which incorporated 8-15 variants and accounted for 0.5-1.12% of 
the phenotypic variance (64, 65, 140-143). Presently, BMI GRSS have only incorporated 
genome-wide significant variants. However, research by Evans et al.(2009), suggests that 
in some cases, including bipolar disorder, coronary heart disease, hypertension and type 
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II diabetes, using liberal thresholds (α = 0.5) for SNP selection in GRSS may improve 
predictive ability. 
The purpose of this study was to test a GRSS comprised of replicated genome-
wide significant variants as well as additional variants with suggestive evidence 
catalogued from large scale meta-analyses for association with BMI in 2,653 European-
Americans and 973 African-Americans from the Molecular Genetics of Schizophrenia 
control sample (MGS-C). Based on the expected BMI effect sizes of 0.05-0.3 kg/m2 per 
allele change in BMI, the MGS-C sample would have limited power to detect genome-
wide significant variants for individual loci. However, the aggregate risk should be 
adequate if a sufficient proportion of the reported variants are real. Therefore, these 
analyses serve as a replication attempt of top variants catalogued from large-scale meta-
analyses via a sum score approach.  
 
MATERIALS AND METHODS 
 
Participants and phenotypes 
 
The MGS-C sample has been previously described in detail (144-146). In summary, 
Knowledge Networks, Inc., a survey research company, recruited self-identified non-
Hispanic European-American and African-Americans from a nationwide panel of survey 
participants, which was assembled by random digit dialing except 772 of the African-
Americans were recruited through a subcontract to Survey Sampling International by 
internet banner ad recruitment. The institutional review board approval was obtained at 
NorthShore University HealthSystem and participants completed an online consent with 
an identical hard-copy consent signed at venipuncture. Participants completed an online 
questionnaire, available at nimhgenetics.org, which included items on height and current 
weight. BMI was calculated from respondents’ self reported height and current weight. 
Participants were removed from data analysis if there was missing data on either height 
or weight or if calculated BMI was less than 15 or greater than 60 as values not in this 
range were likely data entry errors. There were 2,653 European-Americans and 973 
African-Americans included in the present study. Phenotypic details are displayed in 
Table 2 with full sample characteristics found in Sanders et al. (146). 
 
Genotyping 
 
Venipuncture for DNA extraction and establishment of lymphoblastoid cell lines was 
completed at Rutgers University Cell and DNA Repository. DNA samples were 
genotyped using the Affymetrix 6.0 array at the Broad Institute. There were 3,827 
participants genotyped (n=2,817 European-American, n=1,010 African-American) of 
which 3,626 (95%) passed stringent quality control criteria. Principal component (PC) 
scores reflecting continental and within-Europe ancestries of each subject were computed 
and outliers were excluded. Genomic control λ values for autosomes after quality control 
procedures were 1.005 for African-American and 0.998 for the European-Americans.   
 
Selection of 56 SNPs 
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Preliminary SNP selection identified 78 variants meeting criteria for genome-wide or 
suggestive significance in either of two large meta-analyses of BMI, 43 from 
Thorleifsson et al. (2009) and 35 from Willer et al. (64, 65). Thorleifsson and colleagues 
report genome-wide significant (p < 1.6x10-7) associations with 29 SNPs in 11 
chromosomal regions, using a discovery sample of n=34,416 and replication sample of 
n=5,586. The Willer et al. meta-analysis detected 8 genome-wide significant (p<5.0x10-8) 
SNPs in first- and second-stage samples of n=32,387 and n=54,316, respectively.  Only 
variants in or near FTO and MC4R were found to be genome-wide significant in both 
meta-analyses. The remaining genetic loci were suggestive in the opposing meta-analyses 
(p<0.05) except rs7138803 on 12q13 (p=0.14). Significance level for one SNP, 
rs10938397 on 4p12, could not be compared between meta-analyses because there was 
no corresponding proxy SNP. Of the 78 variants catalogued, 29 had matching SNPs on 
the Affymetrix 6.0 array.  For the 49 SNPs not present, proxies (45 r2>0.8; 4 
r2>0.7) were identified using SNP Annotation and Proxy Search V2.1 (147).  Following 
removal of 7 duplicate proxies and 6 variants from Willer et al. for which no proxies 
were available (r2>0.7), 65 SNPs remained. Haploview version 4.10 was used 
to determine phase and corresponding proxy alleles (148, 149). In order to avoid bias due 
to correlated effects, SNP pruning (r2>0.8) was performed using PLINK v. 1.07p 
(150).  Of the 56 remaining SNPs, 19 met genome-wide significance criteria in the two 
meta-analyses.  The additional 37 were included as they were the next top SNPs reported 
(p<0.05). Although our SNP selection threshold was more liberal than the traditional 
genome-wide significance threshold, it was more conservative than other models of 
complex disease risk prediction (151, 152). Table 5 details information on the 78 
catalogued SNPs. 
 
Genetic risk sum score 
 
Under an additive model, 56 variants were used to construct the GRSS. The use of an 
additive model was chosen as specific non-additive effects have yet to be associated and 
confirmed in the literature. The GRSS was calculated by summation of the number of 
risk alleles across the 56 variants divided by the number of SNPs in the score to obtain an 
average number of risk alleles per locus. GRSS were calculated using the profile option 
in PLINK. If SNP information was missing in an individual then the scoring routine 
imputed expected values based on sample allele frequency. R version 2.20.0 was used to 
fit linear regression models using standard covariates and GRSS as predictors with BMI 
as the outcome variable. To facilitate interpretation of effects in linear models 
independent variables were centered.  
 
Prediction of obesity 
 
One method to assess diagnostic efficiency is to graph a receiver operator criteria (ROC) 
curve, which is a plot of the true positive rate (sensitivity) against the false positive rate 
(1 - specificity) and calculate the corresponding area under the curve (AUC). An AUC 
may range from 0.5, non-informative, to a maximum of 1.0, perfect discrimination 
between cases and controls. An AUC is the probability that the predictor is greater for 
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cases than controls (153, 154). Generally, an AUC of 0.80 is suitable for screening while 
0.99 is acceptable for diagnosis (155). To test various BMI thresholds, current BMI was 
dichotomized to create categories of overweight and obesity class I, II and III which had 
corresponding ranges of BMI> 25, 30, 35 and 40 kg/m2 respectively. Binary logistic 
regression was used to calculate predicted probabilities of the models and was used as the 
predictor to generate ROC curves. Discriminative accuracy of the GRSS and covariates 
(molecularly derived ancestry, sex, age, ancestry by sex interactions) to predict BMI 
category was estimated by calculating the AUC from ROC curves using PASW Statistics 
version 17.0.  
 
RESULTS 
 
Phenotypic detail 
 
Descriptive statistics for age and BMI are presented by race and sex in Table 2. The mean 
age of participants was 48.8 and ranged from 18 to 90 and as depicted in Figure 3 
produced a relatively normal distribution. BMI was not significantly associated with age 
(p=0.135, Figure 4). Males were significantly older than females and European-American 
females and males were significantly older than African-American females and males 
(p<0.0001). When partitioning the sample by clinically established BMI (kg/m2) 
categories, 29.0% was either under or normal weight (BMI<25), 33.4% was overweight 
(25≤BMI <30), 20.4% was obese class 1 (30≤BMI<35), 9.5% was obese class II 
(35≤BMI<40) and 7.7% was obese class III (40≤BMI). There was a significant ancestry 
by sex interaction with BMI. As expected, females had significantly greater BMI than 
males with African-American females having greater BMI than European-American 
females and African-American males having greater BMI than European-American 
males (p<0.0001). Phenotypic findings in the MGS-C sample are consistent with cross-
sectional data from the National Center for Health Statistics and National Health and 
Nutrition Examination Study (156), finding obesity more prevalent in women and 
African-Americans. Additional sample characteristics have been previously reported 
(146). 
 
Genetic risk sum score 
Fifty-six variants catalogued from two large-scale BMI meta-analyses were used to 
construct the GRSS (64, 65). These variants were summarized in the GRSS, which was 
calculated by the summation of the number of risk alleles across the SNPs for each 
individual divided by the number of SNPs in the score to achieve an average allele count. 
The frequencies of GRSSs are shown in Figure 1 and produced a relatively normal 
distribution. The mean GRSS, or average number of risk alleles present per locus, was 
0.494 (SD=0.052) with a range from 0.318 to 0.691, which corresponds to an average of 
55 risk alleles per person with a range from 35 to 77.  
Results from linear regression analyses are presented in Table 3. Standard 
covariates known to influence BMI (ancestry, sex and age) were included in the models. 
Described previously (144, 145), 224 ancestry informative markers were used to 
construct 10 PC scores designed to discriminate between European, African, Ameri-
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Indian and Asian ancestry. PC1 (distinguishes European from African ancestry) and PC4 
(distinguishes Eastern and Western European ancestry) were significantly associated with 
BMI and therefore included as covariates. Interactions between the covariates were tested 
and significant interactions were found between PC1 and sex and PC4 and sex. No other 
interactions between the covariates were significant. Model 1, the base model, included 
the standard covariates and the significant interactions between ancestry PCs and sex and 
accounted for 3.5% of the variance in BMI.  Model 2, which added the GRSS to the base 
model, fit significantly better (F (1,3027) =21.8, p=3.2x10-6) and accounted for an 
additional 0.66% of phenotypic variance in BMI for a total of 4.1%. We note that the 
GRSS accounted for more of the variance in BMI than either sex or age. Interactions 
between the covariates and the GRSS were tested but no significant interactions were 
found (presented in Table 6). Therefore, our results suggest that GRSS was equally 
associated with BMI in men and women, in European- and African-Americans and across 
all ages. The relative contributions of the individual loci to the GRSS were examined post 
hoc by dropping the most significantly associated SNP from the score iteratively until the 
score was no longer statistically associated with BMI. As depicted in Figure 2, the GRSS 
reached non-significance after dropping the top 23 variants.  
 
Prediction of obesity 
 
To test the discriminative accuracy of the GRSS and covariates (molecularly 
derived ancestry, sex, age, ancestry by sex interactions) to predict obesity, ROC curves 
were plotted and the corresponding AUC were calculated. To test various BMI 
thresholds, current BMI was dichotomized to create categories of overweight and obesity 
class I, II and III. Figure 2 displays statistics from ROC curve analysis by BMI category. 
AUC estimates indicated that the model significantly predicted overweight and obesity 
classification with maximum discriminating ability when predicting class III obesity 
(AUC=0.697, 95% CI= [0.663, 0.731]). We note that the clinical setting may prefer to 
use self-identified ancestry as opposed to molecularly derived ancestry in risk prediction 
because of genotyping cost. In the MGS-C data, the use of self-identified ancestry did not 
greatly change AUC estimates. For example, when predicting BMI >30 kg/m2, an 
AUC=0.588 was reported when using molecularly derived ancestry versus an 
AUC=0.586 when using self-identified ancestry in the model (full data not shown). 
 
DISCUSSION 
 
In this paper, we have constructed a GRSS comprised of 56 common polygenic variants 
and shown its association with BMI in 2,653 European-Americans and 973 African-
Americans from the MGS-C sample. The GRSS was highly associated with BMI (p-
value = 3.19x10-6) and accounted for 0.66% of phenotypic variance in BMI. The 
association of the GRSS with BMI was comparable to sex, a known factor to influence 
body composition. The average effect of carrying 10 risk variants was an increase in BMI 
of 1.1 kg/m2. This corresponds to a weight increase in an average male (5 feet 9 inches, 
180 pounds) of 8 pounds and an average female (5 feet 4 inches, 155 pounds) of 7 
pounds.  Further, we have shown the association of the GRSS with BMI was not the 
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result of the few most significant SNPs but rather the aggregate of many SNPs of small 
effect. These results are consistent with the common disease common variants hypothesis 
indicating genetic variants common in the population with small effects contributes to the 
heritability of common traits and diseases. 
ROC curves and the corresponding AUC estimates indicated statistical 
discriminative ability to predict obesity (BMI >30 kg/m2, AUC=0.588, 95% CI= [0.567, 
0.610]). AUC estimates were similar to those found in previous studies. For example, 
Renstrom et al. (140)  used a genetic score of 9 SNPs and reported an AUC estimate of 
0.575 in a sample of 353 obese and 1,370 normal weight diabetic and non-diabetic 
northern Swedes. Additionally, a study by Cheung et al. (2010) estimated an AUC of 
0.582 with a genetic score including 13 SNPs in a Chinese sample of 470 obese cases and 
700 normal weight controls. Although these AUC estimates were statistically significant, 
they were below 0.8, the threshold used in clinical practice for screening. In the MGS-C 
sample, however, the ability to predict morbid obesity (class III) was notably better and 
approached clinical criteria for a screening test (AUC=0.697, 95% CI= [0.663, 0.731]).  
In the MGS-C sample, 4.1% of the phenotypic variance in BMI was accounted for 
using a model including sex, ancestry based on molecular derived principal components, 
age, and a GRSS comprised of 56 SNPs. Despite high heritability of BMI, much variance 
in BMI remains unaccounted for. Based on the progress in identifying loci influencing 
height, it is likely that a considerable portion of the ‘missing heritability’ resides in 
unidentified variants yet to be discovered by larger sample sizes (157). Large-scale 
international collaborative groups will be required to identify these additional variants 
with similar and smaller effect sizes.  
Additionally, predictive models have yet to include other sources of variation 
known or hypothesized to influence BMI such as rare variants, gene-gene (GxG) or gene-
environment (GxE) interactions, copy number variation, and epigenetic effects. For 
instance, rare variants which were not included in the current genetic risk profiles are 
likely to contribute to BMI heritability. For example, in a study by Blakemore et 
al.(2009), a rare variant in the visfatin gene was associated (p-value=8.0x10-5, minor 
allele frequency 1.6% in control and 0.4% in obese subjects) with reduced risk for 
obesity. There is also evidence to support the influence of copy number variation (CNV) 
on BMI. In the Willer et al.(2009) meta-analysis, when examining CNV by SNP-CNV 
linkage disequilibrium, they found 10-kb and 45-kb deletion polymorphisms upstream of 
NEGR1 with the 45-kb deletion flanked by their two most associated BMI SNPs. The 
recent advent of SNP arrays designed for CNV detection may reveal additional genetic 
associations with BMI. Epigenetic variation, although more widely researched in 
syndromic obesity such as Prader-Willi, may also be linked to common obesity. Finally, 
GxG interactions have yet to be included in risk prediction of body composition. Twin 
studies support the role of non-additive genetic effects although most study designs have 
limited ability to detect them (35, 158). 
Since obesity has increased dramatically while the genome has arguably remained 
stable, future research needs to address moderation effects of the environment. Known 
obesogenic factors such as physical activity and food intake have been shown to account 
for a significant portion of the variance in BMI with estimates ranging 5-10% (159-162). 
Additionally, research is beginning to elucidate GxE affecting BMI (163-167). At least 
two genes included in the current GRSS show evidence for GxE effects. For example, 
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Rampersaud et al.(2008), in a study of 704 Old Order Amish, found the effects of FTO 
variants associated with elevated body weight were attenuated in subjects with higher 
physical activity levels. Additionally, interactions between MCR4 and dietary intake and 
selection have been shown in model organisms (168-171). For example, mice when given 
a 3-choice diet and administered a melanocortin agonist preferentially decreased fat 
consumption (172). Further, variation in human MCR4 has been associated with binge 
eating (173-175) and with higher total energy intake and selection of foods high in 
dietary fat (165). BMI prediction models will benefit from incorporating known 
obesogenic environmental variables such as physical activity and food selection and 
intake. 
The purpose of this study was to test a GRSS as an alternative approach to 
replication of association of common polygenic variation with BMI. As hypothesized the 
MGS-C sample had limited power to replicate individual loci when employing genome-
wide significant thresholds even though there was strong a priori evidence of these 
variants to influence BMI. However, by constructing a GRSS summarizing the total 
number of risk alleles, the aggregate risk was found to be highly significantly associated 
with BMI. This study provides evidence of the utility of GRSS as an alternative approach 
to replication of common polygenic variation in complex traits. Furthermore, the results 
from the AUC analysis demonstrate meaningful progress towards a screening test that 
perhaps if used in conjunction with known obesogenic predictors such as physical 
activity and food selection and intake could identify persons for early environmental or 
medical intervention to prevent morbid obesity and the associated negative health 
consequences. 
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TABLES AND FIGURES 
 
Figure 1: Frequencies of genetic risk sum score 
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Figure 2: Number of SNPs in genetic risk sum score by –log significance of score  
 
 
Note: GRSS = genetic risk sum score, -log = negative logarithm base 10, SNPs = single 
nucleotide polymorphisms. 
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Table 2: Descriptive statistics of MGS-C sample by race and sex 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note: AA = African-American, EA = European-American, Age = age in years, BMI = 
body mass index kg/m2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Group n Mean SD 
AA Males 381   
   Age  46.59 13.39 
   BMI  29.62 5.95 
AA Females 592   
   Age  44.89 12.93 
   BMI  31.90 8.12 
EA Males 1269   
   Age  52.72 16.04 
   BMI  28.39 5.41 
EA Females 1384   
   Age  48.59 16.42 
   BMI  28.87 7.48 
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Table 3: Linear models predicting BMI in MGS-C sample 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note: BMI = body mass index kg/m2, GRSS = genetic risk sum score, PC1 = principal 
components score distinguishes European from African ancestry, PC2 = principal 
components score distinguishes Eastern from Western European ancestry, Adj. R-squ = 
adjusted R-squared. 
 
 
Model Estimate SE T p-value 
     
Model 1: Covariates    
F(6,3028)=19.18, p-value < 2.2E-16,  Adj. R-squ = 0.0347 
     
  Intercept 29.18 0.12 238.36 < 2E-16 
  PC1 94.78 11.99 7.90 3.8E-15 
  PC4 -49.19 19.05 -2.58 0.009 
  Sex 1.03 0.24 4.16 3.2E-05 
  Age 0.01 0.01 1.49 0.135 
  PC1*Sex 84.31 24.00 3.51 4.5E-04 
  PC4*Sex -76.07 38.00 -2.00 0.045 
     
     
Model 2: Covariates including GRSS   
F(7,3027)=19.66,  p-value < 2.2E-16,  Adj. R-squ = 0.0413 
     
  Intercept 29.18 0.12 239.17 < 2E-16 
  PC1 110.69 12.43 8.90 < 2E-16 
  PC4 -51.66 18.99 -2.72 0.006 
  Sex 1.03   0.24 4.20 2.7E-05 
  Age 0.01 0.01 1.50 0.132 
  PC1*Sex 85.57 23.91 3.57 3.5E-04 
  PC4*Sex -74.42 37.87 -1.96 0.049 
  GRSS 11.41 2.44 4.66 3.2E-06 
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Table 4: Discriminative accuracy of genetic risk sum score and covariates predicting BMI 
category in the MGS-C sample 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note: BMI = body mass index kg/m2, AUC = area under the receiver operator criteria 
curve, Asy. Sig. = asymptotic significance, Overweight = BMI >25 kg/m2, Obese I = 
BMI >30 kg/m2, Obese II = BMI >35 kg/m2, Obese III = BMI >40 kg/m2, predictors 
included in models: molecularly derived ancestry (principal components PC1 and PC4), 
sex, age, PC1 by sex and PC4 by sex interactions and genetic risk sum score. 
 
 
 
  
Group 
n 
(%) 
AUC 
[CI] 
Asy. 
Sig. 
Overweight  2157 
(71.1) 
0.613 
[0.591,0.635] 
1.21E-22 
       
Obese 1  1139 
(37.5) 
0.588 
[0.567,0.610] 
3.11E-16 
    
Obese 2  519 
(17.1) 
0.647 
[0.621,0.673] 
5.32E-26 
      
Obese 3 232 
(7.6) 
0.697 
[0.663,0.731] 
1.75E-23 
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SUPPLEMENTARY MATERIAL 
 
Figure 3: MGS-C distribution of age in years 
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Figure 4: Mean age in years by BMI category 
 
Note: BMI = body mass index kg/m2, BMI category: 0 = underweight (BMI<18.5), 1 = 
normal-weight (18.5≤BMI <25), 2 = overweight (25≤BMI <30), 3 = obese class 1 
(30≤BMI<35), 4 = obese class II (35≤BMI<40) and 5 = obese class III (40≤BMI), age = 
age in years, box plot is 95% .
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Table 5: 78 SNPs catalogued, alleles, frequencies, proxy and association information 
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Table 6: Linear model predicting BMI including GRSS interactions with covariates 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note: BMI = body mass index kg/m2, GRSS = genetic risk sum score, PC1 = principal 
components score distinguishes European from African ancestry, PC2 = principal 
components score distinguishes Eastern from Western European ancestry, Adj. R-squ = 
adjusted R-squared. 
 
  
Model Estimate SE T p-value 
     
Model : Covariates including GRSS   
F(11,3023)  = 13.06, p-value< 2.2E-16,  Adj. R-squ = 0.0418 
     
  Intercept 29.22 0.13 227.85 < 2E-16 
  PC1 115.40 13.42 8.60 < 2E-16 
  PC4 -50.01 19.34 -2.58 0.009 
  Sex 1.03   0.25 4.17 3.1E-05 
  Age 0.01 0.01 1.58 0.113 
  PC1*Sex 98.06 24.86 3.94 8.1E-05 
  PC4*Sex -76.75 38.06 -2.02 0.044 
  GRSS*PC1 164.20 264.30 0.62 0.534 
  GRSS*PC4 -105.40 372.60 -0.28 0.777 
  GRSS*Sex 7.69 4.99 1.53 0.123 
  GRSS*Age -0.20 0.15 -1.32 0.186 
  GRSS 11.69 2.48 4.71 2.6E-06 
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Chapter 3:  Association of common and rare variation 
influencing body mass index: A combined single nucleotide 
polymorphism and copy number variation analysis 
 
 
Adapted from: Roseann E. Peterson, Hermine H. Maes, Peng Lin, John R. Kramer, Victor M. 
Hesselbrock, Lance O. Bauer, John I. Nurnberger, Jr., Howard J. Edenberg, Danielle M. Dick and 
Bradley T. Webb. On the association of common and rare variation influencing body mass index: 
A combined Single Nucleotide Polymorphism and Copy Number Variation analysis. European 
Journal of Human Genetics (Submitted). 
 
ABSTRACT  
 
As the architecture of complex traits incorporates a widening spectrum of genetic 
variation, analyses integrating common and rare variation are needed. Body mass index 
(BMI) represents a model trait, since common variation shows robust association but 
accounts for a fraction of the heritability. A combined analysis of single nucleotide 
polymorphisms (SNP) and copy number variation (CNV) was performed using 2,348 
European and African-Americans from the Study of Addiction: Genetics and 
Environment. Genetic risk sum scores (GRSS) were constructed using 32 BMI-validated 
SNPs and aggregate-risk methods were compared: count versus weighted and proxy 
versus imputation. The weighted SNP-GRSS constructed from imputed probabilities of 
risk alleles performed best and was highly associated with BMI (p=4.3x10-16) accounting 
for 3% of the phenotypic variance. In addition to BMI-validated SNPs, common and rare 
BMI/obesity-associated CNVs were identified from the literature. Of the 84 CNVs 
previously reported, only 21-kilobase deletions on 16p12.3 showed evidence for 
association with BMI (p=0.003, frequency=16.9%), with two CNVs nominally associated 
with moderate-obesity, 1p36.1 duplications (OR=3.1, p=0.009, frequency 1.2%) and 
5q13.2 deletions (OR=1.5, p=0.048, frequency 7.7%). All other CNVs, individually and 
in aggregate, were not associated with BMI or obesity. The combined model, including 
covariates, SNP-GRSS, and 16p12.3 deletion accounted for 11.5% of phenotypic 
variance in BMI (p=3.34x10-54) and area-under-the-curve (AUC) estimates significantly 
predicted obesity classification with maximum discriminative ability for morbid-obesity 
(AUC = 0.750). Results show that incorporating validated effect-sizes and allelic 
probabilities improve prediction algorithms. Although rare-CNVs did not account for 
significant phenotypic variation, results provide a framework for integrated analytic 
approaches. 
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INTRODUCTION 
 
Obesity, defined clinically by a body mass index (BMI) greater than 30 kg/m2, is a 
serious public health problem that occurs in over 1/3 of American adults (11, 12, 127, 
176) and is associated with numerous medical conditions including cardiovascular 
disease (13), type II diabetes (14, 15), cancer (16) and is comorbid with multiple 
psychiatric disorders (17-21). Although nutritional intake and physical activity affect 
relative body weight, twin and family studies have consistently shown a significant 
genetic contribution to body composition with heritability estimates of 40 to 70% (34-
36).  
Genome-wide association studies (GWAS) have successfully identified single 
nucleotide polymorphisms (SNPs) that contribute to inter-individual variation in BMI and 
common obesity (177, 178). To date, there are 32 SNPs showing robustly replicated 
association with BMI; these individually have small effects ranging 0.06 to 0.39 kg/m2 
change in BMI per risk allele and in aggregate they account for a limited proportion of 
the phenotypic variance (~1.45%) (63). The variant with largest effect, 0.39, is located in 
the first intron of the fat mass and obesity-associated (FTO) gene; this effect size 
corresponds to a weight increase per each risk allele of 2.5 pounds for an individual 5 feet 
7 inches. The frequencies of the 32 risk-alleles range from 4 to 87% in populations of 
European descent (63-65).  
Current GWAS designs are limited to detecting trait or disease associations with 
common variation in accordance with the common disease-common variant (CDCV) 
hypothesis (73). Although the number of robustly associated SNPs is limited, using the 
Genome-wide Complex Trait Analysis (GCTA) approach which uses all genetic variation 
measured, accounted for 17% of the phenotypic variance in BMI (179). However, this 
still leaves substantial heritability unaccounted for and has lead to efforts to identify rare 
variants contributing to common disease. Given the heritability of BMI and the 
observation that common SNPs only account for a portion of the expected phenotypic 
variance, additional classes of genetic variants such as structural and lower frequency 
variation are likely to influence body composition. Indeed there is a growing list of rare 
copy number variants (CNV) associated with BMI and obesity (74-82). 
As the architecture of common complex traits and diseases has been associated 
with a widening spectrum of genetic variation, analyses integrating common and rare 
variation are needed. BMI represents a model trait for this approach, since common 
variation shows robust association but accounts for a limited portion of the heritability. 
Additionally, an increasing number of reports implicate structural and rare variation in 
BMI, which may account for a portion of the ‘missing heritability’. Therefore, this study 
constructed and tested an integrated model of common and rare variation associated with 
BMI and obesity in 2,348 Americans of European and African descent from the Study of 
Addiction: Genetics and Environment (SAGE). We catalogued genetic variants 
associated with BMI and obesity from the literature, including common SNPs and 
common and rare CNVs. Given modest effect-sizes of common variants influencing 
BMI; the power to detect statistically significant genome-wide associations is limited. 
Therefore, instead of testing individual loci sequentially, a genetic risk sum score (GRSS) 
summarizing the total number of risk variants using loci with strong a priori evidence 
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was constructed and tested. We constructed SNP-GRSSs using 32 validated BMI-SNPs 
by both count and weighted methods. Additionally, to compare and extend existing 
methods, SNP-GRSSs using imputed genotype probabilities were constructed. Previously 
we applied the count method to a separate sample (180) and are extending this work to 
test weighted scores as well as scores constructed from imputed genotypes. Furthermore, 
common BMI/obesity-associated CNVs were tested individually as well as in aggregate 
by count scores. Given the limited power to detect low frequency variants (181, 182), 
rare BMI/obesity-associated CNVs were tested as collections by CNV-GRSSs. 
Additionally, since rare CNV burden scores have been associated with obesity (74, 77), 
the genome-wide load of rare CNVs was tested. Integrated linear and logistic regression 
models incorporated the following predictors via a stepwise process: standard covariates, 
SNP-GRSS, BMI/obesity-associated common CNVs, common CNV-GRSSs, rare 
BMI/obesity-associated CNV-GRSSs and rare CNV genome-wide burden scores. 
Furthermore, to assess clinical utility, the best fitting models were tested for obesity risk 
prediction by plotting receiver operator criteria (ROC) curves. 
 
PARTICIPANTS AND METHODS 
 
Participants and phenotypes 
 
Participants were from the Study of Addiction: Genes and Environment (SAGE) 
(183) which was one of eight Phase 1 studies in the Gene Environment Association 
(GENEVA) consortium (http://genevastudy.org/) (184). The SAGE sample was drawn 
from three contributing projects, which have been previously described in detail: the 
Collaborative Study on the Genetics of Alcoholism (COGA) (185, 186), the 
Collaborative Study on the Genetics of Nicotine Dependence (COGEND) (187) and the 
Family Study of Cocaine Dependence (FSCD). The FSCD sample did not have body 
composition variables available for analysis and was not included in this analysis. All 
SAGE participants provided written informed consent for genetic studies and agreed to 
share their DNA and phenotypic information for research purposes. All samples were de-
identified and only subjects who consented to health research were included. The 
institutional review boards at all data collection sites granted approval for the use of the 
data.  
Study variables were assessed by interview, using versions of the Semi-Structured 
Assessment for the Genetics of Alcoholism (SSAGA) (188, 189). BMI was calculated 
from self-reported height and weight. Participants were removed from data analysis if 
they had missing data on either height or weight or if calculated BMI was less than 14.5 
or greater than 60, as values not in this range were considered data entry errors. Clinical 
body weight categories were defined as overweight (BMI > 25), obese class I (BMI > 
30), II (BMI > 35) and III (BMI > 40). Age was included as age at interview in years. AD 
was defined by the SSAGA according to DSM-IV criteria (190) and ND was defined as 
having a Fagerström Test for Nicotine Dependence score of 4 or greater as assessed from 
the SSAGA. Power calculations for genetic effects in the SAGE sample were computed 
using the software Quanto from variant frequency, effect-size, odds-ratio and percent 
variance accounted for by variants reported in original papers (191). 
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Genotyping 
 
Samples were genotyped on the Illumina Human 1M beadchip at the Center for Inherited 
Diseases Research at Johns Hopkins University. Data cleaning procedures included 
detection of gender mis-annotation and chromosomal anomalies, cryptic relatedness, 
population structure, batch effects, and Mendelian and duplication error detection. Details 
of quality control procedures have been previously reported (183). To minimize effects of 
population stratification, principal components (PC) were constructed using 
EIGENSOFT 3.0 (192) and SMARTPCA (193). As recommended by Patterson et al., to 
avoid disruption of the eigenvalue structure, SNPs used to construct PC scores were 
pruned at r2 > 0.7 to correct for dependence between markers (193) and also limited to 
autosomes. 577,039 SNPs were used to generate 10 PCs. To circumvent over-fitting, only 
PCs that were associated with BMI and indicative of ancestral background were used in 
subsequent analyses (192-194). 
 
CNV calling  
 
The Illumina 1M array has 1,072,820 probes (which includes 23,812 non-SNP “intensity-
only” markers) that were used for CNV detection. Three widely-used programs were 
used for CNV calling: CNVPartition (Illumina StudioBead software), PennCNV (195), 
and QuantiSNP (196). Genomic waves were adjusted for CNVs called by PennCNV and 
QuantiSNP (197). Both PennCNV and QuantiSNP report a metric score for quality 
control purposes and as recommended by QuantiSNP documentation, CNV calls with a 
Log Bayes Factor (LBF) less than 10 were removed as well as poor quality samples 
based on quality control measures for CNV analysis as described in our previous work 
(198). CNV calls from the three programs were compared against each other and 
Combined CNV (CNVision.org) was used to integrate the calls from the programs (199). 
To increase the positive predicative rate (198), only CNVs that were called by at least 
two programs were analyzed. Given that calls in centromeric, telomeric and 
immunoglobin regions are prone to harbor false positives, CNV calls in those regions 
were removed from analyses (195, 200). 
 
Selection of BMI/obesity-associated genetic variation 
  
BMI SNPs were catalogued from a large-scale BMI meta-analyses by Speliotes and 
colleagues (63). In brief, the meta-analysis incorporated a two-stage approach in which 
GWAS was performed on 249,796 individuals from 46 studies in the first stage and 
association was performed in an additional 125,931 individuals from 42 studies in the 
second stage. The meta-analyses of both stages identified 32 SNPs reaching genome-
wide significance (p<5x10-8). Of the 32 validated BMI SNPs, 15 did not appear on the 
SAGE sample Illumina 1M array. Ungenotyped markers were ascertained by two 
approaches in order to compare methods: 1) imputation and 2) proxy SNPs. IMPUTE2 
was used to phase the observed genotypes and impute unobserved genotypes (201, 202) 
using the 1000 Genomes phase 1 reference panel (release June 2011, b37) (203). The 
proxy method used the LD structure of the genome to identify highly correlated SNPs 
that appear on the array as proxies for the unobserved SNPs. For the 15 SNPs not present 
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on the array, proxies were identified using SNP Annotation and Proxy Search V2.1 (204) 
except for rs11847697, which did not have a highly correlated proxy SNP (r2<0.7) on the 
Illumina 1M array and was therefore not included in SNP-GRSSs constructed by the 
proxy method. Haploview version 4.10 was used to verify phase and corresponding proxy 
alleles (148, 149). Table 11 details information on the 32 catalogued SNPs.  
BMI and obesity associated CNVs were catalogued from research published 
between January 2008 and January 2012 via PubMed search. Case reports, typical of 
monogenic inheritance, were not included in the catalogue as the focus of the current 
study was on common complex obesity. There were 3 BMI (63, 64, 205) and 83 obesity-
associated CNV regions identified from the literature (75-79, 81, 206-209). Table 12 
details information on the 84 catalogued CNVs. 
 
BMI SNP genetic risk sum scores 
 
Common BMI-associated SNPs catalogued from the literature (n = 32) (63) were tested 
in aggregate by constructing GRSSs. There are primarily two methods for constructing 
genetic scores: count and weighted methods. The count method is the sum of the number 
of risk alleles, whereas the weighted method incorporates the sum of the number of risk 
alleles each weighted by its odds-ratio or effect size. In this study, the weighted scores 
were constructed from regression coefficients reported by Speliotes et. al (63). Count and 
weighted scores using the proxy method were calculated using the profile option in 
PLINK (150). If SNP information was missing in an individual then the scoring routine 
imputed expected values based on sample allele frequency. Count and weighted scores 
using imputed genotypes were constructed using R version 2.13.1 (210). Furthermore, to 
extend existing GRSS methodology, count and weighted scores were constructed using 
probabilities of imputed risk alleles (!) genotypes by the equation below. Count scores 
were calculated with β = 1 and weighted scores with β = effect-size of each risk allele (A) 
reported by Speliotes et. al (63) summed over the number of risk alleles in the score (!). 
 
 
 
CNV association 
 
In the SAGE sample, CNVs were considered common if they had a frequency of 1% or 
greater and determined rare if the frequency was less than 1%. Common CNVs 
previously shown to be associated with BMI/obesity were tested individually and in 
aggregate by count scores. Rare CNVs were tested in aggregate by count scores 
constructed from CNVs 1) previously reported to be associated with BMI/obesity and 2) 
not previously associated with BMI/obesity (genome-wide burden of rare variants). 
CNVs previously reported to be associated with BMI/obesity were considered the same 
region in the SAGE sample if the CNV boundaries shared at least 40% overlap with the 
CNV boundaries reported in the literature. Additionally, since there is evidence that the 
positive predictive rate is increased for large CNVs, which is likely due to the increased 
number of probes in larger variants, common and rare scores were also constructed from 
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only CNVs larger than 100-kb to potentially reduce the number of false positive calls in 
the score (198).  
 
Linear models 
 
R (210) was used to fit linear and logistic regression models using established covariates 
for BMI including ancestrally informative PCs, sex and age. AD and ND were also 
included as covariates since SAGE is a sample selected for these traits. Predictors in 
linear models were included in a stepwise process and independent variables were 
centered to facilitate interpretation of effects. Interactions between all variables with 
significant main effects (n=8) were tested and included in the final model if the p-value 
of the interaction was less than the Bonferroni corrected significance level of 0.002.  
 
Prediction of obesity 
 
To test whether the combined model of common and rare variation had clinical utility for 
obesity risk prediction, diagnostic efficiency was assessed. One method is to graph a 
receiver operator criteria (ROC) curve, which is a plot of the true positive rate 
(sensitivity) against the false positive rate (1 - specificity) and calculate the corresponding 
area-under-the-curve (AUC). An AUC is the probability that the predictor is greater for 
cases than controls (153, 154). An AUC may range from 0.5, non-informative (no greater 
than chance), to a maximum of 1.0, perfect discrimination between cases and controls. 
Generally, an AUC of 0.80 is suitable for screening while 0.99 is acceptable for diagnosis 
(211). Binary logistic regression was used to calculate predicted probabilities of the 
models and was used as the predictor to generate ROC curves. Discriminative accuracy 
of the model to predict BMI category was estimated by calculating the AUC from ROC 
curves using SPSS Statistics version 19.0. The StAR software was used to test for 
statistical differences between ROC curves (212). 
 
RESULTS 
 
Phenotypic detail  
 
Complete data on height, weight, AD, ND, genotypes and CNVs were available for 1850 
European-American and 498 African-American SAGE participants. Descriptive statistics 
for study variables are presented by sex in Table 7. The mean age of participants was 
39.8 and ranged from 18 to 77. The average BMI of the sample was 27.5 kg/m2, which is 
considered overweight, with 26.9% of the sample being obese (Table 10). There was a 
significant race by sex interaction with BMI (t-test=6.84, p=1.01x10-11) indicating that 
females and African-Americans tended to have greater BMI. Males were more likely to 
be AD (χ2=286.02, p=3.65x10-64) and ND (χ2=9.36, p=0.002). The age by AD interaction 
was also significant (t-test=-3.11, p=0.002) indicating that older subjects were less likely 
to be AD. Additional sample characteristics have been previously reported (183). 
 
BMI SNP-GRSS 
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The mean number of BMI risk alleles per person for the 32 validated SNPs was 28.5 
(SD=3.4) with a range from 18 to 39. The frequencies and distribution are shown in 
Figure 5. Power analyses calculated for the SAGE sample indicated 80% power to detect 
only one of the 32 BMI-validated variants; rs1558902 in FTO (Table 11) and a sample 
size of 177,492 would be needed to detect the smallest of the BMI-SNP effects. Indeed 
only two of the 32 BMI-SNPs were significantly associated with BMI in the SAGE 
sample after correction for multiple testing which included SNPs in or near FTO and 
BDNF. However, the sample size of SAGE has 99% power to detect the 32 variants in 
aggregate (GRSS), based upon effect-sizes reported in Speliotes et al. 2010 (63). 
Associations of the SNP-GRSSs with BMI are displayed in Table 8 and were highly 
significantly associated with BMI (p < 1.11 x10-12). To compare common methods for 
computing SNP-GRSSs, as well as extend existing approaches, six GRSSs were 
constructed: 1) proxy SNP score by count and 2) by weighted method, 3) imputed SNP 
score by count and 4) by weighted method and 5) imputed probability of risk allele score 
by count and 6) by weighted method (see METHODS section). In general, the SNP-
GRSSs constructed by weighted methods performed better than count methods (z > 7.3, p 
< 0.0001) and increased the percent of variance accounted for by 0.5-0.9%. Additionally, 
SNP-GRSSs that were constructed from imputed genotype probabilities performed better 
than scores constructed by the proxy method (z > 3.2, p < 0.001) and increased the 
percent of variance accounted for by 0.1-0.4%. The SNP-GRSS constructed from 
weighted imputed allelic probabilities performed the best and accounted for 3% of the 
phenotypic variance in BMI.  
 
CNV association 
 
Eighty-four BMI/obesity-associated CNVs were catalogued from the literature and tested 
for association with BMI and obesity in the SAGE sample. Detailed information may be 
found in Table 12. Of the reported CNVs in the literature, only 11 had sufficient 
information on frequency and effect-size/OR for power calculations and only 2 of these 
had 80% power to be detected in the SAGE sample. Power calculations for CNV 
aggregate risk scores were not performed because most of the variants reported in the 
literature did not cite corresponding effect-sizes or ORs. Of the 84 CNVs catalogued 
from the literature, 46 were called in the SAGE sample; 21 of these were common, 
including 17 deletions and 4 duplications, and 25 were rare, including 10 deletions and 15 
duplications. Of the common CNVs, only a 21-kb deletion on 16p12.3 showed evidence 
for association with BMI (β=-0.057, p=0.003, frequency=16.9%). This CNV was also 
nominally associated with obese class I (OR=0.743, p=0.022) and II (OR=0.630, 
p=0.020). Additionally, two common CNVs were nominally associated with moderate-
obesity (obese class II BMI > 35) in the expected direction. The first was a duplication on 
1p36.1 (OR=3.1, p=0.009, frequency 1.2%) which ranged in length from 49.3 to 150.8 kb 
with a median value of 66.4 kb.  The second was a large deletion on 5q13.2 (OR=1.5, 
p=0.048, frequency 7.7%) and ranged in length from 577.5 to 2238 kb with a median 
value of 1635 kb. CNV-GRSSs were constructed separately for common and rare 
variants. Also, deletions and duplications were tested both together and separately as well 
as limited to large CNVs over 100 kb. None of the CNV-GRSSs, common or rare, were 
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significantly associated with BMI or obesity in the SAGE sample. Descriptive statistics 
as well as association results for CNV-GRSSs are presented in Table 13. 
 
Linear models 
 
Results from linear regression analyses are displayed in Table 9. Ancestry was accounted 
for by three principal components PC1, PC4 and PC8 with PC1 distinguishing between 
European and African ancestries. PC1 and PC8 were associated with BMI in the full 
sample and PC4 was associated with BMI in the European-American sample. The base 
model (Model 1), which included the standard covariates, PC1 by sex and age by AD 
interactions but no genetic component accounted for 8.3% of the variance in BMI. Model 
2, which added the SNP-GRSS and the 21-kb deletion on 16p12.3 to the base model, fit 
significantly better [F(3 2335)=27.9, p=9.79x-18] and accounted for an additional 3.2% of 
phenotypic variance in BMI for a total of 11.5%. Interactions between the covariates and 
the SNP-GRSS were not significant except for sex, which suggested that the SNP-GRSS 
was equally associated with BMI in European and African-Americans and across age. No 
significant interactions between the covariates and the 21-kb deletion on 16p12.3 were 
found, which indicated that the CNV was comparably associated with BMI in males and 
females, European and African-Americans and across the age range observed in SAGE. 
 
Obesity risk prediction 
 
To test the discriminative accuracy of models to predict obesity classification, ROC 
curves were plotted and the corresponding AUCs were calculated. Three sets of nested 
models were tested: 1) covariates (molecularly derived ancestry, sex, age, ancestry by sex 
interaction), 2) covariates, SNP-GRSS and interaction with sex and 3) covariates, SNP-
GRSS and three obesity-associated CNVs (the 21 kb deletion on 16p.12.3, the 66 kb 
duplication on 1p36.1, and the 1440 kb deletion on 5q13.2). Table 10 displays statistics 
from ROC curve analysis by BMI category. AUC estimates indicated the models 
significantly predicted overweight and obesity classification with maximum 
discriminative ability when employing model 3 to predict class III obesity (AUC = 0.750, 
95% CI = [0.702, 0.7971]). Models that included genetic information had significantly 
greater AUCs than models only including covariates (Table 10). 
 
DISCUSSION 
 
We have constructed an integrated model of common and rare variation catalogued from 
the literature and demonstrated its association with BMI in 1850 European-American and 
498 African-American SAGE participants. This is one of the first studies to incorporate 
both SNPs and CNVs into an integrated genetic analysis for BMI and obesity risk 
prediction. The best fitting model included standard covariates, SNP-GRSS and a 21-kb 
deletion on 16p12.3, and accounted for 11.5% of the phenotypic variance in BMI 
(p=3.34x10-54).  
The effects of BMI-associated SNPs were incorporated into the integrated model 
via an aggregate risk score. There were six SNP-GRSSs constructed from 32 validated 
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BMI-associated SNPs; count and weighted methods were compared. The weighted score 
constructed from imputed probabilities of risk alleles performed the best and was highly 
associated with BMI (p=4.3x10-16), accounting for 3% of the phenotypic variance. 
Comparisons of SNP-GRSS methodology indicated the variance in BMI accounted for 
was increased by a third when weighted methods and imputed probabilities of risk alleles 
were incorporated. These findings highlight the value of large-scale meta-analysis 
validation efforts to characterized effect sizes for genetic variants. Our results suggest 
that incorporating well-characterized effect sizes into GRSSs as well as utilizing 
genotypic probabilities from imputation procedures may improve BMI prediction 
algorithms. Future research should test these methods for improved risk prediction in 
other complex traits and diseases. 
Although there were 84 BMI/obesity-associated CNVs catalogued from the 
literature, only 46 were detected in SAGE and only one was significantly associated with 
BMI. Speliotes et al., first reported the deletion on 16p12.3 in a large-scale BMI meta-
analysis because a common BMI-decreasing allele was highly correlated with the same 
21 kb deletion (63). In the present study, the CNV was also moderately associated with 
obesity classes I and II. The closest gene to the deletion is GPRC5B, which codes for a 
G-protein coupled receptor (family C group 5 member B); this receptor is of unknown 
function, and resides 50 kb upstream of the CNV (RefSeq, July 2008). Our results 
provide further evidence of a common CNV associated with body composition and 
suggest follow-up functional studies are warranted to verify its relevance to mechanisms 
underlying body composition.  
Additionally, two common CNVs were nominally associated with moderate 
obesity (obese class II BMI>35) in the expected direction. Both of these CNVs were 
originally reported to be associated with obesity in Jarick et al. (208). The first was a 
duplication on 1p36.1 and was originally reported to be associated with early-onset 
extreme obesity in 423 parent-offspring trios (208). The two closest genes were found 
within 50 kb downstream: SYF2, which codes for a nuclear protein which may be 
involved with pre-mRNA splicing, and C1orf63, an open reading frame (RefSeq, July 
2008). The second common CNV of nominal significance with moderate obesity in the 
SAGE sample was a deletion on 5q13.2 (OR=1.5, p=0.048). This CNV was reported to 
be associated with early-onset extreme obesity in 423 parent-offspring trios and in a case-
control sample of 453 extremely obese children/adolescents and 435 normal-weight and 
lean adults (208). This large deletion encompasses numerous genes, which are detailed in 
Supplemental Table 2. 
With the exception of the three aforementioned CNVs, our results did not yield 
additional support for previously reported BMI/obesity-associated CNVs, either 
individually or in aggregate. There are several potential reasons for this. First, it is 
possible that the effect-size and frequency of variants were not large enough to be 
detected in the SAGE sample, even when examined in aggregate. Given the limited 
information on effect-sizes of the CNVs reported in the literature, assessing the power to 
detect these variants in the SAGE sample is not straightforward. Additionally, it is 
conceivable that the collections of CNVs examined here contained a greater number of 
false positives than true variants, which masked the potential for replication by risk 
scores. In fact, only 4 of the 84 CNVs identified from the literature have been associated 
with BMI/obesity in multiple studies (Supplemental Table 2). Large-scale BMI/obesity-
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associated CNV meta-analyses are needed to validate variants and to characterize the 
magnitude of their effects. Another issue with CNV analysis is that the CNV calling 
methodologies from microarrays are limited, as most SNP-arrays were designed to 
measure common variation across the genome and not to primarily detect CNVs (213, 
214). Furthermore, the resolution of arrays to call CNVs, as well as their boundaries, is 
limited by probe density and the use of different algorithms when applied to the same 
data may give inconsistent results (198, 215-221).  
 We also assessed whether the integrated models were clinically useful for obesity 
risk prediction. Our results indicated statistical discriminative ability to predict obesity 
classification from a model including standard covariates, SNP-GRSS and three obesity-
associated CNVs (the 21 kb deletion on 16p.12.3, the 66 kb duplication on 1p36.1, and 
the 1440 kb deletion on 5q13.2). AUC estimates showed the models significantly 
predicted overweight and obesity classification with maximum discriminative ability 
when predicting class III obesity (AUC = 0.750, 95% CI = [0.702, 0.7971]). Previously, 
we had constructed a SNP-score by the count method comprised of 56 genome-wide 
significant as well as suggestive variants to predict obesity in the Molecular Genetics of 
Schizophrenia control sample and also found maximum discriminative ability when 
predicting class III obesity (AUC = 0.697, 95% CI = [0.663, 0.731]) (180). The present 
findings represent a 5% increase in the AUC although fewer markers were used but 
CNVs were also included. Other studies have used SNP-GRSS to predict obesity, which 
have incorporated 8-32 SNPs with corresponding AUC estimates ranging from 0.575 to 
0.597 (63, 140, 142, 143). This study is one of the first to incorporate both SNP and CNV 
information into an integrated model predicting obesity classification. Although the AUC 
estimates were statistically significant, they were below 0.8, the threshold used in clinical 
practice for screening. However, the ability to predict morbid obesity (class III) 
approached clinical criteria for a screening test and performed better than previous 
genetic risk models predicting obesity. 
 There are several possible extensions of the work presented here. First, SAGE 
participants consisted of a selected sample for substance-use behaviors. It is possible that 
the findings reported here are not generalizable to the American population at large. 
Although we have included alcohol and nicotine dependence as covariates in all analyses, 
research has shown these phenotypes to have complex relationships with body 
composition (113, 222), and this may complicate interpretation to the general adult 
population. Additionally, despite incorporating aggregate risk scores, which analyze 
collections of variants simultaneously to increase power and reduce problems associated 
with multiple testing, it is possible that the SAGE sample may still lack adequate power 
to confirm associations in the literature. It is important to note, however, that inclusion of 
variants, which are not well validated in such scores, can reduce the efficiency of this 
method. It is likely that the strong association of the SNP-GRSSs and not the CNV-
GRSSs with BMI is a result of the fact that the BMI-SNPs have been validated by large-
scale meta-analysis while most of the CNVs have not. Therefore, future research should 
test for associations in both larger and population-based samples. 
 For many of the BMI/obesity-associated loci, it has yet to be determined if they do 
indeed represent the causative locus or if they are merely correlated with the causative 
variant. Fine mapping efforts are needed and will likely identify lower-frequency 
variants, which are typically not genotyped on commercial GWAS-arrays. As such, a 
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further extension of the work presented here is to include lower-frequency SNPs and 
INDELs identified by large-scale exome and genome sequencing efforts. Such studies are 
underway and include the UK10K project, a whole-genome sequencing study of 4,000 
individuals and exome sequencing of an additional 6,000 individuals including 2,000 
with extreme obesity phenotypes (83).  
 Furthermore, an important extension of an integrated model of BMI and obesity is 
to incorporate the moderating effects of the environment. Energy balance affects body 
composition, and research indicates that physical activity and food intake account for a 
significant portion of the variance in BMI, with estimates ranging from 5 to 10% (159-
162). Additionally, at least two of the BMI-validated SNPs exhibit gene by environment 
interactions (GxE) (163, 165, 167, 173, 174, 223). For example, a large meta-analysis 
found that in physically active adults the effect of the FTO risk allele on obesity was 
attenuated by 27% (224). Given the considerable impact of the environment on body 
composition, future research needs to incorporate environmental variables into models of 
disease and risk prediction. Despite the potential limitations of the current study, this 
work provides a framework for integrating common and rare variation as both an 
alternative form of replication of genetic effects as well as for risk prediction of complex 
traits.  
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TABLES AND FIGURES 
 
Figure 5: Frequency of BMI risk alleles per person (SAGE) 
 
 
Note: BMI = body mass index kg/m2. 
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Table 7: Descriptive statistics by sex in the SAGE sample 
 
 
 
 
 
 
 
 
 
 
Note: Age = age at interview, BMI = body mass index kg/m2, Obese = BMI > 30 kg/m2, 
AD = alcohol dependence, ND = nicotine dependence. 
 
  
Group Males Females 
 Mean SD Mean SD 
   Age 40.6 9.4 39.3 8.6 
   BMI 27.7 4.7 27.5 7.0 
 N % N % 
 1011 43.7% 1337 56.3% 
   Obese 256 25.3% 376 28.1% 
   AD 672 66.5% 420 31.4% 
   ND 531 52.5% 617 46.1% 
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Table 8: Comparison of GRSSs constructed by count and weighted methods 
 
GRSS Method 
Mean 
(SD) 
Estimate 
(SE) 
T p-value R2 
1. Proxy Count 0.450 
(0.06) 
15.99 
(2.22) 
7.18 9.07x10-13 0.022 
2. Proxy Weighted 0.063 
(0.01) 
126.22 
(14.75) 
8.56 2.05 x10-17 0.027 
3. Imputed Count 0.447 
(0.05) 
16.28 
(2.27) 
7.16 1.11 x10-12 0.022 
4. Imputed Weighted 0.062 
(0.01) 
128.75 
(15.12) 
8.51 2.94 x10-17 0.030 
5. Imputed Probability Count 0.894 
(0.11) 
8.17 
(1.13) 
7.21 7.33 x10-13 0.022 
6. Imputed Probability Weighted 0.124 
(0.02) 
64.42 
(7.55) 
8.54 2.43 x10-17 0.031 
Note: GRSS = genetic risk sum score, Mean = mean score for GRSS, Estimate = 
regression coefficient for GRSS, Count = GRSS constructed from the summation of the 
number of risk alleles, Weighted = GRSS constructed from the number of risk alleles 
weighted by effect-sizes reported in Speliotes et al. 2010, SNP = single nucleotide 
polymorphism, Proxy = highly correlated substitute SNPs were used for variants not 
directly genotyped on the array, Imputed = genotypes were inferred from 1000 Genomes 
reference panel, Imputed probability = probability of genotypes inferred from 1000 
Genomes reference panel.  
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Table 9: Linear models predicting BMI in the SAGE sample 
 
Model Estimate SE T p-value 
Model 1: Covariates [F(9 2,338) = 23.66, p-value = 4.58x10-39, R2 = 0.083] 
  Intercept 27.63 0.12 227.36 < 2x10-16 
  PC1 -98.82 8.67 -11.40 2.40x10-29 
  PC4 10.54 7.63 1.38 0.167 
  PC8 -30.20 9.59 -3.15 0.002 
  Sex -0.46 0.26 -1.75 0.081 
  Age 0.04 0.01 3.31 9.45x10-4 
  AD -0.20 0.07 -2.81 0.004 
  ND -0.06 0.06 -0.91 0.361 
  PC1*Sex -122.29 17.28 -7.08 1.92x10-12 
  Age*AD -0.02 0.01 -3.60 3.20x10-4 
Model 2: Covariates, GRSS & CNV [F(12 2,335) = 25.34, p-value = 3.34x10-54, R2 = 0.115] 
  Intercept 27.63 0.12 231.26 < 2x10-16 
  PC1 -110.22 8.72 -12.63 1.89x10-35 
  PC4 10.14 7.50 1.35 0.176 
  PC8 -31.53 9.43 -3.34 8.36x10-4 
  Sex -0.43 0.26 -1.65 0.099 
  Age 0.04 0.01 3.35 8.15x10-4 
  AD -0.20 0.07 -2.81 0.005 
  ND -0.07 0.06 -1.14 0.253 
  PC1*Sex -131.38 17.26 -7.61 3.91x10-14 
  Age*AD -0.02 0.01 -3.41 6.59x10-4 
  SNP-GRSS 62.44 7.62 8.19 4.30x10-16 
  Sex*SNP-GRSS 44.37 15.19 2.92 0.003 
  Del 16p12.3 -0.57 0.32 -1.78 0.075 
Note: BMI = body mass index kg/m2, GRSS = genetic risk sum score, PC = principal 
component score reflecting ancestral background, Age = age at interview, AD = alcohol 
dependence, ND = nicotine dependence, CNV = copy number variation, Del = deletion. 
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Table 10: Discriminative accuracy of covariates, SNP-GRSS and CNV predicting BMI 
category in the SAGE sample 
Model AUC 95% CI Asy. Sig. 
Overweight: n = 1443 (61.4%) 
  1. Covariates 0.679 [0.657,0.700] 2.68x10-48 
  2. SNP-GRSS       0.692*** [0.671,0.714] 9.23x10-56 
  3. CNV       0.694*** [0.672,0.715] 1.27x10-56 
Obese Class I:  n = 632 (26.9%) 
  1. Covariates 0.621 [0.594,0.647] 2.74x10-19 
  2. SNP-GRSS       0.661*** [0.637,0.686] 2.77x10-33 
  3. CNV       0.662*** [0.638,0.687] 1.12x10-33 
Obese Class II:  n = 264 (11.2%) 
  1. Covariates 0.648 [0.610,0.685] 5.22x10-15 
  2. SNP-GRSS   0.681* [0.646,0.716] 6.97x10-22 
  3. CNV     0.690** [0.656,0.725] 5.58x10-24 
Obese Class III:  n = 106, (4.5%) 
  1. Covariates 0.711 [0.660,0.762] 1.97x1013 
  2. SNP-GRSS   0.741* [0.692,0.790] 4.81x10-17 
  3. CNV     0.750** [0.702,0.797] 3.15x10-18 
Note: BMI = body mass index kg/m2, SNP = single nucleotide polymorphism, SNP-
GRSS = genetic risk sum score constructed from imputed probability of carrying 32 
BMI-associated SNPs by the weighted method, CNV = copy number variation, AUC = 
area-under the receiver operator criteria curve, Asy. Sig. = asymptotic significance, 
Overweight = BMI > 25 kg/m2, Obese I = BMI > 30 kg/m2, Obese II = BMI > 35 kg/m2, 
Obese III = BMI > 40 kg/m2, Covariates = PC1, PC4, PC8, sex, age, AD, ND, PC1*sex, 
age*AD, PC = principal component score reflecting ancestral background, Age = age at 
interview, AD = alcohol dependence, ND = nicotine dependence, * = difference in AUC 
of the Model and Model 1 (Covariates) is p <0.05, ** = difference in AUC of the Model 
and Model 1 (Covariates) is p <0.01, *** = difference in AUC of the Model and Model 1 
(Covariates) is p <0.001. 
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Table 11: 32 BMI SNPs  
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Table 12: CNVs catalogued from the literature and frequency in the SAGE sub-sample 
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Chapter 4: Association of common polygenic variation with 
body mass index across adolescent development: A 
longitudinal twin study 
 
 
Adapted from: On the association of common polygenic variation with body mass index across 
adolescent development: A longitudinal twin study. Roseann E. Peterson, Bradley T. Webb, 
Elizabeth C. Prom-Wormley, Judy L. Silberg, Lindon J. Eaves, and Hermine H. Maes. 
Presentation. The 42nd Annual Meeting of the Behavior Genetics Association. June 24th, 2012. 
Edinburgh, Scotland, UK. 
 
ABSTRACT 
 
A dramatic increase in the prevalence of obesity in developed countries and the numerous 
adverse consequences associated with elevated body weight in both children and adults 
highlight the necessity of research that aims to understand the genetic and environmental 
trajectories of relative body weight. Genome-wide association studies of body mass index 
(BMI) using large-scale adult samples have yielded 32 robustly associated genetic 
variants. Further research should address when during human development these variants 
begin to influence body weight. Therefore, we sought to utilize a developmental twin 
study design in order to determine the genetic and environmental architecture of BMI by 
variance components analysis and assess the effects of adult-validated BMI-SNPs across 
adolescence. Data analyses included 2,794 twin participants from the Virginia Twin 
Study of Adolescent Behavioral Development (ABD) ranging in age from 8 to 18 years 
old. BMI was calculated from weight and height for up to three waves of data collection. 
Variation in BMI at each age, as well as covariation across the age range was modeled 
using the independent pathway (IP) models which includes both genetic and 
environmental common and time-specific factors. BMI was found to be highly heritable, 
accounting for 74-91% of the variance over the course of adolescent development. Our 
best-fitting model indicated multiple genetic factors that contributed to BMI liability, 
including a genetic factor that loaded across development, a second common genetic 
factor that loaded later in adolescence and time-specific genetic factors important in mid-
adolescence. Additionally, shared environmental effects were found to account for 
significant portions of the phenotypic variance (1-18%) for ages 11-16 in females and 
ages 8-14 in males. A unique environmental factor accounted for 2-13% of the 
phenotypic variance across development. To understand the importance of adult BMI-
associated genetic variants across adolescent development, a genetic risk sum score 
(GRSS) was tested as an effect on latent genetic factors as well as on mean BMI. 
Preliminary results, assessed on a sub-sample of ABD twins, indicated that the GRSS 
was best modeled as an effect on mean BMI at each age group suggesting association 
across development with the magnitude of the effect differing at each time point 
considered. The GRSS accounted for 1-2.3% of the phenotypic variance in BMI across 
adolescence. These results, although preliminary, merit future research, which considers 
pubertal stage, both in the full ABD sample and additional replication cohorts. 
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INTRODUCTION 
 
Recent years have seen a dramatic increase in the prevalence of obesity in developed 
countries (32), with reports from the National Center for Health Statistics indicating over 
35% of American adults and 17% of children and adolescents are obese (2). Childhood 
obesity is a serious public health problem that is associated with both immediate and 
long-term health consequences including increases in blood pressure, cholesterol and 
insulin resistance as well as social and psychological problems (22-25). Furthermore, 
research has demonstrated that obese children are more likely to become obese adults 
(26-30), which is associated with considerable morbidity and mortality including many 
leading causes of death in developed nations such as diabetes, heart disease and some 
types of cancer (2, 30, 225). Adolescence represents an important developmental period 
in which to study obesity because during this time there are rapid changes in physical 
growth, maturation, and nutritional needs as well as many health-related behaviors are 
established. Further research is warranted to understand the dynamic process of genetic 
and environmental influences on BMI from adolescence into adulthood.  
 Twin and family studies have shown consistently that relative body weight is 
under considerable genetic influence both in children and adults, with heritability 
estimates ranging from 50% to 90% (35, 51-54). There have been numerous twin studies 
examining genetic and environmental influences on adolescent BMI and obesity (35, 54, 
55, 57-60, 226-241). However, only five of these studies have reported across the entire 
time-span of adolescence into adulthood (54, 55, 231, 238, 240). Two large twin study 
meta-analyses on BMI from birth to young adulthood have reported on over 12,000 twin 
pairs and found that the contribution of additive genetic effects (A) tend to increase over 
time while environmental factors common to family members (C) is greatest in childhood 
but diminishes in adolescence between the ages of 13 and 17 (54, 55). While impressive 
on scale, these studies do not address the architecture of these effects (i.e., number of 
factors, persistence across time). Three other studies that reported across adolescence, 
while longitudinal in design, applied only limited models (Cholesky parameterization), 
which do not quantify the relative proportion of factors that are common across time 
versus those that are time specific (242, 243) or examine variance components on rate of 
BMI change over time (244, 245). Therefore, further twin studies examining alternative 
models of the genetic and environmental structure across adolescence and into adulthood 
are warranted.  
Genome-wide association studies (GWAS) of BMI using large-scale adult 
samples have yielded 32 robustly associated genetic variants (63-65) accounting for 
1.45% of the phenotypic variation in BMI (63). In a meta-analysis by Speliotes et al., the 
adult BMI-associated variants were also tested for association in sub-samples of children 
and adolescents. Based on case/control studies of extreme childhood obesity (n = 1,301-
12,891), the authors found nine variants associated with obesity (after correction for 
multiple testing), including single nucleotide polymorphisms (SNP) in and near FTO, 
TMEM18 and MC4R; in population based samples (n = 354-8,540), three obesity-
associated variants were identified in or near POMC, CADM2 and TNNI3K; and in 
parent-child trios with one extreme obese child, the transmission disequilibrium test 
(TDT) indicated that only alleles in FTO were significantly over-transmitted to obese 
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children, however, 24 of the 32 effect sizes were in the expected direction (63). 
Furthermore, a study of 1,097 extreme obese and 2,760 lean controls aged 2-18, found 9 
of the 32 adult BMI variants associated with increased risk of obesity including variants 
in and near FTO, TMEM18, NRXN3, MC4R, SEC16B, GNPDA2, TNNI3K, QPCTL, and 
BDNF and also reported 28 variants that were directionally consistent (246). Although, 
somewhat underpowered, these results indicate adult BMI-associated variants may also 
be important in childhood and adolescent obesity. A recent GWAS meta-analysis of 
5,530 obese and 8,318 control children and adolescents aged 2-18, Bradfield et al. 
reported nine variants significantly associated with obesity. Of these, 7 were previously 
shown to be associated with adult BMI (FTO, TMEM18, POMC, MC4R, FAIM2, 
TNNI3K and SEC16B) and two were in novel loci for childhood obesity (OLFM4 and 
HOXB5) (247).  
While the aforementioned studies implicate a number of genetic variants 
associated in childhood, adulthood and potentially across the lifespan, they do not address 
when in development genetic effects begin to influence relative body weight. Therefore, 
we sought to utilize a developmental twin study design in order to determine the genetic 
and environmental architecture of BMI by variance components analysis and assess the 
effects of adult-validated BMI-SNPs across adolescence into adulthood. BMI was 
calculated from weight and height collected on up to three waves of data collection and 
ages ranging from 8 to 18 in 2,794 twin participants from the Virginia Twin Study of 
Adolescent Behavioral Development (ABD).  
 
METHODS 
 
Participants 
 
Participants were from the Virginia Twin Study of Adolescent Behavioral Development 
(ABD), a longitudinal population-based twin study of adolescent psychopathology. 
Ascertainment and data collection have been described previously in detail (248-250). In 
brief, Caucasian twins aged 8 to 17 were recruited through Virginia schools and were 
followed-up every 18 months for up to three waves of data collection. Of 1,894 eligible 
Virginia families, 1412 participated in the ﬁrst wave of data collection (74.5%); 1,047 of 
1,302 families that continued to meet the age and Virginia residence requirements 
completed a second home interview (80%); 628 of 777 eligible families (81%) 
participated in a third wave of assessment. BMI was calculated from weight and height 
measurements were collected by trained field interviewers during home interviews who 
followed a standard protocol using portable scales and tape measures and was available 
for 2,794 of the ABD twin participants (54% female). For sufficient number of 
observations over time, age was binned to create five time points: 8-10, 11-12, 13-14, 15-
16 and 17-18. If BMI data was collected more than once within a time interval then the 
average of the assessments was used. 
 
Genotyping 
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In total, there were 913 participants from 639 families (291 twin pairs, 348 singletons) 
genotyped on the Illumina Human 660 array. Our quality control procedures removed 
2619 monomorphic SNPs, 19984 markers with minor allele frequency less than 1%, 
23114 SNPs with greater than 1% missing data and 14 SNPs which deviated from Hardy-
Weinberg Equilibrium (p <10-6). Following these exclusions 497,153 genotyped markers 
remained for analysis. To reduce the effects of population stratification, principal 
components (PC) were constructed using EIGENSOFT 3.0 (192) and SMARTPCA 
(193). Because the ABD sample includes related individuals, standard PC analysis s 
subject to bias. Therefore, the HapMap3 reference panel (988 individuals from 11 human 
populations) (251) was used to determine SNP weights for each eigenvector and the ABD 
data was projected onto these values to generate PCs. As recommended by Patterson et 
al., SNPs used to construct PC scores were pruned at r2 > 0.7 to correct for dependence 
between markers, thereby avoiding disruption of the eigenvalue structure (193). A total of 
254,680 autosomal SNPs were used to generate 10 PCs. To circumvent over-fitting, only 
the first two PCs, distinguishing European from African ancestry, were used in 
subsequent analyses (192-194). 
 
Genetic risk sum score 
 
BMI SNPs were catalogued from a large-scale BMI meta-analyses by Speliotes et al. 
(63), with 32 SNPs identified as reaching genome-wide significance (p<5x10-8). Of the 
32 validated BMI SNPs, 15 did not appear on the ABD Illumina 660 array. Therefore, 
highly-correlated SNPs (r2>0.7) that appeared on the array were used as proxies for 
ungenotyped SNPs. Proxies for the missing SNPs were identified using SNP Annotation 
and Proxy Search V2.1 (204), except rs11847697 and rs13107325, for which proxies 
were unavailable. Haploview v4.10 was used to verify phase and corresponding proxy 
alleles (148, 149). BMI-associated SNPs were tested in aggregate by constructing 
GRSSs. There are primarily two approaches for constructing genetic scores: count and 
weighted methods. The count method is the summation of the number of risk alleles, 
whereas the weighted method incorporates the sum of the number of risk alleles each 
weighted by its odds-ratio or effect size. This study utilized the weighted method and 
constructed GRSS from regression coefficients reported by Speliotes et. al (63). GRSSs 
were calculated using the profile option in PLINK (150). 
 
Variance components modeling 
 
The use of family data allows the particular sources of trait variance to be estimated. In 
the classical twin design, covariances of MZ and DZ twins are used to estimate the 
magnitude of genetic and environmental causes of family resemblance (252). This 
methodology is premised upon monozygotic, or “identical”, twins (MZ) sharing all of 
their genes, while dizygotic, or “fraternal”, twins (DZ) sharing half of their genes on 
average, and MZ and DZ twins sharing environmental experiences to the same extent 
(equal environment assumption). Following this logic, the correlation between genetic 
components is modeled as1.0 for MZ twins and 0.5 for DZ twins. Under the assumptions 
of random mating, no genotype-environment correlation or interaction, and equal 
environments for MZ and DZ twins, a greater similarity between MZ versus DZ twins is 
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attributed to additive genetic effects (A). Common environmental effects, as defined in 
biometrical twin modeling, refer to environmental influences that make family members 
more similar to each other. Therefore, by definition, these influences correlate 1.0 
between both MZ and DZ twins. These shared environmental influences (C) will 
contribute to twin similarity in both MZ and DZ twins and will tend to increase DZ 
correlations relative to MZ correlations. However, non-additive genetic effects, known as 
dominance (D), tend to reduce the DZ correlation relative to MZ twins. The correlation of 
D is modeled as 1.0 between MZ twins and 0.25 for DZ twins. An additional source of 
variance is the unique environment (E), which includes factors in the environment that 
are not shared within families as well as random measurement error. Unique 
environmental influences are uncorrelated between co-twins and have the effect of 
decreasing the covariance between siblings. Furthermore, the principles of variance 
decomposition for the univariate case may be extended to estimating the covariance 
structure between multiple variables. 
One approach to partitioning variance is to use structural equation modeling 
(SEM) (system of linear equations) and path analysis, which allows for flexible 
specification of models that include both latent (unobserved) and measured variables 
(253). In this study, we used SEM to examine the genetic and environmental architecture 
of BMI across adolescence development. As depicted in Figure 8, independent pathway 
(IP) models were specified to partition phenotypic variance into genetic and 
environmental factors that were shared across development as well as components that 
were time specific (243, 253). These models allow for the contributions of the common 
factors on the phenotypes measured over time to be different for each of the sources of 
variance, hence the name ‘independent pathways’. ACE models, as opposed to ADE 
models, were fit as previous research has found shared environment to be important in 
adolescent BMI (35, 53, 54, 231-236, 238, 241, 254, 255) and upon inspection of the 
ABD data, the DZ correlations tended to be greater than half MZ correlations which is 
suggestive of common environmental effects. IP model fitting began with two common 
factors for each source of variance, A, C and E, along with specific A, C and E at each 
time point. To simplify the full model, A and C common and specific factors and E 
common factors were dropped one-by-one from the model. Specific unique 
environmental effects were not dropped as these include errors of measurement. Variance 
components models were fit separately by sex and parameters were estimated by full 
information maximum likelihood using OpenMx (256) in R (210). The log likelihood (-
2LL) and Akaike’s Information Criterion (AIC) were used to assess goodness-of-fit and 
relative parsimony of alternative models. 
The collective effect of adult BMI-associated genetic variants on BMI across 
adolescent development was tested via a GRSS (see METHODS Genetic risk sum score). 
The GRSS was added to the best fitting ACE-IP model and was tested as an effect on 
mean BMI at each time point and separately as an effect on each of the latent genetic 
factors (Figure 12). To reduce the effects of population stratification, PC scores 
representing ancestral background were included as covariates in the models as an effect 
on the mean. As these models include covariates as definition variables, only twins with 
non-missing values may be used in the analyses. As a consequence, the effective sample 
size was reduced considerably (Table 18). However, including phenotypic data on 
ungenotyped relatives has been shown to improve statistical power to detect effects of 
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genetic variants, as a finite mixture distribution may be used to estimate the probability of 
genotypes of those ungenotyped (257, 258). Although applying the mixture distribution 
approach represents the ideal method for this data, we tested the effect of the GRSS by 
two alternative methods in order to generate preliminary results. First, analyses were 
performed on an unrelated subset of the ABD twin sample for whom genotyping data was 
available. Path estimates of the best fitting IP model from the full twin sample were 
entered as fixed effects while the means, the regression on the PCs and the effects of the 
GRSS were estimated on mean BMI at each age and separately as an effect on each of the 
latent genetic factors. Second, we used the parameterization of the best-fit IP model from 
the full sample but allowed the ACE variance components to be estimated as well as the 
effect of the GRSS on a sub-sample of ABD twin pairs that were both genotyped. For 
each method, ten models were evaluated for each sex. Model I estimated the means at 
each age for the specified model (best-fit IP model) and Model II included the effect of 
PC covariates on Model I and was considered the baseline for subsequent model 
comparisons. Model III-VII added the effect of the GRSS separately at each age while 
Model VIII included the effect at all ages. Model IX included the effect of the GRSS on 
the first latent common genetic factor and Model X included the effect on the second 
common genetic factor. The significance of the score was evaluated by comparing 
models that included the effect of the GRSS and those without and goodness-of-fit of 
alternative models were assessed by -2LL and AIC. 
 
RESULTS 
 
Descriptive statistics 
 
Means and variances of BMI across age groups are presented by sex and zygosity in 
Table 14. Females tended to have greater BMI than males at younger ages, while mean 
BMI for males and females were similar in older age groups (Figure 6). As depicted in 
Figure 7, the phenotypic variance of BMI tended to increase over time in both males and 
females, with the largest variance at age 17 for females.  
 
Twin model fitting 
 
The full IP model included two common factors for A, C and E components as well as 
specific A, C and E components for each of five time points across adolescent 
development (age 8-18). Model fit and parameter estimates for full and reduced models 
appear in Table 15 and Table 16. In both females and males, the second C factor and all 
C specifics could be dropped without significant loss in model fit (Model II.c). According 
to AIC, the best fitting parameterization of the common C factor featured loadings on age 
groups 11-16 in females and 8-14 in males (Model II.e). Except for the loadings on age 
11 in females, none of the common A factor loadings could be dropped (Model III).  
However, some of the specific A components could be dropped including age groups 8 
and 17 in females and males and, additionally, age group 13 in males (Model V). 
Furthermore, the second E factor could be dropped in both sexes (Model IV) without 
significant loss in model fit. Partial path diagrams for best-fit models are displayed in 
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Figure 9 and Figure 10. BMI was found to be highly heritable, accounting for 74-91% of 
the variance over the course of adolescent development. The total heritability and 
proportion of heritability due to common and specific genetic factors for BMI across 
adolescence are displayed in Table 17 and Figure 11. The proportion of phenotypic 
variance accounted for by common and specific ACE factors are displayed by age in 
Figure 11. In summary, the first common genetic factor, which loaded on all time points, 
tended to account for less of the variance over time from 88 to 41% in females and 74 to 
39% in males while the second common genetic factor tended to increase over time from 
15 to 49% between ages 13-17 in females and 8 to 50% between ages 11-17 in males. At 
age 11, 18% and 23% of the heritability was due to a specific genetic factor in females 
and males, respectively; 14% and 0% at age group 13; and 1% and 8% at age group 15. 
Thus, the majority of the genetic variance is accounted for by factors that contribute 
across the adolescent timeframe. Additionally, a common C factor accounted for 2-18% 
of the phenotypic variation in females from age 11 to 16 and 1-6% in males from age 8 to 
14. Furthermore, a common E factor was significant across development and accounted 
for 2-6% of the phenotypic variance in females and 5-13% in males and specific E factors 
at each time point accounted for 2-10% of the variance.  
 
Genetic risk sum score (GRSS) 
 
To understand the importance of adult BMI-associated genetic variants across adolescent 
development, variants were tested collectively by using a GRSS with an effect on each of 
the common genetic factors and on mean BMI at each age by two alternative methods. 
The first method assessed the effect of the GRSS in a subsample of unrelated ABD twins 
(359 females, 258 males) against the background of fixed genetic and environmental 
factors estimated from the full twin sample (2,794 twins, 54% female). The best fitting 
model according to goodness-of-fit statistics for both females and males, was Model VIII, 
which included the effect of the GRSS at each age. Results of model fitting appear in 
Table 18. The regression coefficients for the GRSS at each age ranged in effect from 0.05 
to 1.7 kg/m2 change in BMI and were in the expected direction (positive, BMI 
increasing). Next, we assessed the effect of the GRSS while simultaneously estimating 
genetic and environmental factors in a subsample of genotyped ABD twin pairs (242 
female pairs, 152 male pairs). In agreement with the first method, the best fitting model, 
according to goodness-of-fit statistics, was Model VIII, which included the effect of the 
GRSS at each age. The results of model fitting are reported in Table 19. The regression 
coefficients for the GRSS at each age are in the expected direction and ranged in effect 
from 0.5 to 2.4 kg/m2 change in BMI. However, the best fitting model according to the 
AIC, which accounts for model parsimony, differed for males and females; for females, 
Model VI was the best-fitting model, which only included the effect of the GRSS at age 
15 (-0.55 change in BMI); for males, the best-fitting model was IX, which included the 
effect of the GRSS on the first genetic factor (0.74 kg/m2 change in BMI). Linear 
regression indicated that the GRSS accounted for 1-2.3% of the phenotypic variance on 
BMI across adolescence. 
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DISCUSSION 
 
The purpose of this study was to utilize a developmental twin study design in order to 
determine the genetic and environmental architecture of BMI by variance components 
analysis and to assess the effects of adult-validated BMI SNPs across adolescence. 
Consistent with other twin and family studies (35, 54, 55, 57-60, 226-241), BMI was 
found to be highly heritable in the ABD sample, accounting for 74-91% of the variance 
over the course of adolescent development.  
To date, only limited models of the genetic and environmental architecture of 
BMI have been applied across adolescent development (35, 36, 53). To extend results 
reported in the literature, independent pathway models were fit to examine genetic and 
environmental factors, which persisted across time, as well as, time specific. The best-
fitting model indicated multiple genetic factors that contributed to BMI liability, 
including a factor that loaded across development, a second common genetic factor that 
loaded later in adolescence, and time-specific genetic factors important during mid-
adolescence (ages 11 to 15). It is possible that these specific genetic components are 
reflective of genetic effects related to puberty. Puberty stage has been shown to be highly 
heritable (259) and to have a significant effect on BMI variance, with higher genetic 
variance at later pubertal stages (240). The findings reported here do not incorporate 
effects of puberty and are likely confounded by the use of chronological age without 
consideration of puberty stage. Accordingly, our forthcoming analyses will incorporate 
the effects of puberty on adolescent BMI development.  
Our results indicated that shared environmental effects accounted for a portion of 
the phenotypic variance in adolescent BMI (1-18%), although timing differed between 
the sexes, with significant effects until ages 14 and 16 in males and females, respectively. 
These results were consistent with other twin studies which report environmental effects 
shared within families to be important for BMI, as well as, confirming these effects 
diminished in adolescence between the ages of 13 and 17 (54, 55). Additionally, our 
results indicated a common unique environmental factor, which loaded across 
development, accounting for 2-13% of the phenotypic variance in BMI. These results 
suggested that there were environmental factors specific to individuals that persisted 
across time to influence body composition. These results further supported the 
importance of environmental factors, both within families and specific to individuals, 
contributing to the progression of relative body weight. Previous research has identified 
specific environmental factors shown to influence obesity including food selection, 
physical activity, socioeconomic status and childhood abuse (260-268). For example, the 
heritability of BMI has been shown to decrease with high physical activity (260-262). 
Future research should incorporate known environmental moderators into variance 
decomposition modeling to further clarify the genetic and environmental architecture and 
tracking of relative body weight across the lifespan. 
In addition, to investigate the effect of adult BMI-associated genetic variants in 
adolescence, variants were tested as a collection by a GRSS with an effect on each 
common genetic factor and on mean BMI at each age by two alternative methods. To the 
best of our knowledge, this is the first study to examine the association of adult BMI-
variants across adolescence assessed within the context of genetic and environmental 
components determined by variance decomposition. Preliminary results, evaluated using 
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subsamples of ABD twins, indicated that the GRSS was best modeled as an effect on 
mean BMI at each age group, suggesting association across development, with the 
magnitude of the effect differing at each time point considered and ranged in effect from 
0.05 to 2.4 kg/m2 change in BMI.  
The initial GRSS results reported here should be interpreted in light of several 
limitations. First, since only a portion of the ABD sample was genotyped, association 
analyses were performed on a reduced sample of twins, limiting our power to detect 
significant associations. Despite reported test-statistics reflecting improvement in model-
fit with the addition of genetic scores, confidence intervals on the corresponding effect-
sizes were large and often inclusive of zero, indicating the need for larger sample sizes to 
resolve the nature of these effects. The inclusion of DZ twin pairs of opposite sex (DZo) 
in subsequent analyses would increase the effective sample size, as well as, allow for 
statistical examination of sex effects. Indeed, genetic epidemiology studies of adolescent 
body composition support the presence of sex limitation (51, 54, 56-60), as do molecular 
genetic studies (269, 270). Additionally, research indicates that including phenotypic data 
on ungenotyped relatives improves statistical power to detect effects of genetic variants, 
as a finite mixture distribution may be used to estimate the probability of unobserved 
genotypes in untyped individuals (257, 258). Thus, extensions to this work will not only 
include DZo twins to track sex effects in BMI across adolescence, but also incorporate 
mixture distribution methodology, to increase power to potentially detect relevant 
associations. 
Additionally, our results found that a GRSS comprised of 30 adult BMI-
associated genetic variants accounted for 1-2.3% of the phenotypic variance in BMI 
across adolescence. Other studies examining genetic risk scores in children incorporated 
8 to 17 risk variants and found them to account for 0.8 to 2.2% of the phenotypic 
variance in BMI (271-275). To date, no studies of adolescent body weight have 
incorporated genetic risk scores in the context of twin methodology and variance 
decomposition. However, one longitudinal twin study by Haworth et al., modeled the 
genetic and environmental architecture of BMI in children aged 4 to 11 by Cholesky 
decomposition and then separately examined the effect of a variant in FTO in a subset of 
unrelated twins. The authors reported that the SNP accounted for 0.1% of the variance at 
age 4 and increased over time to 1.0% by age 11 (234). There is a need for additional 
research examining the effects of validated obesity loci across development.  
A number of extensions may be applied to the genetic sum score methodology 
presented herein. For example, other classes of genetic variation such as copy number 
variation (CNV), insertions, deletions and lower-frequency SNPs may be incorporated 
into genetic profiles, as well as comparison of methods based on allelic count versus 
weights. For example, our group has previously examined CNVs reported to be 
associated with BMI and obesity (Chapter 3), replicating an association with a deletion 
on 16p12.3 in an adult sample. Future research should examine these variants in samples 
of children and incorporate these into genetic burden scores. In addition, there are various 
other latent variable models that may be applied in conjunction with genetic risk scores to 
expand insight on the development of relative body weight. Potential models include 
simplex and growth curves, which would allow the assessment of variance components 
and genetic variants on innovations, transmissions and rate of change of BMI across time. 
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In summary, we have utilized a developmental twin study design to examine the 
genetic and environmental architecture of BMI by variance components analysis. We 
found BMI to be highly heritable accounting for 74-94% of the variance across 
adolescence, which was reflected by several genetic factors associated across time and at 
specific ages, as well as environmental factors, both common to family members and 
specific to individuals, persisting across development. Furthermore, we assessed the 
effects of adult-validated BMI-SNPs across adolescence within the context of genetic and 
environmental factors determined by variance decomposition. Our results indicated that 
the GRSS was associated across development and accounted for 1-2.3% of the 
phenotypic variance in BMI across adolescence. These findings, although preliminary, 
merit future research, which considers pubertal stage, both in the full ABD sample and 
additional replication cohorts. Understanding obesity development will aid in identifying 
obesogenic vulnerability time-points and facilitate targeted prevention and treatment 
efforts. 
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TABLES AND FIGURES 
 
Table 14: Descriptive statistics for BMI by zygosity and age group 
 
 FEMALES MALES 
Age 
Zyg 
Mean T1 
(Var) 
Mean T2 
(Var) 
Cor 
(Cov) 
Pairs/ 
Singles 
Mean T1 
(Var) 
Mean T2 
(Var) 
Cor 
(Cov) 
Pairs/ 
Singles 
8 MZ 17.80 
(8.38) 
17.64 
(8.51) 
0.86 
(7.29) 
141/3 17.13 
(8.30) 
16.94 
(7.29) 
0.74 
(5.74) 
87/1 
8 DZ 18.57 
(17.50) 
17.47 
(11.53) 
0.52 
(7.38) 
58/1 17.28 
(11.35) 
17.49 
(13.61) 
0.45 
(5.58) 
64/2 
11 MZ 18.97 
(12.14) 
18.87 
(11.19) 
0.87 
(10.13) 
159/0 19.05 
(13.18) 
18.50 
(12.03) 
0.92 
(11.53) 
132/1 
11 DZ 20.04 
(19.76) 
19.55 
(22.01) 
0.57 
(11.80) 
82/1 18.89 
(18.71) 
18.30 
(17.18) 
0.59 
(10.49) 
81/0 
13 MZ 20.20 
(12.79) 
20.25 
(14.07) 
0.88 
(11.80) 
199/1 20.34 
(13.83) 
19.93 
(13.63) 
0.90 
(12.37) 
165/2 
13 DZ 22.33 
(25.50) 
21.64 
(22.91) 
0.58 
(14.04) 
101/2 20.63 
(21.97) 
19.80 
(26.84) 
0.59 
(14.26) 
92/0 
15 MZ 21.60 
(17.87) 
21.42 
(14.96) 
0.88 
(14.45) 
223/3 21.30 
(11.99) 
21.03 
(10.86) 
0.87 
(9.92) 
170/2 
15 DZ 23.29 
(23.96) 
22.31 
(19.39) 
0.58 
(12.55) 
80/0 22.22 
(17.02) 
21.97 
(23.05) 
0.44 
(8.78) 
98/2 
17 MZ 22.14 
(27.86) 
21.95 
(22.15) 
0.9 
(22.39) 
124/4 23.09 
(18.83) 
22.89 
(21.84) 
0.9 
(18.32) 
120/1 
17 DZ 23.40 
(28.03) 
22.59 
(16.54) 
0.58 
(12.55) 
49/3 23.01 
(22.10) 
22.87 
(14.39) 
0.41 
(7.35) 
50/4 
Note: BMI = body mass index, Age = age group in years, Zyg = zygosity, MZ = 
monozygotic, DZ = dizygotic, T1 = twin one, T2 = twin two, Var = variance, Cov = 
covariance, Cor = within-pair Pearson correlation coefficient, Pairs = number of complete 
twin pairs, Singles = number of twin singletons. 
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Figure 6: Mean BMI by sex and age group in the ABD sample 
 
 
Figure 7: Variance BMI by sex and age group in the ABD sample 
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Table 15: IP-1f Females and Males ABD 
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Table 16: IP-2f Females and Males in the ABD sample 
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Figure 8: Independent pathway diagram for two common ACE factors and specific ACE 
components for five observed variables  
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Figure 9: Partial IP path diagram with path estimates for females in the ABD sample 
 
Figure 10: Partial IP path diagram with path estimates for males in the ABD sample 
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Figure 11: Proportion of phenotypic variance accounted for by common and specific 
genetic and environmental components by sex 
a) Females 
 b) Males 
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Figure 12: Partial path diagram including effects of GRSS on BMI in females across 
adolescence 
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Table 17: Total heritability and proportion of heritability due to common and specific 
genetic factors for BMI across adolescence 
 
Age 
Group Sex 
Total 
Heritability 
% A 
Factor 1 
% A 
Factor 2 
% A 
Specific  
8-10 Female 0.88 100 0 0 
 Male 0.74 100 0 0 
11-12 Female 0.89 82 0 18 
 Male 0.89 68 9 23 
13-14 Female 0.74 66 20 14 
 Male 0.85 96 4 0 
15-16 Female 0.84 60 39 1 
 Male 0.91 73 19 8 
17-18 Female 0.91 45 55 0 
 Male 0.89 44 56 0 
Note: BMI = body mass index, A = additive genetic component.  
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Table 18: Effect of GRSS on common genetic factors and mean BMI by sex in an un-
related subsample of genotyped ABD participants (Method 1) 
  
I. Means 5 4471.75 794 2883.75 - - - - 17.9 18.6 20.9 21.9 22.6
II. Means & PCs 15 4412.09 784 2844.09 - - - - 17.8 19.2 20.9 21.9 23.0
III. Age 8-10 16 4410.25 783 2844.25 1.84 1 0.17 0.287 18.2 19.2 20.9 21.9 23.0
 [-0.129,0.704]
IV. Age 11-12 16 4411 783 2845 1.1 1 0.3 -0.205 17.8 18.9 20.9 21.9 23.0
[-0.590,0.180]
V. Age 13-14 16 4397.2 783 2831.2 14.89 1 <0.001 0.626 17.8 19.2 21.9 21.9 23.0
[0.307,0.944]
VI. Age 15-16 16 4397.27 783 2831.27 14.83 1 <0.001 -0.488 17.8 19.2 20.9 21.2 23.0
[-0.736,-0.239]
VII. Age 17-18 16 4405.52 783 2839.52 6.57 1 0.01 0.609 17.8 19.2 20.9 21.9 23.9
[0.142,1.078]
VIII. Each age 20 4391.6 779 2833.6 20.5 5 <0.001 0.573 0.743 1.027 0.352 0.651 18.6 20.3 22.4 22.4 24.0
[-0.157,1.304] [-0.101,1.587] [0.127,1.927] [-0.557,1.261] [-0.439,1.740]
VIII.a Age 13-18 18 4394.71 781 2832.71 17.38 3 <0.001 0.424 -0.184 0.155 17.8 19.2 21.6 21.6 23.2
[-0.151,0.999] [-0.866,0.497] [-0.775,1.085]
IX. Common A1 16 4410.15 783 2844.15 1.94 1 0.16 0.159 18.5 19.9 21.6 22.6 23.7
[-0.065,0.384]
X. Common A2 16 4412.09 783 2846.09 <0.001 1 0.98 0.004 17.8 19.2 20.9 21.9 23.0
[-0.245,0.252]
I. Means 5 2914.75 571 1772.75 - - - - 17.0 18.9 20.7 22.0 22.6
II. Means & PCs 15 2902.49 561 1780.49 - - - -  16.9 18.9 20.3 22.0 22.7
III. Age 8-10 16 2899.06 560 1779.06 3.43 1 0.06 -0.627 16.2 18.9 20.3 21.9 22.7
[-1.296,0.041]
IV. Age 11-12 16 2894.64 560 1774.64 7.85 1 0.01 1.052 17.0 20.3 20.3 21.9 22.7
[0.311,1.793]
V. Age 13-14 16 2902.42 560 1782.42 0.07 1 0.79 0.079 16.9 18.9 20.4 21.9 22.7
[-0.555,0.714]
VI. Age 15-16 16 2894.71 560 1774.71 7.77 1 0.01 0.845 17.0 18.9 20.3 23.1 22.7
[0.248,1.443]
VII. Age 17-18 16 2891.76 560 1771.76 10.73 1 p <0.001 -1.575 17.0 18.9 20.3 22.0 20.4
[-2.525,-0.625]
VIII. Each age 20 2875.93 556 1763.93 26.56 5 p <0.001 0.535 1.763 1.579 1.679 0.046 17.8 21.3 22.5 24.3 22.6
[-0.372,1.443] [0.700,2.827] [0.461,2.698] [0.602,2.757] [-1.274,1.365]
IX. Common A1 16 2891.2 560 1771.2 11.29 1 p <0.001 0.465 18.5 20.8 22.8 24.2 24.4
[0.193,0.737]
X. Common A2 16 2902.01 560 1782.01 0.47 1 0.49 0.123 16.9 19.0 20.4 22.2 23.2
[-0.231,0.477]
Model: Females EP -2LL df AIC Diff LL Difdf p-value Beta                                                                                              
[95%CI] Estimated Means
Model: Males EP -2LL df AIC Diff LL Difdf p-value Beta                                                                                              
[95%CI] Estimated Means
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Table 19: Effect of GRSS on common genetic factors and mean BMI by sex in a 
subsample of genotyped ABD twin pairs (Method 2) 
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SUPPLEMENTAL MATERIAL 
 
Table 20: ABD sample sizes by age and zygosity 
 
 
 
 
 
   
ABD Sample 8-10 11-12 13-14 15-16 17-18
Total 
Families
ABD BMI Female (pairs/singles) 199/4 241/1 300/3 303/3 173/7 607
     MZ 141/3 159/0 199/1 223/3 124/4
     DZ 58/1 82/1 101/2 80/0 49/3
ABD BMI Male (pairs/singles) 151/3 213/1 255/2 268/4 170/5 495
     MZ 87/1 132/1 165/2 170/2 120/1
     DZ 64/2 81/0 92/0 98/2 50/4
ABD BMI Female GRSS T1 & T2 77/3 101/0 135/0 138/0 91/0 242/45
     MZ (pairs/singles) 64/3 80/0 108/0 118/0 74/0
     DZ (pairs/singles) 13/0 21/0 27/0 20/0 17/0
ABD BMI Male GRSS T1 & T2 41/2 59/0 87/0 94/0 63/0 152/46
     MZ (pairs/singles) 35/0 48/0 68/0 72/0 54/0
     DZ (pairs/singles) 6/2 11/0 19/0 22/0 9/0
ABD BMI Female independent 119 159 194 195 132 359
     MZ 64 80 109 119 74
     DZ 30 44 49 41 27
     DZO 25 35 36 35 31
ABD BMI Male independent 74 105 135 160 102 258
     MZ 35 48 69 72 54
     DZ 24 29 41 47 23
     DZO 15 28 25 41 25
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Chapter 5:  Comparisons of energy intake and energy 
expenditure in overweight and obese women with and without 
binge eating disorder 
 
 
Adapted from: 
1) Bartholome LT*, Peterson RE*, Raatz SK, Raymond NC. *Authors contributed equally to 
this work. A comparison of the accuracy of self-reported intake with measured intake of a 
laboratory overeating episode in overweight and obese women with and without binge eating 
disorder. Eur J Nutr. 2012 Feb 3. 
2) Raymond NC, Peterson RE, Bartholome LT, Raatz SK, Jensen MD, Levine JA. Comparisons 
of Energy Intake and Energy Expenditure in Overweight and Obese Women with and 
Without Binge Eating Disorder. Obesity. 2012 Apr;20(4):765-72. Epub 2011 Oct 20. 
 
ABSTRACT 
 
The purpose of this study was to determine whether there are differences in energy intake 
or energy expenditure that distinguish overweight/obese women with and without binge 
eating disorder (BED). Furthermore, research has demonstrated significant 
underreporting of food intake in obese individuals with and without BED.  An improved 
understanding of the accuracy of self-reported food intake is central to diagnosis of eating 
disorders and monitoring response to treatment. Seventeen overweight/obese women with 
BED and 17 overweight/obese controls completed random 24-hour dietary recall 
interviews, participated in a laboratory eating episode and had total daily energy 
expenditure (TDEE) assessed by the doubly labeled water technique with concurrent food 
log data collection.  Results indicated no between group differences in TDEE, basal 
metabolic rate (BMR) or thermal effect of food (TEF). According to dietary recall data, 
the BED group had significantly higher caloric intake on days when they had binge 
eating episodes than on days when they did not (3255 vs. 2343 kilocalories (kcal)).  
There was no difference between BED non-binge day intake and control group intake 
(2233 vs. 2140 kcal). Similar results were found for food log data and laboratory 
measured intake. Furthermore, when comparing TDEE to dietary recall and food log 
data, both groups displayed significant underreporting of caloric intake of similar 
magnitudes ranging 20-33%. Predicted energy requirements estimated via the Harris-
Benedict equation underestimated measured TDEE by 23-24%. The BED group self-
reported 90% of the laboratory measured intake compared to 98% for the control group.  
Mean differences between the methods indicated that on average both groups under-
reported intake, however the mean difference between methods was significantly greater 
in the BED group. Findings confirm that those with BED consume significantly more 
than controls during a laboratory binge and controls tended to be more accurate in 
recalling their intake 24 hours later. Our data suggest that increased energy intake 
reported by BED individuals is due to increased food consumption and not metabolic or 
reporting differences.  
 
 
 
 
74  
INTRODUCTION 
 
Binge eating disorder (BED) is currently classified in the Diagnostic and Statistical 
Manual of Mental Disorders, 4th Edition (DSM-IV) (190) as a provisional diagnosis 
requiring further study to support its utility as an eating disorders diagnosis.  Two central 
criteria describe binge eating in the DSM-IV: 1) “Eating in a discrete period of time an 
amount of food that is definitely larger than most individuals would eat during a similar 
period of time and under similar circumstances” and 2) “a sense of lack of control” (190).  
This study was designed to examine whether there are differences in energy intake or 
energy expenditure patterns, which distinguish those with binge eating disorder from 
typical overweight/obese controls.  Differences in these biological and behavioral factors 
between groups may help to clarify whether BED is a distinct eating disorder from 
obesity by identifying metabolic and food intake differences between groups. 
In both clinical and research settings, the food intake data necessary to determine 
if an individual fulfills the first criteria above are collected utilizing self-report 
techniques.  Throughout medicine, there are concerns regarding the accuracy of self-
reported data.  Research has demonstrated significant underreporting of food intake in 
obese individuals with (276, 277) and without BED (278-280). For those with BED, 
precise measurements of energy intake are associated with additional challenges since 
eating episodes are often secretive and associated with feelings of embarrassment and 
guilt over how much one is eating (281-283). These characteristics of binge eating may 
influence accuracy of reporting.  
Despite the challenges associated with precise, objective measurement of eating 
behaviors, laboratory studies have been utilized to study food intake in obese women 
with and without BED.  Our group and others have measured food intake in the 
laboratory through the administration of a test meal to simulate a binge eating episode. 
Test meal composition has varied by laboratory and included liquid meals (284, 285), 
single item meals (286-289) and multiple item arrays of food (287, 290-293).  Despite 
differing laboratory methodologies, results have consistently demonstrated that 
individuals with BED have greater total energy intake than non-BED weight matched 
controls when instructed to overeat. Furthermore, there is additional indirect evidence 
that women with BED are eating more than they expend as research has shown the 
proportion of women with BED in obese samples increases as BMI increases (294-296).  
According to previous reports in the literature, having a positive energy balance 
(i.e., chronic overfeeding) leads to increased TDEE (297-299).  TDEE is most accurately 
measured using doubly labeled water (DLW) method, which estimates TDEE within 4-
5% in free living individuals (300).  Reports utilizing the DLW method to measure TDEE 
suggest that obese individuals report approximately 60% of their actual energy intake 
(278, 279). However, few studies have specifically examined the accuracy of self-
reported food intake data in BED. Yanovski’s group examined the accuracy of self-
reported data by comparing average daily food intake assessed by food records to 
estimated daily energy expenditure calculated by the Harris-Benedict equation (HBE) 
(276).  The BED group reported energy intake equivalent to 94% of their predicted 
energy requirements compared to 60% in the non-BED obese group. The authors 
suggested that the BED group may be more accurate in reporting food intake than 
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controls because of the psychological distress associated with binge eating may make the 
experience more memorable and thereby more accurate. However, given the limited 
number of studies, it remains unclear whether those with BED and non-BED individuals 
report food intake with comparable levels of accuracy. If these groups do not have 
consistent reporting patterns, food intake data must be interpreted with caution when 
trying to determine if they manifest distinctive eating patterns. An improved 
understanding of the accuracy of self-reported food intake data is central to distinguishing 
BED from typical obesity, making sound diagnosis, and monitoring response to 
treatment. 
In the current study, we sought to replicate findings by our group and others that 
participants with BED will consume more kilocalories than their non-BED counterparts 
when instructed to overeat in the laboratory. Secondly, we hypothesize that those with 
BED are in a constant state of positive energy balance and therefore will have an elevated 
TDEE compared to the non-binge eating women. This is the first study to utilize the 
DLW method in the assessment of TDEE in BED. Additionally, Measured food intake in 
the laboratory was compared to dietary recall data to ascertain the accuracy of 
participants’ recall of the overeating episode.  We hypothesized that the overweight/obese 
control group would report approximately 60% of measured test meal intake, consistent 
with previous reports (278, 279), while the BED group would be more accurate as 
observed by Yanovksi and colleagues (276).  Further, we sought to confirm the positive 
correlation between total food intake and BMI in those with BED during an overeating 
episode.  A final aim of this paper was to explore the possibility of reduced dietary intake 
as a potential precursor to binge eating in BED.  We compared food intake preceding the 
laboratory overeating episode to test meal intake to ascertain whether caloric intake 
before the test meal influences eating during the test meal. 
 
 
METHODS AND PROCEDURES 
  
Participants 
 
Participants were 17 women who met DSM IV criteria for BED as defined in the 
appendix titled Criteria Sets and Axes Provided for Further Study and 17 women with no 
history of eating disorder symptoms including binge eating or purging behaviors.  In 
order to participate in the study, women were required to be between the ages of 18 and 
55, have no history of substance abuse or dependence within the six months prior to the 
study, and have no unstable comorbid medical or psychiatric conditions.  Participants 
could not be smokers, pregnant, nursing or on a weight reduction diet as all of these 
conditions affect energy metabolism.  Because of the difficulty recruiting participants 
free of psychiatric medications, participants were not excluded if they were on a stable 
dose (for at least 6 months) of antidepressant medication, were psychiatrically stable and 
had no plans to modify their medication during the duration of the study.  Six participants 
with BED and 2 controls were on antidepressants during the time they were participating 
in the study. The study was conducted at the General Clinical Research Center (GCRC) 
of the University of Minnesota.  This protocol was reviewed and approved by the 
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Institutional Review Board at the University of Minnesota and all participants partook in 
the informed consent process and signed a consent form. 
Recruitment was performed by newspaper advertisements inviting overweight 
women aged 18 to 55 years old to participate in a paid research study at the University of 
Minnesota.  A telephone screen was used to assess preliminary eligibility for the BED 
and control groups.  Participants meeting initial criteria were scheduled for a complete 
evaluation at the Ambulatory Research Center (ARC) to determine eligibility.  During 
this evaluation participants were interviewed using the Structured Clinical Interview for 
DSM-IV Axis I Disorders, Patient Edition (SCID-I/P) (301); the Structured Clinical 
Interview for Axis II Personality Disorders (SCID-II) (302); and the Eating Disorder 
Examination, version 12.0D (EDE) (303).  These assessments were used to confirm that 
BED participants fulfilled diagnostic criteria and to rule out any history of eating disorder 
symptoms in the control group.  A physical exam, complete blood count, basic metabolic 
panel, and thyroid and liver function tests were performed to detect unknown medical 
conditions that could influence eligibility.  
As part of the initial evaluation, participants were interviewed by a registered 
dietitian who was blind to their diagnostic status to assess typical food intake patterns, 
food selection, and preferred snack foods.  Participants were presented with a 
standardized list of food items and asked to indicate which appealed to them.  In addition, 
participants were asked if they had other favorite foods or recipes that they consumed 
when overeating.  Based on this information, the dietitian created a snack tray 
personalized to each participant’s eating preferences for the laboratory overeating 
episode.  Snack trays included 6-10 food items, consisting of both savory and sweet, in 
quantities 2-3 times what participants reportedly consumed during an overeating episode.   
Eligible participants were then scheduled for a 24-hour inpatient stay at the 
GCRC during which they would engage in a laboratory overeating episode and 
subsequently complete a telephone dietary recall of 24-hour period including the test 
meal.  Patients were not informed that they were scheduled for a dietary recall interview 
until after completion of the overeating episode.  This was done to ensure that knowledge 
of the recall would not influence eating behaviors in the laboratory. In addition to 
collecting food intake data for the test meal, the dietary recall protocol gathered self-
reported food intake for the periods preceding and following the overeating episode.  This 
enabled a comparison of pre-binge and post-binge food intake to intake during the test 
meal.   
Eligible participants were scheduled for two procedures, six random 24-hour 
dietary recall interviews and a 24-hour inpatient stay on the General Clinical Research 
Center (GCRC).   On the day of admission, participants were instructed not to eat after 
12:00 noon.  While on the inpatient unit, they consumed doubly labeled water for the 
TDEE measurement, received two baseline (DXA) scans and had BMR and TEF 
measured using indirect calorimetry. Details of each of these methods are provided 
below.  Participants’ height and weight were measured on admission.  Weight was 
repeated two weeks later.  The inpatient stay was scheduled to coincide with the luteal 
phase of the menstrual cycle, confirmed by estradiol and progesterone levels, to control 
for hormonal influences on food intake.  
 
Laboratory binge eating episode 
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Participants were instructed not to consume any food or caloric beverages after 12 
pm and to arrive at the GCRC no later than 5:30 pm.  After admission procedures, 
participants were presented with a standard hospital dinner plus an excess of their 
preferential binge foods as ascertained by the dietary assessment.  They were instructed 
to “Let yourself go and eat as much as you like”.  Participants were left alone to eat and 
told to notify the research team when they were finished with the meal.  This same 
laboratory test meal protocol has been utilized in previous work by our group (293).   
Upon completion of the meal, food trays were removed from the room. All food 
items presented to participants were weighed in the GCRC metabolic kitchen prior to 
service, and remaining portions were weighed after completion of the overeating episode.  
The exact quantity of each item consumed was calculated by difference in mass.  The 
computer program Nutritionist IV (304) was used to calculate total food intake in kcal 
and grams (gm) and macronutrient intake in gm.  To compare our results with others, 
macronutrient values in kcal were estimated from measured values in grams by the 
following standard conversion: 4.0 kcal/gm carbohydrate, 4.0 kcal/gm protein, and 9.0 
kcal/gm fat.   
 
Twenty-four hour dietary recall 
 
Over a six to eight week period of time (that excluded the DLW data collection period) 
each participant received six random 24-hour dietary recall interviews that were 
conducted by the staff of the Nutrition Coordinating Center (NCC), Department of 
Epidemiology, School of Public Health, University of Minnesota.  Four of the six were 
conducted during weekdays and two on weekends as this best approximates normal 
intake.  The dietary recall interviews involved a detailed discussion of food intake and 
portion sizes with expert interviewers. The 24-hour dietary recall interview protocol has 
been described in previous studies by our group (305, 306). Dietary interviewers 
collected the 24-hour dietary recalls using a current version of the database each year.  At 
the end of data collection, nutrients were recalculated for all dietary intake records on the 
most current version of the Nutrition Data System for Research (NDS-R) software 
version 4.01, Food and Nutrient Database 30, released November 1999.  NDS-R is 
developed and maintained by the NCC, University of Minnesota, Minneapolis, MN.  The 
NDS-R system prompts the interviewer to ask detailed questions about food intake over a 
24-hour period.  The interviewer asks the participant to recall the first eating episode 
during the 24-hour period.  As the interviewer records food items during that eating 
episode the program prompts the interviewer to ask about additional foods that may be 
typically eaten with the specific item (e.g. condiments with hot dogs or the type of milk 
or sugar added to cereal). When the first eating episode is fully explored, the interviewer 
asks about the next eating episode and proceeds in this fashion through the entire 24 hour 
period. Prior to the data collection participants were trained in the use of food-portion 
visuals (picture of containers and shapes of specific quantities that are drawn to scale) to 
estimate dietary intake as described by Posner (307).  
Additionally, on the afternoon following the laboratory test meal, participants 
completed a dietary recall interview for the 24-hour time period from midnight to 
midnight during which they engaged in the overeating episode. At the time the dietary 
 
 
 
 
78  
recall of the inpatient binge eating episode was collected, all participants had already 
competed at least one random recall with the NCC interviewers as part of the larger 
research protocol in which they were participating.  Following collection of dietary recall 
data, eating episodes that occurred during the 24-hour period were defined as pre-binge, 
binge or post-binge.  Pre-binge intake was defined as food consumption beginning at 12 
am up to delivery of the test meal.  Binge intake included only the test meal administered 
at the GCRC.  Post-binge intake was defined as food consumption after the test meal until 
11:59 pm.  This breakdown enabled a comparison of pre-binge and binge intake to 
examine the role of reduced caloric intake as a precursor to binge eating episodes.      
 
Food log 
  
During the two weeks of urine collection participants also kept a food diary so that 
recorded intake could be compared to measured TDEE during the two week period of 
time.  Participants were trained in the use of food logs by a training tape provided by the 
GCRC dietician. Food logs were routinely reviewed by the research team and further 
questions regarding intake were asked if recorded data lacked sufficient detail for 
calculation of energy intake.  
 
Basal metabolic rate (BMR) and thermic effect of food (TEF) 
 
BMR and TEF were measured using the Delta Track Metabolic Cart (SensorMedics, 
Yorba Linda, CA).  BMR and TEF were collected for two participants (one BED and one 
control) on a SensorMedics Vmax 29 Metabolic cart (SensorMedics, Yorba Linda, CA) 
because of technical issues with equipment. Participants were awakened at a standardized 
morning hour, allowed to void, and then rested for one-half hour before BMR was 
measured.  BMR was assessed using a thirty minute recording under the plastic hood 
while awake, in a semi-recumbent position in bed.  The first 10 minutes were used to 
obtain a stable baseline.  BMR was then calculated from the average of the next 20 
minutes of data collection. Participants then drank a standardized oral meal replacement 
formula (Ensure High Protein, Abbot Laboratories) which contained 250 kilocalories 
(protein 14.4%, carbohydrate 64.0%, Fat 21.6%).  TEF or postprandial thermogenesis 
was measured based on data collected over the next 5 hours by placing the participant 
under the hood to collect data for 15 minutes of every 30 minutes to prevent participant 
fatigue or agitation. The first 5 minutes of every 15 minute period was used to establish a 
stable baseline. Conventional methods were used to calculate daily TEF. 
 
Total daily energy expenditure 
 
TDEE was measured over 14 days using the doubly labeled water protocol (25, 30, 31).  
Baseline urine specimens were collected immediately prior to the timed ingestion of the 
isotopes (2H and O18).  The amount administered was calculated according to a 
standardized procedure (25, 26).  Following timed administration of the isotopes, urine 
samples were collected at 12 hour intervals each day for 14 days.   Date and exact 
collection times were recorded on each bottle and specimens were dropped off to the 
clinic every three to four days during the two weeks of data collection.  TDEE was 
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derived using the slope-intercept equations described by Coward, et al. (32). Validation 
studies have determined the precision of the method to be within 4-5% (33). 
 
Assessment of change in body composition through repeated DXA scans 
 
Two baseline DXA scans (Lunar Prodigy, General Electric Medical, Madison, WI) were 
collected on the day the DLW was administered.  They were repeated two weeks later at 
the completion of DLW protocol.  Assessment of body composition is essential because 
if body weight and composition are stable, energy intake must be equal to energy 
expenditure.  Collection of body composition data allows for an accurate comparison of 
food intake data (collected via dietary recalls and food logs) to the TDEE measured by 
DLW.  If there was no change in body weight or composition, the measured TDEE 
should be equal to energy intake.  Therefore, by comparing reported food intake to 
measured energy expenditure, we examined the accuracy of food log data kept over the 
two-week period when TDEE was assessed.   
 
Predicted energy requirements 
 
The Harris-Benedict equation (HBE), commonly used in clinical settings, calculates 
resting metabolic rate based on gender, weight, height and age (34). Predicted energy 
requirements can be made by adjusting for activity level. To attain predicted energy 
needs, participants’ HBE estimates were multiplied by 1.35 to account for light activity.  
 
Analysis of DLW by isotope ratio/mass spectrometry 
 
Deuterium and 18O in urine were measured using a dual inlet ThermoFinnigan DeltaS 
Isotope Ratio Mass Spectrometer (ThermoFisher Scientific, Bremen, Germany).  
Deuterium was analyzed using an H-Device by reducing 1µL water via a chromium 
furnace held at 825°C. The deuterium produced was measured against a calibrated 
hydrogen reference gas. 18O was measured in a separate assay by equilibration of urine 
with CO2. 1ml urine was introduced into a 12ml exetainer and 5% CO2 in Helium added 
to the tube. The sample was then allowed to equilibrate overnight at room temperature. 
Analysis of the C18O16O produced was performed by measurement against a CO2 
reference gas using a breath bench carousel inlet. In both assays, calibration curves were 
prepared to which the samples were compared. 
  
Statistical analysis 
 
Descriptive statistics, Pearson correlation coefficients and analysis of variance were 
calculated using SPSS version 17.0. The reporting accuracy was defined by two methods. 
The first method was the directional difference, which was defined as the mean 
difference of measured intake minus reported intake. Negative values reflect over-
reporting while positive values signify under-reporting. The second method to determine 
reporting accuracy was the absolute difference, which was defined as the absolute value 
of the measured intake less the reported intake. Greater absolute difference values 
indicated greater inaccuracy overall despite whether the difference arose from under or 
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over-reporting. Analysis of variance was used to determine between group differences on 
total and macronutrient intake, directional and absolute difference between laboratory 
and dietary recall, and energy consumption throughout the day. The proportion of energy 
intake from carbohydrate, fat and protein was examined by dividing the macronutrient 
intake by total intake. Pearson’s correlation coefficient was used to determine the 
relationship between BMI and total food intake. Student’s t-tests and paired samples 
correlation coefficients were used to compare within group differences on laboratory, 
dietary recall data and energy consumption throughout the day. To assess the difference 
between correlation coefficients between groups, Fischer’s r-to-z transformations were 
used. 
 
RESULTS 
 
Demographic data 
   
There were no statistically significant differences between groups with regard to age and 
BMI (Table 21).  The BMI range for the participants was 25.6 to 51.9 with 20.7% of the 
sample overweight (4 BEDs and 2 controls). Baseline binge frequency according to EDE 
assessments in the BED group ranged from twice per week to daily with a group mean of 
17 episodes per month (median = 12).  
  
Metabolic measurements 
 
There were no between group differences in TDEE, BMR, or TEF (Table 21). TDEE was 
significantly correlated with total food intake in kcal as assessed by 24-hour recall in the 
whole sample (n = 29, r2 = 0.422, p = 0 .025) but not by food logs.  When the two groups 
were examined separately there was no significant correlation between TDEE and intake 
as assessed by dietary recall in the BED group, but there was a trend that indicated a 
possible correlation in the control group (n = 13, r2 = 0.522, p = 0.056). 
 
Body composition 
 
There were no differences between groups on baseline measures of fat and lean tissue 
compartment, follow-up fat and lean tissue compartments or on change in fat, change in 
lean, according to the DXA scan data.  There were also no within group differences in 
baseline and follow-up on fat or lean tissue compartments.  There were no within or 
between group differences in weight from baseline to follow-up.   
  
Random 24-hour dietary recall data  
 
BED participants had an average of 2.29 binge days during the 6 dietary recalls (median 
= 2, range = [0,5]). The BED group had a significantly higher caloric intake on days 
when they had binge eating episodes than on days when they did not (Table 23).  
Additionally, caloric intake in the BED group on binge days was significantly higher than 
control average intake.  There was no difference between BED non-binge day intake and 
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control intake (Table 22).  There was a trend toward higher average daily intake in the 
BED group (p=0.053).  There was a significant group difference in number of 
kilocalories consumed per unit of BMI with the BED group consuming 76.2 kcal/BMI 
unit and the controls consuming 61.0 kcal/BMI unit. 
  
Food log data  
 
BED participants had an average of 7.5 binge days during 14 days of food log entries 
(median = 7.5, range = [4,11]). The food log data corroborated that BED participants 
consumed significantly more kcal on binge days than non-binge days (Table 23) and had 
greater intake on binge days than controls (Table 22).  The BED group had similar intake 
on non-binge days to controls.  There were no significant differences in average intake or 
kcal/BMI unit between groups according to food log data.   
 
Energy expenditure versus reported intake  
 
Daily intake as reported by the 24-hour recall data and the food log data were compared 
to actual TDEE as assessed by DLW (Table 24).  BED participants reported caloric 
intake that was 80% of TDEE according to dietary recall data and 70% of TDEE 
according to food log data.  Control participants reported caloric intake that was 67% and 
72% of TDEE according to dietary recall and food log data, respectively. There were no 
significant group differences in under-reporting between groups.  
  
Predicted energy requirements versus energy expenditure  
 
There were no between group differences on HBE predicted energy requirements. When 
comparing predicted energy requirements to actual TDEE there were no group 
differences. Predicted energy requirements accounted for 76% and 77% of actual TDEE 
for BED and control groups respectively (Table 24).     
 
Energy and macronutrient intake during an overeating episode: laboratory vs. dietary 
recall 
 
Table 25 reports descriptive and test statistics for laboratory and dietary recall intake. 
Total food intake was significantly greater in those with BED than those without 
according to laboratory (2305.1 vs. 1461.8 kcal; 466.3 vs. 294.4 gm) and dietary recall 
methodologies (2091.1 vs. 1312.8 kcal; 411.1 vs. 261.6 gm).  Compared to 
overweight/obese controls, those with BED consumed significantly more grams of 
carbohydrate (laboratory: 294 vs. 71 gm; recall: 251 vs. 151 gm) and grams of fat 
(laboratory: 96 vs. 63 gm; recall: 99.7 vs. 59 gm) according to both methodologies. There 
was no significant difference between BED and control participants in protein intake.    
The proportion of energy intake from carbohydrate, fat and protein was also 
examined. There was no significant difference between BED and control groups in the 
proportion of intake from carbohydrates and fats.  Controls consumed a significantly 
greater proportion of energy intake from protein than those with BED according to the 
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dietary recall data (15.1% vs. 20.1%).  This difference was not significant when 
measured in the laboratory. 
 
Multiple methods to evaluate accuracy of self-reported food intake data 
 
Paired samples t-tests demonstrated no significant within group differences in total food 
and macronutrient intake between laboratory and dietary recall methodologies in either 
BED or control groups (Table 25).  One exception was the proportion of total intake from 
fat, with the BED group reporting to consume more % fat in the dietary recall than was 
measured by the laboratory (24.1 vs. 19.7% %).  Accuracy of reporting was further 
examined by calculating the ratio of self-reported intake assessed by dietary recall to 
measured intake in the laboratory (dietary recall / laboratory).  The proportion of reported 
to measured food intake measured in grams was 0.94 (SD = 0.040) in the BED group and 
0.89 (SD = 0.36) in the control group.  There was no significant difference between 
groups (F (1, 28) = 0.147, p = 0.704).  Additionally, there was no significant difference 
between groups when evaluating the dietary recall / laboratory ratio with food intake 
measured in kcal (0.98, SD = 0.45 vs. 0.90, SD = 0.36; F (1, 28) = 0.308, p = 0.584). The 
correlation between laboratory and dietary recall methodologies was calculated to 
evaluate accuracy of self-reported data. In both BED and obese control groups, 
significant within group correlations were found between laboratory and recall methods 
for total food intake measured in kcal (BED: r = 0.530, p=0.05, CON: r = 0.805, p < 
0.001). Total food intake measured in grams was significantly correlated between 
methods in the control group (r = 0.777, p < 0.001), but only a trend towards significance 
in the BED group (r = 0.465, p = 0.09). The difference between the two correlation 
coefficients approached significance (kcal z = 1.33, p = 0.091, gm z = 1.36, p = 0.086). 
To further explore the accuracy of self-reported intake, we performed a between 
group comparison of the directional difference and the absolute value of the mean 
difference for total food and macronutrient intake assessed by laboratory and dietary 
recall methods (Table 26). Results demonstrated that the BED participants had much 
greater variability in their self-reported data as can be seen by the standard deviation of 
the group means and the magnitude of the absolute values of the mean for the majority of 
the comparisons in Table 26. There was a trend toward the absolute value of the 
difference being significantly greater in those with BED than obese controls.  
 
Relationship between total food intake and BMI 
 
Examining BED and obese control groups together, BMI and total food intake were not 
significantly correlated according to laboratory (kcal: r = 0.192, p = 0.292; gm: r = 0.199, 
p = 0.274) or dietary recall methodologies (kcal: r = 0.214, p = 0.265; gm: r = 0.206, p = 
0.284).  In the control group, BMI was significantly correlated with food intake in the 
laboratory (kcal: r = 0.541, p = 0.025; gm: r = 0.562, p = 0.019) and dietary recall data 
(kcal: r = 0.540, p = 0.038; gm: r = 0.543, p= 0.036).  In those with BED, BMI and food 
intake were not significantly correlated according to laboratory (kcal: r = -0.057, p = 
0.840; gm: r = -0.054, p = 0.849) or dietary recall data (kcal: r = -0.108, p = 0.714; g: r = 
-0.123, p = 0.675). 
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Patterns of energy consumption throughout the day 
 
Table 27 reports descriptive and test statistics for patterns of energy consumption 
throughout the day. There were no significant differences between BED and obese 
control groups in pre-binge or post-binge caloric intake. No significant correlations were 
found between pre-binge and binge intake or post-binge and binge intake in the BED 
group.  In the obese control group, pre-binge intake was significantly correlated with 
binge intake (r = 0.576, p = 0.025) and post-binge intake was marginally significant (r = 
0.505, p = 0.055).  Pre-binge and post-binge intake were significantly positively 
correlated in those with BED (r = 0.616, p = 0.019), obese controls (r = 0.564, p = 0.028) 
and overall (r = 0.465, p = 0.011). 
 
DISCUSSION 
 
The data do not support the hypothesis of higher energy expenditure in the BED group as 
there were no statistical differences in TDEE, BMR, or TEF between BED participants 
and overweight/obese controls.  Using the doubly labeled water method in the current 
study, TDEE was 3214 and 3172 kcal/day in BED and non-BED participants, 
respectively.  To the best of our knowledge, this is the first study to measure TDEE by 
the DLW method in overweight/obese females with BED.  Obesity researchers using 
DLW to measure TDEE have reported values ranging from 2090 kcal/day in obese 
females during periods of dietary restraint (35) to 3708 kcal/day in obese females with a 
mean BMI of 37.4 kg/m2 (36).  Examining studies of obese females with a BMI range 
from 29.6 to 33.0, the reported TDEE ranged from 2452 to 2952 kcal/day (37-41). The 
high TDEE in our study may be a result of higher BMI in our BED (34.8) and control 
groups (35.2) that approached that of Platte’s participants (37.4) (36).  Measurements of 
BMR in our BED and control groups are consistent with those for obese females reported 
in the literature ranging from 1502 kcal/day to 1680 kcal/day (37, 39, 40). As stated 
above, we found no difference between BED and non-BED in the thermic effect of food.  
Some researchers have demonstrated decreased TEF in obese participants (42), but these 
findings are controversial as others have found no difference between obese and normal 
weight individuals. Together these results suggest that there are not significant 
differences in energy expenditure and metabolic measurements between 
overweight/obese women with and without BED. Additionally, there was no difference in 
body composition between groups and no change in body composition over the two 
weeks of DLW sample collection within either group.  
In clinical practice and weight loss programs, many still rely on the Harris-
Benedict equation (HBE) to estimate energy requirements. We calculated daily energy 
expenditure using the HBE and compared it to TDEE measured by the DLW method.  
The HBE substantially underestimated measured TDEE in this sample by about 23% and 
24% in the BED and control groups, respectively. Estimates of predicted energy 
expenditure calculated using the HBE should be interpreted with caution given this 
discrepancy.  Further research is needed to validate the utility of the Harris-Benedict 
equation as an estimate of energy expenditure in overweight/obese and eating disordered 
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individuals. Equations may need to be adjusted for accurate prediction of energy 
requirements for overweight/obese populations. 
A second objective of this study was to assess differences in energy intake 
between groups.  In the current study, the BED group ate significantly more on binge 
days than on non-binge days and controls. This finding was detected by both laboratory 
(2305 vs. 1462 kcal) and dietary recall methodologies (2091 vs. 1313 kcal). There was no 
difference between BED non-binge days and average daily consumption by controls.  
There was a trend toward the BED group consuming more kilocalories on average than 
the controls as assessed by 24-hour recall (BED = 2586.9 kcal, SD = 640.1, Control = 
2140.0 kcal, SD = 659.1, F(1,32) = 4.032, p = .053) but not according to food log data. 
These discrepant results are likely due to the 24-hour recalls being a more accurate 
account of food intake than the food log entries (24-hour recall estimates were closer to 
TDEE as determined by DLW). It is also important to note that the BED group consumed 
significantly more kilocalories per BMI unit than did the control group adding additional 
support to the finding of higher daily caloric intake in the BED group.  
Macronutrient intake data indicated that those with BED eat significantly greater 
amounts of carbohydrate and fat than obese controls during a laboratory overeating 
episode.  However, there were no differences in the proportion of total energy intake 
derived from carbohydrates and fat between groups. This suggests that the differences in 
total carbohydrate and fat intake observed were secondary to increased food intake in 
BED participants and do not reflect differences in food selection. This is consistent with 
previous work by our group in which those with BED consumed significantly more total 
fat than obese controls, but the proportion of energy intake from fat was not significantly 
different between groups (293).  Dietary recall data indicated that control participants 
consumed a significantly greater proportion of total energy from protein compared to the 
BED group.  However, this difference was not significant according to laboratory 
measurements, which is the gold standard for measuring dietary intake. Results of our 
previous study detected no difference in total or proportion of protein intake between 
groups (293).  We suspect this finding represents differences between groups in accuracy 
of reporting rather than a true difference in macronutrient consumption. 
Other research groups have examined macronutrient intake when obese women 
with and without BED are instructed to overeat in the laboratory. Yanovski found that 
those with BED consumed significantly more fat (38.9% vs. 33.5%) and less protein 
(11.4% vs. 15.4%) than obese controls (292). Guss reported that obese women with BED 
(BMI >28) consumed a significantly greater proportion of energy from fat than normal 
weight controls (BMI 19-23), but observed no difference between obese women with and 
without BED (292).  In contrast, Goldfein reported no difference in the proportions of 
macronutrient intake between obese women with and without BED when instructed to 
overeat in the laboratory (287).  Given these findings and those of the present study, it 
remains unclear whether differences in macronutrient intake exist between obese women 
with and without BED.  The three studies discussed above utilized an identical laboratory 
paradigm.  Direct comparison of these findings to the current study is difficult because 
macronutrient consumption reflects both food selection and food presentation, which 
varies by laboratory protocol.   
Our results and the literature review above raise important questions. If there are 
no differences between the BED and control groups metabolically and the BED group 
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consumes more energy than the control group then over time the BED group should gain 
more weight.  However, we did not find any statistically significant differences in body 
composition between baseline measures and the two week follow up. If the BED group is 
actually consuming more energy and the TDEE is not different from controls then it is 
possible that our method of measuring change in body composition was not sensitive 
enough to detect increases in body mass over the two week period or we did not have 
enough power to statistically support such differences between groups. The test-retest 
differences for duplicate measures on the DXA scanner was <2%, with the ability to 
detect changes as low as 0.6 kg (SD = 0.023) (44). The change in kg over the two week 
collection period for the BED group was +0.033 (SD = 1.62 )  and for the control group 
was -0.671 (SD = 1.66) which was not statistically different between groups. 
Additionally, our post hoc power to detect a mean difference of this magnitude between 
groups at an alpha level of 0.05 was 31.2%. Given the body composition change in this 
sample was within the confidence limits of the DXA scanner and the limited power to 
detect changes over a small time period, further research is needed to confirm that indeed 
BED is associated with higher overall caloric intake and weight gain.  
  A third objective was to determine the accuracy of caloric intake as assessed by 
dietary recall interview and food log data. This was done by comparing recorded intake 
with measured energy expenditure (TDEE) obtained from the doubly labeled water 
method.  Since there was no change in body weight or composition as assessed by DXA 
during the 14 days of doubly water collection, we can assume that energy intake was 
equal to TDEE. BED participants reported caloric intake that was 80% of TDEE 
according to dietary recall data and 68% of TDEE according to food log data.  Control 
participants reported caloric intake that was 70% and 73% of TDEE according to dietary 
recall and food log data, respectively.  There were no significant differences between 
groups by either method.  Reports comparing recorded intake in obese individuals to 
energy expenditure measured by the DLW method suggest that most report intake that is 
approximately 60% of predicted expenditure (19, 20).  Although the expected 60% 
accuracy was within our 95% confidence region, our estimates on average were greater. 
It is possible that our BED and control groups reported intake with greater 
accuracy as a result of the dietary recall interviews that the women participated in prior to 
collecting the self-reported food log data.  The dietary recall interviews involved a 
detailed discussion of food intake and portion sizes with expert interviewers. 
Additionally, participants were required to watch a food record training video 
immediately prior to the two weeks of food log data collection. These activities may have 
trained participants in monitoring food consumption, leading to increased accuracy when 
recording intake in a food log later in the project.  This may account for our groups 
reporting a higher percentage of TDEE than the 60% seen in most studies.   
To expand on the findings above, we compared measured food intake in the 
laboratory to dietary recall estimates of intake to ascertain the accuracy of self-reported 
data in obese women with and without BED.  To the best of our knowledge, this is the 
first study to compare laboratory and dietary recall measurements of a specific eating 
episode in adult women with BED.  According to dietary recall interviews, BED and 
obese control groups reported 90% and 98% of measured food intake during an 
overeating episode in the laboratory, respectively.  Furthermore, there were no 
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differences between groups in the accuracy of self-reported carbohydrate, fat, or protein 
intake.  
When comparing random 24-hour dietary recall data with TDEE assessed using 
the DLW method in these same participants, we noted that the BED and obese control 
groups reported daily food intake at 80% and 68% of TDEE, respectively (277) Since 
accuracy of self-reported data for an isolated laboratory overeating episode was examined 
in the current study, direct comparisons to the results above cannot be made.  Further 
research is required to determine if these findings can be replicated and, if so, what 
factors facilitate the observed improvement in reporting.  It is possible that the 
participants in this study may have reported with greater accuracy because the laboratory 
environment and unique food presentation made the episode more memorable than eating 
in the natural environment thus resulting in improved recall of intake.  
While there is not total consistency throughout the results, the three methods used 
to examine the accuracy of self-reported food intake taken together suggest that those 
with BED were less accurate than obese controls.  Within group comparisons 
demonstrated no significant differences between laboratory and dietary recall methods in 
total food or macronutrient intake in either group.  Significant positive correlations 
between measured and self-reported intake were observed in both groups.  However, the 
correlation coefficients were larger in the control group (r = 0.805 vs. 0.530), indicating 
that they were on average more accurate than those with BED. There was a trend toward 
a significant difference between these correlation coefficients (p = 0.09).  We also 
examined the directional difference and the absolute value of the mean difference 
between reported and measured intake to examine the direction and magnitude of the 
inaccuracies in the two groups.  Mean differences indicated that both groups under-
reported intake, but those with BED did so to a greater extent (215 vs. 160 kcal, p = 
0.021).  The mean of the absolute value of the difference suggests that the BED group 
tended to be less accurate at reporting their intake overall than controls (779 vs. 438 kcal, 
p = 0.061).  The BED group also demonstrated greater variability in reporting as 
evidenced by standard deviations that were larger than those noted in controls.  Overall, 
these findings are suggestive that those with BED tended to be less accurate with self-
reported intake than obese controls. 
Our findings suggest that the overweight/obese control participants demonstrated 
a trend to be more accurate at estimating total energy and macronutrient intake.  It is 
possible that decreased accuracy of dietary recall data in participants with BED may be 
the result of subjective loss of control and consumption of an extremely large amount of 
food in a short period of time.  Both of these factors may impair awareness of food 
consumption in BED relative to control participants.  Further research is needed to 
confirm that BED participants are less accurate at reporting food intake than non-BED 
overweight/obese and to understand the mechanism of impaired accuracy.    
Researchers have observed a positive correlation between food intake and BMI 
when participants with BED were instructed to binge eat in the laboratory (291)  In the 
current study, we sought to confirm that eating in proportion to BMI accounts for the 
variability in food intake reported in those with BED.  Our results indicated that BMI and 
food intake were significantly correlated in the obese control group, but not in the BED 
group. These findings are not consistent with those reported by Guss and colleagues 
(291), who noted a positive correlation between meal size and BMI in the BED group 
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under binge eating conditions.  Significant correlations were not observed in the BED 
group when they were instructed to eat a normal meal or in obese control participants 
under binge or normal eating conditions.  These results are not consistent with our 
findings and question the role of BMI in modulating food intake during a single eating 
episode in those with BED.  Methodological differences between these studies make 
comparison of results difficult and demonstrate the need for further research addressing 
this issue.  
A final aim of this study was to explore the role of reduced caloric intake as a 
potential precursor to binge eating in BED.  To analyze patterns of energy consumption 
throughout the day, total daily caloric intake assessed by dietary recall was categorized as 
pre-binge, binge, or post binge intake. There were no significant correlations detected 
between pre-binge and binge intake or binge and post-binge intake in the BED group.  
These findings suggest that food intake preceding and following an overeating episode is 
not associated with food consumption during the overeating episode alone.  In contrast, in 
the obese control group there were positive correlations between all of the comparisons, 
suggesting that those who eat more before the overeating episode also eat more during 
and afterwards.  Further, significant positive correlations were noted between pre-binge 
and post-binge food intake in both groups.  This observation suggests that those who 
tended to consume a larger amount of food preceding the overeating episode also tended 
to eat more following it.  Likewise, those who ate less before the overeating episode also 
ate less following it.  Failure to compensate for overeating with reduced dietary intake 
may contribute to the development of obesity. 
Strengths of our study include the multiple methods used to assess energy intake 
and the use of the gold standard doubly labeled water method to assess energy 
expenditure. Although the size of the sample is larger than much of the previous work in 
this area, it is still a limitation of this study.  A larger sample size may have clarified the 
issue of whether there is a significant difference in average daily intake between those 
with BED and controls.  A further limitation is the lack of inclusion of data on physical 
activity due to participant noncompliance and technical issues with monitors.  Although 
BED is more common in females, another limitation is the lack of inclusion of men. 
Future studies should include both sexes. 
In summary, a major finding of this study is that regardless of the method used to 
assess intake, both the BED and control groups underestimate their caloric consumption.  
It is also interesting to note that there is greater disparity in daily caloric intake between 
the two methods in the BED group than in the controls.  However, both groups reported 
fewer kcal than required to maintain their current weight since the reported intake was 
less than the TDEE by both methods of assessment.  Thus the main positive finding in 
our study was well summarized by Lichtman et al in their1992 article in which they 
compared TDEE using DLW with reported intake, “The failure of some obese subjects to 
lose weight while eating a diet they report as low in calories is due to an energy intake 
substantially higher than reported and an overestimation of physical activity, not the 
abnormality in thermogenesis” (35).  
The findings of our group and others repeatedly demonstrate increased intake on 
binge days compared to non-binge days in BED women.  This distinguishes those with 
BED from typical obesity and lends further support to the diagnostic utility of BED and 
its inclusion in the upcoming DSM-V.  Further research will clarify with increasing 
 
 
 
 
88  
precision the quantity, nutrient composition, and food selections that characterize binge 
eating episodes in BED.  Characterizing the eating behaviors associated with BED – both 
in the laboratory and through self-reported data - will facilitate accurate diagnosis and 
assessment of treatment response.  
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TABLES 
 
Table 21: Descriptive statistics and group differences in demographics, energy 
expenditure and energy intake measures 
 
 
(n=BED/n=CON) 
 
BED 
Mean 
(SD) 
 
 
CON 
Mean 
(SD) 
 
 
F 
 
p 
 
Age (years) 
(17/17) 
 
 
30.8  
(7.2) 
 
31.7  
(8.5) 
 
0.107 
 
0.745 
BMI (kg/m2) 
(17/17) 
 
34.8  
(6.0) 
35.2  
(6.9) 
0.019 0.891 
TDEE 
(15/14) 
 
3213.9  
(552.8) 
3171.8  
(525.3) 
0.044 0.835 
TEF 
(15/14) 
 
35.4  
(20.0) 
29.7  
(21.4) 
0.534 0.472 
BMR 
(15/14) 
 
1607.7  
(246.8) 
1628.1  
(336.8) 
0.035 0.853 
24-hour Recall (Kcals)  
(17/17) 
 
2586.9  
(640.1) 
2140.0  
(659.1) 
4.023 0.053 
24-hour Recall 
(Kcals/BMI)  (17/17) 
 
76.2  
(23.4) 
61.0  
(14.2) 
5.268 0.030 
Food Log (Kcals) 
(14/16) 
 
2234.4  
(386.0) 
2185.0  
(535.4) 
0.082 0.777 
Food Log 
(Kcals/BMI) (14/16) 
 
67.5  
(17.4) 
62.6  
(14.0) 
0.707 0.408 
 
Note: BED = binge eating disorder, CON = control, n = sample size, SD = standard 
deviation, BMI = body mass index, TDEE = total daily energy expenditure, TEF = 
thermic effect of food, BMR = basal metabolic rate. 
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Table 22: Comparison of caloric intake on BED binge days and non-binge days with 
control data 
 
 
BED 
Binge 
Days 
 
BED 
Non-Binge 
Days 
 
Controls 
 
BED Binge  
vs. Control 
 
BED Non-Binge 
vs. Control 
 
Mean 
(SD) 
n 
 
Mean 
(SD) 
n 
 
Mean 
(SD) 
n 
 
F 
 
p 
 
F 
 
p 
 
24-hour Recall 
 
3254.5 
(520.0) 
14 
2233.4 
(584.0) 
17 
2140.0 
(659.1) 
17 
26.429 <0.0001 0.191 0.665 
 
Food Log 
 
2983.0 
(432.6) 
11 
1972.1 
(305.0) 
14 
2185.0 
(535.4) 
16 
 
16.815 <0.0001 1.721 0.200 
 
Note: BED = binge eating disorder, SD = standard deviation. 
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Table 23: Comparison of caloric intake on BED binge days with BED non-binge days 
 
BED 
Binge 
Days 
 
 
BED 
Non-Binge 
Days 
 
Binge Day vs.  
Non-Binge Day  
 
Mean 
(SD) 
n 
 
Mean 
(SD) 
n 
 
F  
 
p 
 
24-hour Recall 
 
3254.5 
(520.0) 
14 
2343.1 
(556.6) 
14 
26.429 
 
<0.0001 
 
Food Log 
 
2983.0 
(432.6) 
11 
 
1972.5 
(343.7) 
11 16.815 
 
<0.0001 
 
Note: BED = binge eating disorder, SD = standard deviation. 
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Table 24: Descriptive statistics and group differences in energy expenditure versus 
reported intake 
 
 
 (n=BED/n=Control)  
 
BED 
Mean  
(SD) 
 
 
Control  
Mean  
(SD) 
 
F 
 
p 
 
24-hour Recall/TDEE 
(15/14) 
 
 
0.797 
(0.23) 
 
0.675 
(0.25) 
 
1.885 
 
0.181 
Food Log/TDEE      
(15/13) 
 
0.702 
(0.19) 
0.725 
(0.24) 
0.081 0.778 
HBE 
(15/14) 
 
1759.5 
(175.4) 
1790.7 
(257.4) 
0.148 0.704 
PER 
(15/14) 
 
2375.3 
(236.8) 
2417.5 
(347.5) 
0.148 0.704 
PER/TDEE 
(15/14) 
 
0.757 
(0.14) 
0.774 
(0.12) 
0.121 0.731 
Note: BED = binge eating disorder, SD = standard deviation, TDEE = total daily energy 
expenditure, HBE = Harris-Benedict equation, PER = predicted energy requirements 
based on HBE and light activity. 
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Table 25:  Mean total energy and macronutrient intake during a laboratory over eating 
episode: Laboratory measurement vs. dietary recall interview 
 
 
Note: BED = binge eating disorder, CON = control, Kcal = kilocalories, CHO = 
carbohydrate, gm = grams, SD = standard deviation, F = between groups F-test, t = 
within groups paired sample t-test, Kcal values were estimated from measured 
macronutrient values in gm using the following standard conversions: 4 kcal/gm CHO, 4 
kcal/gm protein, 9 kcal/gm fat.  
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Table 26: Mean differences of total energy and macronutrient intake between laboratory 
and dietary recall methodologies 
 
Directional Difference Absolute Value of Mean Difference 
 BED CON  BED CON  
 MD (SD) MD (SD) F (1,28) (p) |MD| (SD) |MD| (SD) F (1,28) (p) 
Total kcal 215.7 (939.0) 160.9 (502.4) 6.03 (0.021) 779.1 (527.5) 438.6 (272.1) 3.83 (0.061) 
Total grams 54.0 (190.7) 35.4(100.6) 0.11 (0.744) 158.9 (110.9) 87.3 (57.6) 4.87 (0.036) 
CHO (g) 42.2 (114.7) 28.0 (68.5) 4.21 (0.050) 97.0 (70.3) 56.8 (45.6) 2.30 (0.141) 
Fat (g) -1.5 (43.2) 3.4 (23.3) 5.00 (0.034) 35.0 (23.4) 19.4 (12.4) 6.99 (0.014) 
Protein (g) 13.3 (43.9) 4.02 (16.9) 4.00 (0.055) 30.7 (33.2) 14.1 (9.6) 4.85 (0.036) 
Note: BED = binge eating disorder, CON = control, Kcal = kilocalories, g = grams, CHO 
= carbohydrate, SD = standard deviation, MD = mean difference between laboratory and 
dietary recall, |MD| = absolute value of mean difference between laboratory and dietary 
recall. 
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Table 27: Patterns of energy consumption throughout the day: Pre-binge, binge, and post-
binge food intake 
 
Food intake (kcal) 
 
BED 
 
CON 
 
BED vs. CON 
    
 Mean (SD) Mean (SD) F (1,28) (p) 
 
Pre-binge 
 
1188.9 (449.9) 
 
1038.0 (346.3) 
 
1.032 (0.319) 
Binge 2091.1 (1044.1) 1312.8 (847.5) 4.889 (0.036) 
Post-binge 182.6 (152.0) 270.7 (338.6) 0.798 (0.380) 
 
Correlations 
 
BED 
 
CON 
 
Overall 
  
r (p) 
 
r (p) 
 
r (p) 
 
Pre-binge and binge 
 
-0.145 (0.620) 
 
0.576 (0.025) 
 
0.206 (0.284) 
Post-binge and 
binge 
0.107 (0.715) 0.505 (0.055) 0.234 (0.222) 
Pre and post-binge 0.616 (0.019) 0.564 (0.028) 0.465 (0.011) 
Note: BED = binge eating disorder, CON = control, Kcal = kilocalories, SD = standard 
deviation, r = Pearson’s correlation coefficient. 
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Chapter 6:  Binge eating disorder mediates links between 
symptoms of depression, anxiety, and caloric intake in 
overweight and obese women 
 
 
Adapted from: Roseann E. Peterson, Shawn J. Latendresse, Lindsay T. Bartholome, Cortney S. 
Warren, Nancy C. Raymond. Binge eating disorder mediates links between symptoms of 
depression, anxiety, and energy intake in overweight and obese women. Journal of Obesity [Epub 
2012 Apr 12] 
 
ABSTRACT 
 
Despite considerable comorbidity between mood disorders, binge eating disorder (BED) 
and obesity, the underlying mechanisms remain unresolved. Therefore, the purpose of 
this study was to examine models by which internalizing behaviors of depression and 
anxiety influence food intake in overweight/obese women. Thirty-two women (15 BED, 
17 controls) participated in a laboratory eating-episode and completed questionnaires 
assessing symptoms of anxiety and depression. Path analysis was used to test mediation 
and moderation models to determine the mechanisms by which internalizing-symptoms 
influenced kilocalorie (kcal) intake. The BED group endorsed significantly more 
symptoms of depression (10.1 vs. 4.8, p=0.005) and anxiety (8.5 vs. 2.7, p=0.003). Linear 
regression indicated that BED diagnosis and internalizing-symptoms accounted for 30% 
of the variance in kcal-intake (F(3,28)=4.002, p=0.017). Results from path analysis 
suggested that BED mediates the influence of internalizing-symptoms on total kcal-intake 
(empirical p<0.001). The associations between internalizing-symptoms and food intake 
are best described as operating indirectly through a BED diagnosis. This suggests that 
symptoms of depression and anxiety influence whether one engages in binge eating, 
which influences kcal-intake. Greater understanding of the mechanisms underlying the 
associations between mood, binge eating and food intake will facilitate the development 
of more effective prevention and treatment strategies for both BED and obesity. 
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INTRODUCTION 
 
Although there is considerable comorbidity between obesity, eating disorders and other 
major psychiatric disorders, the mechanisms underlying these associations have yet to be 
resolved. Binge eating disorder (BED), often associated with elevated body weight and 
mood disorders, is under consideration for inclusion in the Diagnostic and Statistical 
Manual of Mental Disorders, fifth edition (DSM-V). BED is defined by the DSM-IV as a 
provisional eating disorder diagnosis characterized by recurrent episodes of binge eating 
without weight control compensatory behavior and includes:  (1) “eating, in a discrete 
period of time (e.g., within any 2-hour period), an amount of food that is definitely larger 
than what most people would eat during a similar period of time and under similar 
circumstances,” and (2) “a sense of lack of control over eating during the episode”. In 
addition, individuals with BED must experience distress about their binge eating and 
endorse three of the following symptoms: eating more rapidly than normal, eating until 
uncomfortably full, eating large amounts when not hungry, eating alone because of 
embarrassment, and feeling disgusted, depressed or guilty about overeating (87).  
Although obesity is not a requirement for a BED diagnosis, research indicates that 
approximately 70% of those meeting criteria for BED are obese (21). While the 
prevalence of BED in community samples ranges from 2-5%, approximately 30% of 
obese individuals seeking weight control treatment meet criteria for BED (88, 89). The 
recurrent overeating that characterizes BED, along with the absence of compensatory 
behaviors exhibited by those with bulimia nervosa (BN), is most likely responsible for 
the high frequency of obesity in this group. Laboratory studies have demonstrated  that 
obese BED individuals consume significantly more kilocalories (kcal) during an 
overeating episode than obese individuals without a BED diagnosis (285, 288, 290, 292, 
305, 306, 308-310). 
Psychiatric disorders, including depression and anxiety, have been associated with 
obesity and BED. The lifetime prevalence of major depressive disorder (MDD) and 
anxiety disorders in the United States is estimated at 17% and 29%, respectively (90). 
However, within obese populations, reported lifetime prevalence rates are increased to 
32.8% for depression and 30.5% for anxiety (20). Additionally, Strine et al. found adults 
with a current or lifetime diagnosis of depression or anxiety were significantly more 
likely to engage in unhealthy behaviors such as physical inactivity and to be obese (20). 
Furthermore, research shows obese individuals with comorbid BED have even greater 
rates of depression and anxiety than obese individuals without BED (21, 295, 311-313). 
For example, Grilo et al. report, in a study of 404 BED patients, that lifetime history 
estimates were elevated to 52% for mood and 37.1% for anxiety disorders (311).  
Despite general acknowledgment of the associations between body weight, BED 
and comorbid psychiatric disorders, the mechanisms underlying these relationships 
remain largely unknown.  Previously, we have reported that overweight/obese women 
with BED consume significantly greater kcal-intake during a laboratory eating-episode 
than weight-matched women without BED (2305 vs. 1462 kcal) (310). To extend this 
work, we assessed symptoms of depression and anxiety in this sample and sought to 
examine how internalizing behaviors and BED may be associated with kcal-intake during 
the laboratory eating-episode. Based on the literature, we hypothesized that participants 
meeting BED criteria would endorse significantly more symptoms of depression and 
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anxiety than weight-matched non-BED controls. However, the impact of a BED 
diagnosis and symptoms of depression and anxiety on kcal-intake was less clear as there 
are several potential mechanisms responsible for the association. It is possible that 
increased kcal-intake is the result of BED symptomatology. For instance, those with BED 
may use binge eating to alleviate or escape symptoms of depression and anxiety. 
Additionally, in converse, it is possible that BED symptomatology such as distress 
regarding lack of control over eating specifically elevates internalizing symptoms. For 
example, depression may increase food intake through increased appetite, a clinical 
feature of atypical depression subtype. Furthermore, it is possible that having both a BED 
diagnosis and elevated symptoms of depression and anxiety synergistically influence 
food intake in a non-additive manner.  
 A common statistical approach to examining relationships between variables is 
path analysis, in which alternative models can be applied to evaluate theoretical 
relationships and determine directionality of effects. We assessed three alternative 
models, depicted in Figure 13, to determine the mechanism of association that best fit our 
data. Path analysis was employed to evaluate three potential models: 1) The symptoms of 
depression and anxiety increase susceptibility to BED, which in turn influences caloric 
intake (Figure 13a), 2) A BED diagnosis influences symptoms of depression and anxiety, 
which subsequently influences caloric intake (Figure 13b) and 3) A BED diagnosis and 
symptoms of depression and anxiety function interdependently in relation to energy 
intake (Figure 13c). 
 
METHODS 
 
Participants 
 
 Participants were recruited by newspaper and online advertisements inviting 
women at least 50 pounds overweight and between the ages of 18 and 45 to participate in 
a paid research study. Thirty-two women, including 15 meeting DSM-IV criteria for BED 
and 17 overweight/obese controls with no history of any binge eating or eating disorder 
behaviors, participated in the study. These women were recruited as part of a larger study 
examining food intake and energy expenditure measured via the doubly labeled water 
method (277, 310). 
 
   Group Assignment 
 
Potential participants were interviewed with the Structured Clinical Interview for 
DSM-IV Axis I Disorders, Patient Edition (SCID-I/P) (301) , and the Eating Disorder 
Examination (EDE), Version 12.0D (303) to determine study eligibility and group 
assignment.  Additionally, a medical history, physical exam and battery of laboratory 
tests were completed to detect unstable medical conditions, such as diabetes and impaired 
thyroid function, which would influence eligibility. Participants were excluded from the 
study if they had any unstable medical or psychiatric conditions, met DSM-IV criteria for 
substance abuse or dependency within 6 months of participation, or were currently 
dieting or participating in a weight loss program.  Those with any history of BN or 
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compensatory behaviors were also excluded.  Non-BED controls were free of any current 
or past eating disorder symptoms. The protocol was reviewed and approved by the 
Institutional Review Board at the University of Minnesota and all participants took part 
in the informed consent process and signed a consent form. Participants were paid $300 
upon completion of the entire study protocol. 
 
Laboratory binge eating episode 
 
 This study utilized a protocol our group has previously reported (293, 306, 310). 
In brief, participants were interviewed by a research dietician regarding their general 
eating patterns and foods on which they typically snacked or overate.  They indicated 
which items from a standardized list of snack foods appealed to them and could suggest 
extra foods or recipes.  Based on the information gathered during the interview, a tray of 
binge foods was created for each participant incorporating their personalized snacking 
preferences.  Each participant received 6 to 10 different kinds of food on their snack tray.  
Food items were presented in excessive quantities (two to three times what they endorsed 
eating during a binge) to ensure binge size was not limited by quantity of food.   
 Participants were admitted to the General Clinical Research Center (GCRC) for 
an overnight stay to participate in several study activities.  They were instructed not to 
consume any food or caloric beverages between 12 and 5 PM. At approximately 5:30 PM 
they were presented with a multiple item array of foods, including their personalized 
binge tray and a standard hospital dinner, and were instructed to “Let yourself go and eat 
as much as you like.” They were left alone in a private room to eat for as long as they 
liked and signaled the nursing staff when they were finished.  The GCRC metabolic 
kitchen staff measured pre and post-prandial quantities of food.  Caloric and 
macronutrient intake for the laboratory eating episodes were calculated using Nutritionist 
IV (304).   
 
Self report measures of depression and anxiety 
 
 During the initial evaluation participants completed the Beck Depression 
Inventory (BDI) and the Beck Anxiety Inventory (BAI) which are widely used self-report 
questionnaires consisting of items addressing how one has been feeling in the last week 
and measures the severity of depression and anxiety symptoms (314, 315). The scales 
have high internal consistency coefficients (i.e., BDI upwards of 0.80) and validity with 
other clinical assessments (316, 317). Scores on these indices range from 0 to 63 and 
correspond to normal (0-9 BDI, 0-7 BAI), mild (10-18 BDI, 8-15 BAI), moderate (19-29 
BDI, 16-25 BAI) and severe (30-63 BDI, 26-63 BAI) depression and anxiety.  
 
Analytic strategy and model validation 
 
A set of three, theoretically driven path models (see Figure 13) were tested using 
Mplus version 5.0 (318). As MacKinnon and colleagues (319) have suggested, the 
traditional causal steps approach (320, 321) may lack the statistical power to detect some 
meaningful indirect effects.  The mediation analyses presented here utilized the product 
of coefficients strategy (319, 322) to evaluate the extent to which a predictor influences 
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an outcome through some intermediary variable (Figure 13a and b).  In doing so, the 
indirect effect is derived by taking a ratio of the product of the path coefficients from (1) 
the independent variable to the mediator and (2) the mediator to the dependent variable 
over the normal-theory standard error for that product [i.e., (β1*β2)/SE(β1*β2)], the results 
of which are evaluated with respect to the Z-distribution.  Moderation (Figure 13c) was 
assessed via the partial path coefficient for a product term (i.e., β/SEβ) in the presence of 
its individual components, and evaluated with respect to a t-distribution.  
To protect against potential bias introduced by the small size of our sample, 
evidence of significance was assessed via permutation testing (153).  From the original 
observed data, ten thousand novel datasets were generated via the random reordering of 
individuals’ values on BED and kcal intake. This procedure was performed in R version 
2.9.1 (323).  Each of the permuted datasets can thus be reanalyzed within Mplus version 
5.0 (318), with respect to the three alternative models depicted in Figure 13, and the test 
statistics from each iteration can be used to generate null distributions for each of the 
effects being scrutinized. Criteria for significance (i.e., empiric p-values) can be 
calculated using the formula (p+1)/(n+1), where p is the number of null tests that are 
more significant than the test conducted with the original data, and n is the total number 
of permutations (i.e., 10,000) on which the analyses are rerun. As a result, we are able to 
assess whether each of the hypothesized models would achieve significance in a much 
larger sample (i.e., 320,000), given the characteristics of our observed sample. 
 
RESULTS 
 
Descriptive statistics 
 
Of the thirty-two women participants, 27 were European-American, 3 were African-
American (9.4%) and 2 were Asian-American (6.3%). Means and standard deviations for 
total energy intake, depression and anxiety scores, and potential covariates (i.e., age and 
BMI) are presented by BED diagnosis on the diagonal in Table 28.  ANOVA indicated 
that there were significant group differences in depression scores (10.1 vs. 4.8, F(1,30) = 
9.308, p = 0.005) and anxiety scores (8.5 vs. 2.7, F(1,30) = 10.830, p = 0.003) with BED 
participants having significantly higher mean scores than controls across these indices. 
No between-group differences were found regarding BMI (F(1,30) = 3.203, p = 0.784) or 
age ( F(1,30) = 10.737, p = 0.674). Table 29 reports the prevalence of lifetime clinical 
depression and anxiety diagnoses by group. The BED group had significantly greater 
prevalence of mild depression (60 vs. 17.6%, χ2 = 6.10, p = 0.014), mild/moderate 
anxiety (33.3 vs. 5.9%, χ2 = 3.94, p = 0.047) and anxiety disorders (46.7 vs. 11.8%, χ2 = 
4.80, p = 0.028). A detailed examination of food intake and energy expenditure in these 
participants are reported in additional manuscripts from our group (277, 310)   
Pearson’s correlation coefficients for bivariate associations between study 
variables are presented in the off-diagonal cells in Table 28. Within each cell, 
associations are presented separately for participants diagnosed with BED (top), weight-
matched controls (middle) and across the entire sample (bottom). Significant positive 
correlations were found between kcal intake and depression, kcal intake and anxiety, and 
depression and anxiety within the full sample. When assessed within groups, no 
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significant correlations were found except between depression and anxiety scales in the 
control group.  Since neither BED nor internalizing symptoms were associated with age 
or BMI, these latter variables were not included in the path models described below. 
 
Model fitting 
 
Separate path models were run to test (a) the intermediary role of BED in 
associations between depression and anxiety symptoms and caloric intake, (b) the 
intermediary role of depression and anxiety symptoms in associations between BED and 
caloric intake, and (c) the interactive influences of BED and symptoms of depression and 
anxiety on caloric intake.  In each case, the theoretical model accounted for a significant 
amount (~30%) of the variance in energy intake.  However, examination of the three 
alternative theoretical models revealed important mechanistic differences in the 
relationship between BED and symptoms of depression and anxiety as they serve to 
jointly influence energy intake.  Results of the models (Table 30) depicted in Figure 13a 
and b suggest that while kcal intake is significantly influenced by both depression and 
anxiety symptoms (βtotal, depression = 0.409, p = 0.006; βtotal, anxiety = 0.399, p = 0.003) and 
binge eating status (βtotal, BED = -0.508, p ≤ 0.001), the effects attributed to symptoms of 
depression and anxiety operate, in large part, through the influences they have on BED 
(βindirect, depression via BED = 0.197, p = 0.052; βindirect, anxiety via BED = 0.212, p = 0.046). Note 
that the sign of the effects reflect coding of 1 for BED and 2 for controls in all analyses. 
That is, roughly half of the influence of depression (~48%) and anxiety (~53%) on caloric 
intake is mediated through BED.  In contrast, the influence of BED status on caloric 
intake appears not to be mediated by symptoms of depression or anxiety (βindirect, BED via 
depression = -0.103, p = 0.282; βindirect, BED via anxiety = -0.096, p = 0.329); rather, those direct 
effects remained strong (βdirect, BED with depression = -0.404, p = 0.027; βdirect, BED with anxiety = -
0.411, p = 0.014).  Results of the model depicted in Figure 13c indicate that BED and 
symptoms of depression and anxiety do not interdependently influence caloric intake.  
That is, neither the model including depression, nor the model including anxiety yielded 
significant partial path coefficients for an interaction between BED and the 
corresponding depression or anxiety symptoms (βBED x depression = -0.279, p = 0.598; βBED x 
anxiety = -0.268, p = 0.609) after taking into account their combined main effects; in each 
case, accounting for less than 1% of the total variance. 
As described above, post-hoc analyses were conducted with 10,000 permuted 
datasets to determine whether the results observed with respect to the first theoretical 
model (i.e., BED mediating the association between symptoms of depression and anxiety 
and caloric intake) were simply due to chance and/or an artifact of the modest size of the 
present sample.  The null distributions generated from these analyses suggested that the 
indirect effects of both depression and anxiety through BED were highly significant, as 
far fewer than 5% of the tests exceeded the p-values observed in the original data.   In 
fact, of the 10,000 randomly generated datasets, only seven yielded indirect effects of 
depression through BED that were more significant than the effect observed in the 
original data (p = 0.0008), with only thirty-eight indirect effects of anxiety on BED 
exceeding the observed level of significance (p = 0.0009). 
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DISCUSSION 
 
The purpose of this study was to examine models by which internalizing symptoms of 
depression and anxiety influence food intake in overweight/obese women. Our results 
indicate that BED women endorse significantly more symptoms of depression and 
anxiety. Additionally, linear regression indicated that BED diagnosis and internalizing-
symptoms accounted for 30% of the variance in kcal-intake. Furthermore, results from 
path analysis imply that BED mediates the influence of internalizing-symptoms on total 
kcal-intake, which suggests the associations between internalizing-symptoms and food 
intake are best described as operating indirectly through a BED diagnosis.  
The present study found that overweight/obese women with BED endorsed more 
symptoms of depression and anxiety than non-BED weight-matched controls. Mean 
scores for the BDI and the BAI indicated mild depression and anxiety in the BED group 
but normal levels in the control group. Other studies have found elevated depression and 
anxiety scores in BED individuals (285, 292, 312, 313, 324, 325). For example, in a study 
by Fandino et al., depression and anxiety scores were significantly greater in the BED 
group than the obese control group as assessed by the Symptom Checklist 90 and the BDI 
(325). The lifetime prevalence of MDD in the BED and control groups was 46.7% and 
29.4% respectively.  These rates are similar to previous reports in BED (21, 295, 311-
313) and non-BED obese groups (20). Lifetime prevalence of anxiety disorders was 
similar to rates of depression in the BED group (46.7%) but was much lower in the 
control group (11.8%). It is possible that the lower rates of anxiety disorders in the 
control group were due to the inclusion of overweight women or was an artifact of the 
limited sample size. 
Laboratory studies have demonstrated that those with BED have greater total food 
intake than obese controls when instructed to overeat (285, 288, 290, 292, 305, 306, 308-
310). Two such studies have reported on both food intake and depression symptoms (285, 
292). In a sample of 10 obese BED women and 9 obese controls, Yanovski et al., found 
that the BED group consumed significantly more kcals (2962 vs 2017) and had 
significantly greater depression scores as measured by the BDI (18.9 vs 5.4) than 
controls. Additionally, they observed significant positive correlations between kcal intake 
and BDI score (r2 = 0.41) and between binge meal energy intake and BDI (r2 = 0.28). 
Geliebter and colleagues compared consumption of a liquid test-meal for 30 obese BED 
individuals (18 women) and 55 obese controls (43 women). The BED group consumed 
significantly more grams (1,032 vs 737) of the liquid test meal and endorsed significantly 
higher depression scores assessed by the Zung Depression Scale. However, a significant 
correlation between test meal intake and depression score was not found. The 
discrepancy could be due to several study design differences, including proportion of 
BED and control participants, inclusion of men and type of food intake (solid vs. liquid 
meal).  
Furthermore, results from linear regression indicated that BED diagnosis and 
symptoms of depression and anxiety accounted for a significant amount (~30%) of the 
variance in caloric intake. However, examination of the three alternative models revealed 
important mechanistic differences in the relationship between BED, symptoms of 
depression and anxiety and subsequent energy intake. The model that best fit our data 
indicated that BED mediated the influence of depression and anxiety symptoms on total 
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kcal intake (Figure 13a). Specifically, our results suggest that the associations found 
between symptoms of depression and anxiety and food intake are best described as 
operating indirectly through a BED diagnosis. That is, symptoms of depression and 
anxiety influence whether one engages in pathological binge eating, which, in turn, 
influences caloric intake. Our findings did not support model b (BED predicted 
symptoms of depression and anxiety which, in turn, influence kcal intake) or model c (a 
significant interaction between symptoms of depression and anxiety and BED as being 
predictive of kcal intake). 
These results highlight the importance of mood in relation to a BED diagnosis and 
subsequent caloric intake. Other research has also implicated mood in BED. Telch et al. 
interviewed 60 obese women with BED regarding their definition of binge eating and 
33% reported it as eating to regulate negative affect (326). With the advent of Ecological 
Momentary Assessment procedures (EMA), prospective data on precursors to binge 
eating in the natural environment have been collected (327-331). A study by Stein et al. 
found in 33 obese women with BED that negative mood was significantly greater at pre-
binge times than at non-binge times and that participants attributed binge eating to mood 
more frequently than hunger or violation of extreme dietary restraint (abstinence 
violation) (329). Additionally, a study by Hilbert and Tuschen-Caffier, found that mood 
preceding a binge eating episode was more negative than mood prior to regular eating or 
at random assessments in a sample of 20 obese women with BED (330). Furthermore, in 
a meta-analysis of 36 EMA studies of BED and BN, negative affect was significantly 
greater preceding binge-eating relative to average affect and affect before regular eating 
(331). A growing body of literature implicates negative affect as a precursor to binge 
eating in BED. 
The implications of the present study are potentially relevant to the clinical 
treatment of BED and obesity. Research has indicated that mood and eating disorder 
diagnoses affect weight loss and other treatment efforts. For example, Pagoto et al. 
reported that both BED and depression were associated with less weight loss and 
depression was associated with study attrition (332). Furthermore, in BED treatment, 
depression symptoms have been associated with both attrition from cognitive-behavioral 
therapy and severity of eating disorder psychopathology (333). The current results 
suggest that targeting mood may be useful in the treatment of BED and accentuate the 
importance of considering mood and BED status in weight management. 
Among the major strengths of this study were utilizing path analysis to test 
relationships between BED, symptoms of depression and anxiety and kcal intake as well 
as using permutation procedures for model validation and statistical support. EMA 
studies have consistently demonstrated negative affect as a precursor to binge eating 
(331) in BED. However, these studies have relied on self-report of food intake. Research 
indicates that obese and BED populations tend to underreport their food intake (276-280, 
310, 334, 335). Therefore, a further strength of this work was the inclusion of laboratory 
measured food intake to avoid inaccuracies often associated with self-report of dietary 
intake. Potential limitations include limited sample size and age range, exclusion of male 
participants and use of self-report questionnaires to measure symptoms of depression and 
anxiety. Future research is warranted to confirm our findings and should seek to compare 
energy intake and depression and anxiety in both women and men. Greater understanding 
of the mechanisms underlying the associations of depression and anxiety symptoms, 
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binge eating and caloric intake will facilitate the development of more effective 
prevention and treatment strategies for both BED and obesity. 
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TABLES AND FIGURES 
 
Figure 13: Theoretical models of the associations between internalizing symptoms, binge 
eating and caloric intake 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 18. Theoretical models examined: (a) binge eating disorder mediates the 
associations between internalizing symptoms and kilocalorie intake, (b) internalizing 
symptoms mediate the association between binge eating disorder and kilocalorie intake, 
and (c) binge eating disorder interacts with internalizing symptoms in the prediction of 
kilocalorie intake. Note: Internalizing = symptoms of depression and anxiety. 
  
Binge Eating 
Diagnosis 
Internalizing 
Symptoms 
Kcal 
Intake 
Internalizing 
Symptoms 
Binge Eating 
Diagnosis 
Kcal 
Intake 
Binge Eating 
Diagnosis 
Kcal 
Intake 
Internalizing 
Symptoms 
Internalizing 
x 
Binge Eating 
(a) 
(b) 
(c) 
 
 
 
 
106  
Table 28: Group means and inter-correlations for study variables 
 
* p < 0.05; ** p < 0.01; *** p < 0.001 
 
Note: Off-diagonal cells depict Pearson’s correlation coefficients for participants 
diagnosed with binge eating disorder (top; n = 15), controls (middle; n = 17), and the 
overall sample (bottom; n = 32); values on the diagonal reflect means and standard 
deviations for cases (top) and controls (bottom), with bold-face type indicating group 
differences (p < 0.01) as assessed via F-statistic with 1, 30 degrees of freedom. 
 
 
  
 1 2 3 4 5 
1. Age 
 
30.1 (6.7) 
31.3 (8.5)     
2. Body Mass Index (kg/m2) -0.17 
-0.14 
-0.15 
34.3 (5.5) 
34.9 (7.2)    
3. Depression Symptoms -0.09 
0.06 
-0.04 
-0.33 
0.34 
0.04 
10.1 (4.8) 
4.8 (5.0)   
4. Anxiety Symptoms -0.05 
0.35 
0.04 
-0.29 
0.24 
-0.08 
0.34 
0.66** 
0.57*** 
8.5 (6.5) 
2.7 (3.1)  
5. Kilocalorie Intake -0.10 
-0.26 
-0.19 
    -0.06 
     0.54* 
  0.02 
0.28 
0.15 
0.41* 
0.27 
0.00 
0.40* 
2305.1 (834.0) 
1461.8 (641.9) 
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Table 29: Lifetime clinical depression and anxiety diagnoses by group 
Diagnosis 
BED 
n 
(%) 
Control 
n 
(%) 
Chi-square p-value 
     
BDI-Mild 9 (60%) 
3 
(17.6%) 6.10 0.014 
BAI-
Mild/Moderate 
5 
(33.3%) 
1 
(5.9%) 3.94 0.047 
MDD 7 (46.7%) 
5 
(29.4%) 1.01 0.314 
Dep NOS 1 (6.7%) 
0 
(0%) 1.17 0.279 
GAD 1 (6.7%) 
0 
(0%) 1.17 0.279 
Social Phobia 4 (26.7%) 
1 
(5.9%) 2.61 0.106 
Specific Phobia 2 (13.3%) 
0 
(0%) 2.42 0.120 
Panic Disorder 1 (6.7%) 
0 
(0%) 1.17 0.279 
PTSD 1 (6.7%) 
0 
(0%) 1.17 0.279 
Anx NOS 0 (0%) 
2 
(11.8%) 1.88 0.170 
Any Dep Dx 8 (53.3%) 
5 
(29.4%) 1.89 0.169 
Any Anx Dx 7 (46.7%) 
2 
(11.8%) 4.80 0.028 
Any Dep/Anx Dx 10 (66.7%) 
6 
(35.3%) 3.14 0.077 
     
Note: BED = binge eating disorder, Chi-square = Pearson’s Chi-square 1 degree of 
freedom test, BDI-Mild = mild depression as assessed by the Beck Depression Inventory 
which corresponds to scores 10-18, BAI-Mild/moderate = mild to moderate anxiety as 
assessed by the Beck Anxiety Inventory which corresponds to scores 8-25, MDD = major 
depressive disorder, Dep NOS = depressive disorder not otherwise specified, PTSD = 
post traumatic stress disorder, Anx NOS = anxiety disorder not otherwise specified, Any 
Dep Dx = any DSM-IV depressive disorder diagnosis, Any Anx Dx = any DSM-IV 
anxiety disorder diagnosis, Any Dep/Anx Dx = any DSM-IV depressive or anxiety 
disorder diagnosis, dysthymic disorder and obsessive compulsive disorder were omitted 
from table because no participants met criteria for these disorders. 
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Table 30: Standardized effects coefficients, standard errors and corresponding p-values 
for mediation models 
 
 
 
a corresponding to the two-tailed test statistics for models run with sample data. 
b corresponding to the two-tailed test statistics for a series of analyses with 10,000 
permuted datasets. 
Note: BED = binge eating disorder, Signs of effects reflect coding of BED status as 1 and 
control as 2 in all analyses. 
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Chapter 7:  Genetic and environmental associations between 
body mass index, depression symptoms and impulsivity in a 
population-based sample of twins: VA30k 
 
 
Adapted from: On the association of body mass index and depression in a population-based 
sample of twins. Roseann E. Peterson, B.A., Hermine H. Maes, Ph.D., Lindon J. Eaves, Ph.D., 
D.Sc., Presentation, June 19, 2009. Behavior Genetics Association. Minneapolis, Minnesota. 
 
 ABSTRACT 
 
Obesity and major depressive disorder each represent diseases with complex 
etiologies which pose a significant burden to public health, affecting 33 and 16 percent of 
Americans, respectively. Reported heritability estimates are moderate-to-high and studies 
suggest both positive and negative correlations of these traits. Impulsivity is likely 
involved in the link between obesity and depression, as it has been associated with each. 
Despite numerous phenotypic associations between these traits, there has been a lack of 
reports in the literature investigating genetic and environmental associations between 
these phenotypes. Therefore, the purpose of this research was to use twin study 
methodology to investigate if shared genetic and/or environmental liability is potentially 
responsible for phenotypic associations found between relative body weight, depression 
symptoms, and impulsivity. Participants were ascertained through the Virginia Twin 
Registry and a volunteer twin sample solicited through the American Association of 
Retired Persons (n=14,457 twins, 63.8% female). Female respondents were found to have 
significantly lower body mas index (BMI) and impulsivity scores (Eysenck Personality 
Questionnaire), but significantly higher depression symptom scores (Symptoms 
Checklist) than males. A significant quadratic relationship was found between BMI and 
depression symptoms, indicating that those with the highest and the lowest BMI were 
more likely to have greater depression scores. Bivariate twin modeling results did not 
indicate a significant genetic or environmental correlation between BMI and depression 
symptoms. However, significant genetic and environmental correlations were found 
between BMI and impulsivity (rG =0.115, rE=0.046) and a significant genetic correlation 
between depression and impulsivity (rG=0.075). Trivariate independent pathway twin 
modeling indicated shared genetic and environmental liability between these traits, 
although, some sex differences were observed. A common genetic factor accounted for 2-
16% of the genetic variance in these traits. For females, an environmental factor common 
to BMI and impulsivity accounted for 0.5% of the environmental variance in BMI and 
62% in impulsivity. For males, an environmental factor common to depression symptoms 
and impulsivity accounted for 0.5% of the environmental variance in depression 
symptoms and 56% in impulsivity. Our findings warrant future research in order to 
confirm these results in additional cohorts as well as to examine how shared genetic risk 
may impact gene identification efforts. 
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INTRODUCTION 
 
Obesity and major depressive disorder (MDD) represent serious public health problems 
and research suggests a prominent sex difference in both, with women appearing to be at 
increased risk (176, 336). According to the National Center for Health Statistics over 
33% of American adults are considered obese while another 33% are overweight (127). 
Obesity is a general medical condition, defined clinically by a body mass index (BMI) 
greater than 30 kg/m2, and is associated with increased risk of numerous medical 
conditions including cardiovascular disease, insulin-resistance, cancer, and poor quality 
of life (12, 127). Similarly, depression is a debilitating psychiatric condition that has 
demonstrated correlations with decreased quality of life, impaired social functioning, 
eating disorders, substance abuse, and cardiovascular disease (295, 336-338). As reported 
by the 2006 National Comorbidity Survey Replication, the lifetime history estimates of 
MDD are 12.7% in men and 21.3% in women (90). However, within obese populations, 
reported lifetime prevalence rates of depression have been shown to be elevated upwards 
of 32% (20). Additionally, Strine et al. found adults with a current or lifetime diagnosis 
of depression were significantly more likely to engage in unhealthy behaviors such as 
physical inactivity and to be obese (20). Cross-sectional studies of BMI and depression 
have reported positive(93-97), negative (primarily in males) (98, 99) and no association 
(100-102) between these traits. However, a population based study from the Netherlands 
found a quadratic (U-shaped) association of BMI and depression indicating those with the 
lowest and the highest relative body weight were more likely to present with depression. 
In light of current DSM-IV MDD criteria, which include items related to increase and 
decrease in appetite, weight and energy expenditure, it is feasible that BMI in 
underweight and obese individuals may be associated with greater levels of depression 
(103). Further research is needed to clarify the nature of the association between body 
weight and depression. 
 A growing body of research implicates impulsivity in the development and 
maintenance of obesity. A national study found 17% of the general American population 
to be impulsive, with odds greater for men and those of younger ages (339). Impulsivity 
has been considered a multi-dimensional construct consisting of several components: 
urgency, lack of perseverance, lack of premeditation and sensation seeking (340). Obesity 
has been associated with dimensions of impulsivity based on both self-report and 
laboratory-based paradigms (341-348). For example, research conducted using the Iowa 
Gambling Task has shown obese groups tend to choose immediate rewards, even when 
future long-term negative consequences are associated with them (342, 345). 
Furthermore, impulsivity has been associated with dietary disinhibition and may 
represent a mechanism by which impulsivity may influence body weight via the inability 
to control what or how much one is eating (349). Dietary disinhibition, a construct from 
the Three Factor Eating Questionnaire which reflects a responsiveness to food stimuli and 
eating in response to emotional states (350), has been associated with BMI, obesity, over-
eating, decreased healthy food choices, and eating disorders including BED and BN, with 
less weight loss and with lower levels of physical activity (for a literature review see 
Bryant et al. 2007) (351, 352) .   
Impulsivity has been shown to be comorbid with psychiatric disorders. A recent 
report indicated 83% of those who endorsed impulsivity in a sample of American adults, 
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also met criteria for lifetime history of at least one psychiatric disorder (339). Research 
reports positive associations between impulsivity and depression. For example Peluso et 
al., found significantly higher trait impulsivity, as assessed by the Barratt impulsivity 
scale (BIS), in participants with comorbid bipolar and MDD than controls (353). 
Additionally, work by our group found a significant positive correlation (r=0.354) 
between BIS scores and depression symptoms, as measured by the Beck depression 
inventory, in a sample of obese women with and without binge eating disorder (Peterson 
et al., in preparation). Furthermore, impulsivity has been shown to be a predictor of 
future MDD diagnosis (339, 354) and suicidality in depressed persons (355-358). 
Research indicates that genetic factors influence individual differences in BMI, 
depression and impulsivity. Twin, adoption and family studies have consistently shown a 
significant genetic contribution to body composition with heritability estimates ranging 
40 to 70% (34-36). Heritability estimates for depression symptoms have been estimated 
between 30 and 40% (359) and for MDD between 40 and 50% (360). A large meta-
analysis of 11,100 adults indicated impulsivity was moderately heritable, with 31% of the 
phenotypic variance due to additive genetic effects and 10% to dominance(361). Dietary 
disinhibition, an impulsivity-associated trait, has been shown to be moderately heritable 
with 45% of the variance due to additive genetic effects (362).  
To date two family studies have examined the genetic and environmental 
architecture of depression and body composition (363, 364). The first, by Choy et al., 
was based on 2383 participants from the Netherlands Erasmus Rucphen Family study and 
did not find a significant genetic correlation between obesity and depression symptoms 
measured by the Center for Epidemiologic Studies Depression Scale (CES-D) or the 
depression subscale of the Hospital Anxiety and Depression Scale (HADS-D) (363).  
However, a study by Afari et al., using a sample of 993 female twin pairs from the 
University of Washington Twin Registry, found significant phenotypic (OR=1.6, 
95%CI=[1.2,2.1]) and genetic correlations (12%) between obesity and self-report 
endorsement of “Has your doctor ever told you that you have depression? (364).” Despite 
considerable phenotypic associations, there have been no twin and family studies 
reported in the literature investigating the genetic and environmental associations 
between BMI and impulsivity or depression and impulsivity. More research is needed to 
determine if shared genetic and/or environmental liability is responsible for the 
phenotypic associations found between these traits. Therefore, the purpose of this study 
was to examine phenotypic associations and the genetic and environmental architecture 
of BMI, depression symptoms, and impulsivity in a population based sample of twins, the 
Virginia 30,000 (VA30k).  
 
METHODS 
 
Participants and phenotypes 
 
Ascertainment for the VA30k sample was through two sources, a volunteer twin sample 
solicited through the American Association of Retired Persons and the Virginia Twin 
Registry. Participants completed the Health and Lifestyle Questionnaire, which included 
abbreviated versions of the Symptoms Checklist (SCL-90) and the Eysenck Personality 
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Questionnaire (EPQ). Depression symptom scores were calculated from 10 questions 
from the SCL-90 depression sub-scale and impulsivity scores were calculated from 7 
items from the EPQ impulsivity subscale. BMI, a standard measure of adiposity, was 
calculated from self-reported height and current weight. BMI categories were determined 
from standard clinical groups of underweight (<18.5), normal (18.5-24.9), overweight 
(25-29.9), obese (30-39.9) and morbidly obese (>40). BMI and depression scores were 
log transformed and impulsivity scores were arcsine transformed to meet assumptions of 
normality. Analysis of variance (ANOVA) was used to determine if there were 
significant differences in study variables by BMI category and age. Tukey’s HSD 
multiple comparison procedure was used to infer in which groups the differences 
occurred. To explore possible differences in depression symptom profiles between BMI 
categories ANOVA was applied to individual depression symptom items.  
 
Classical twin methodology 
 
The use of family data allows trait variance to be partitioned into the familial versus 
residual non-familial sources. In the classical twin design, covariances of MZ and DZ 
twins are used to estimate the magnitude of genetic and environmental causes of family 
resemblance (252). This methodology is premised upon monozygotic, or “identical”, 
twins (MZ) sharing all of their genes, while dizygotic, or “fraternal”, twins (DZ) sharing 
half of their genes on average, and MZ and DZ twins sharing trait-relevant environmental 
experiences to the same extent (equal environment assumption). Following this logic, the 
correlation between genetic components is modeled as1.0 for MZ twins and 0.5 for DZ 
twins. Under the assumptions of random mating, no genotype-environment correlation or 
interaction, and equal environments for MZ and DZ twins, a greater similarity between 
MZ versus DZ twins is attributed to additive genetic effects (A). Common environmental 
effects, as defined in biometrical twin modeling, refer to environmental influences that 
make family members more similar to each other. Therefore, by definition, these 
influences correlate 1.0 between both MZ and DZ twins. These shared environmental 
influences (C) will contribute to twin similarity in both MZ and DZ twins and will tend to 
increase DZ correlations relative to MZ correlations. However, non-additive genetic 
effects, known as dominance (D), tend to reduce the DZ correlation relative to MZ twins. 
The correlation of D is modeled as 1.0 between MZ twins and 0.25 for DZ twins. An 
additional source of variance is the unique environment (E), which includes factors in the 
environment that are not shared within families as well as random measurement error. 
Unique environmental influences are uncorrelated between co-twins and have the effect 
of decreasing the covariance between siblings. Furthermore, the principles of variance 
decomposition for the univariate case may be extended to estimating the covariance 
structure between multiple variables.  
 
Model-fit 
 
One approach to partitioning variance is to use structural equation modeling (SEM) and 
path analysis, which allows for flexible specification of models that include both latent 
(unobserved) and measured variables (253). In this study, SEM was used to examine the 
genetic and environmental architecture of BMI, depression symptoms, and impulsivity 
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for both univariate and multivariate modeling. Model parameters were estimated by full 
information maximum likelihood using OpenMx(256) in R(210). The goodness-of-fit 
was assessed by the likelihood-ratio test, which compares minus twice the log likelihood 
(-2LL) of models. This approximates a χ2-distribution and may be used for significance 
testing. Additionally, the relative parsimony of alternative models was assessed by 
Akaike’s Information Criterion (AIC), with smaller values indicating better fit. 
 
Univariate twin modeling and sex-limitation 
 
Univariate models were applied to estimate heritability of individual traits, test the 
random sample assumption, and determine if there were significant sex differences in the 
genetic and environmental architecture of the phenotypes. Under the assumption that the 
twin sample reflects a random sample of the population, there should be no statistical 
differences on phenotypic mean or variance by twin order or type (zygosity). To test this 
assumption in the VA30k, phenotypic means and variances were equated by twin order 
and zygosity to determine if the model fit is significantly worse when compared to the 
model that estimated them freely. If no differences were found this suggested that the 
random sample assumptions were met. If significant differences were found, then these 
could indeed be due to the sample not being random or to some form of social interaction 
(i.e., sibling cooperation). Furthermore, if there are significant differences in trait 
variance by gender then it is possible that sex limitation may account for this difference. 
Two sources of sex limitation are: (1) quantitative, also known as scalar sex limitation, 
defined as sex differences in the magnitude of the genetic or environmental components 
and (2) qualitative, or non-scalar sex limitation, regarded as differences in the actual sets 
of genes or family environments that influence traits for males and females. For the latter 
source of sex limitation, addition of opposite sex DZ twins (DZo) to analyses is 
necessary. In designs of twins reared together, C and D sources of variance cannot be 
estimated simultaneously. Therefore, ACE and ADE models were tested separately. 
Along with ACE/ADE models, quantitative and qualitative sex differences were formally 
tested for BMI, depression symptoms, and impulsivity.  
 
Bivariate twin modeling 
 
To test for genetic and environmental contributions to the covariance between two traits, 
bivariate Cholesky decomposition was applied. This parameterization allows the 
phenotypic variance to be partitioned into (1) genetic/environmental components that 
account for variance in trait one and covariance with trait two and (2) a second 
genetic/environmental component accounting for the residual variance in the second trait, 
not accounted for by the first factors. As such, the ordering of the variables determines 
the interpretation (i.e., how much of the genetic variation in trait two is shared with trait 
one) [169, 179]. The specification of ACE/ADE models was dependent on best-fit models 
from univariate modeling. To simplify the full model, A and C/D common and specific 
factors and E common factors were dropped one-by-one from the model. Specific unique 
environmental effects were not dropped as these include errors of measurement. 
 
Trivariate twin modeling 
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To test for shared genetic and environmental liability between BMI, depression 
symptoms and impulsivity, multivariate Cholesky parameterization and independent 
pathway (IP) models were fit to the data. Trivariate Cholesky decomposition was used as 
baseline fit for IP model comparison. As depicted in Figure 26, IP models were specified 
to partition phenotypic variance into genetic and environmental factors that were shared 
across all three phenotypes as well as components that were trait specific (243, 253). 
These models allow for the contributions of the common factors on the measured 
phenotypes to be different for each of the sources of variance, hence the name 
‘independent pathways’. IP model fitting began with two common factors for each source 
of variance, A, D and E, along with specific A, D and E for each variable. To simplify the 
full model, A and D common and specific factors and E common factors were dropped 
one-by-one from the model. As noted with previous models, specific unique 
environmental effects were not dropped as these include errors of measurement.  
 
RESULTS 
 
Phenotypic associations between age, BMI, depression symptoms, and impulsivity 
 
BMI data was available for n=14,457 twins, of whom n=9,227 (63.8%) were female. The 
mean age was 52.3 and 48.9 years for females and males, respectively. As depicted in 
Figure 14, females tended to be older than males (F(1,14357)=119.1, p=1.25x10-27). 
Mean BMI was significantly lower for females (23.8 kg/m2) than for males (25.1 kg/m2) 
(F(1,14455)=310.1, p=1.05x10-27) and sex accounted for 2% of the phenotypic variance 
in BMI. Figure 15 displays the distribution of BMI by weight category and sex. Based on 
a definition of BMI greater than 30 kg/m2, 12% of the sample was considered obese. A 
quadratic association was observed between age and BMI, which accounted for 5.5% of 
the phenotypic variance in BMI (Figure 16). 
Depression symptom scores, as assessed by the SCL-90 subscale, indicated that 
females endorsed significantly higher rates of depression symptoms than males (14.0 
females, 13.5 males, F(1,14118)=306.8, p=5.69x10-68). Additionally, age was found to be 
significantly associated with depression symptoms. Specifically, depression scores tended 
to be greater at younger ages (Figure 17). There was not a significant correlation between 
BMI and depression scores in females. However, in males a small negative correlation 
was observed (r=-0.06, p=1.8x10-6). As depicted in Figure 19, the depression symptom 
score was found to have a significant quadratic association with BMI, which accounted 
for 0.2% of the phenotypic variance. Exploration of depression symptom profiles by BMI 
category indicated similar endorsement of specific depression items for the underweight 
and obese groups, except loss of sexual interest, which showed no association with BMI 
status (Figure 22). 
Impulsivity scores, as assessed by the EPQ subscale, indicated that males 
endorsed significantly higher rates of impulsivity symptoms than females (0.459 females, 
0.485 males, F(1,12670)=26.9, p=2.19x10-7). In addition, age was found to be 
significantly associated with impulsivity score, with greater impulsivity observed at 
younger ages (Figure 18). As depicted in Figure 20, the impulsivity score was found to 
 
 
 
 
115  
have a significant positive association with BMI, which accounted for 0.7% of the 
phenotypic variance. Additionally, a small but significant correlation was found between 
depression symptoms and impulsivity in females (r=0.045, p=6.0x10-5) and males 
(r=0.070, p=2.2x10-6). Standardized depression symptom and impulsivity scores are 
displayed together by BMI category in Figure 21. 
 
Univariate and sex-limitation twin modeling  
 
The phenotypic means and variances of BMI are presented by twin order and zygosity 
type in Table 31. Means and variances were equated across twin order and across 
zygosity groups of the same sex without significant loss of model fit, indicating that 
assumptions regarding random population samples had been met (Table 32). However, 
means and variances could not be equated between males and females, which was 
suggestive of possible sex effects. Therefore, sex limitation models were applied in order 
to test for quantitative and qualitative differences between males and females. Variance 
component modeling results are displayed in Table 33 (ACE) and Table 34 (ADE). 
According to the AIC, the best fitting model was an AE model, with the genetic 
correlation between males and females being estimated. The results indicated that 
additive genetic effects accounted for 77% of the variance in females and 75% in males. 
The genetic correlation between males and females was estimated at 0.820 (95% CI = 
[0.697,0.956]), indicating significant qualitative sex differences although a considerable 
amount of the additive genetic effects associated with BMI was shared between males 
and females. These findings suggested that the increased phenotypic variance in females 
was due, in part, to greater additive genetic variance. 
The phenotypic means and variances of depression symptoms, as assessed by the 
depression subscale of the SCL-90, are presented by twin order and zygosity type in 
Table 35. Means and variances could be equated across twin order and across zygosity 
groups of the same sex without significant loss of model fit (Table 36). However, means 
and variances could not be equated between males and females, which was suggestive of 
possible sex effects. Therefore, sex limitation models were applied to test for quantitative 
and qualitative differences between the sexes. Variance component modeling results are 
displayed in Table 37 (ACE) and Table 38 (ADE). Based on the AIC, the best fitting 
models were an ACE model in females and an AE model in males, with the genetic 
correlation between males and females equated to one, which indicates no qualitative sex 
differences for additive genetic effects. Results indicated additive genetic effects 
accounted for 28% and 36% of the variance in females and males, respectively, with 
approximately 8% of the variance in females due to shared environment. 
The phenotypic means and variances of impulsivity, as assessed by the subscale 
of the EPQ, are presented by twin order and zygosity type in Table 39. Means and 
variances could be equated across twin order and across zygosity groups of the same sex 
without a significant drop in model fit (Table 40). However, means and variances could 
not be equated between males and females, suggesting possible sex effects. Therefore, 
sex limitation models were applied to test for quantitative and qualitative differences 
between males and females. Variance component modeling results are displayed in Table 
41 (ADE). According to the AIC, the best fitting models were an ADE model in females 
and an AE model in males, with the genetic correlation between males and females 
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equated to one. The results indicate additive genetic effects accounted for 8% and 32% of 
the variance in females and males, respectively, with approximately 24% of the variance 
in females accounted for by dominant genetic effects. 
 
Bivariate twin modeling 
 
Bivariate models were fit to BMI and depression symptoms and results are given in Table 
42a. According to the AIC, the best fitting parameterization was model V, which 
indicated there were no statistically significant shared genetic or environmental liabilities 
between BMI and depression symptoms. The proportion of variance due to ACE factors 
is shown in Figure 23.  
Variance decomposition models of BMI and impulsivity are displayed in Table 
42b. The best fitting model according to AIC was III.b, which indicated that there were 
statistically significant shared genetic (rG = 0.115, 95%CI = [0.053,0.178]) and 
environmental correlations (rE = 0.046, 95%CI = [0.011,0.082]) between BMI and 
impulsivity symptoms. The relative proportion of ADE components are depicted in 
Figure 24. The proportion of the variance in impulsivity due to genetic effects shared 
with BMI was 2.8% and 4.4%, in females and males respectively, corresponding to 8.3% 
and 13% of the total genetic variance. The proportion of the variance in impulsivity due 
to environmental effects shared with BMI was 1.9% for females (2.8% of total 
environmental variance) and 1.5% for males (2.3% of total environmental variance).  
Results of bivariate model-fitting for depression and impulsivity are displayed in 
Table 42c. According to AIC, the best fitting model was IV, which indicated a 
statistically significant shared genetic correlation (rG = 0.075, 95%CI = [0.003,0.151]) 
between depression and impulsivity symptoms. The variance decomposition is shown in 
Figure 25. The proportion of the variance in impulsivity due to genetic effects shared 
with depression symptoms was 1.3% for females and 2.2% for males, which 
corresponded to 4.0% and 6.5% of the total genetic variance.  
 
Trivariate twin modeling 
 
To test for shared genetic and environmental liability between BMI, depression 
symptoms and impulsivity, multivariate Cholesky parameterization and independent 
pathway models were fit to the data. The parameter estimates and fit-statistics are 
displayed in Table 43 and Table 44. The best fitting model according to the AIC was IP 
model IV.b and is depicted in Figure 27. The results indicated a significant common 
genetic factor that loaded on all traits, as well as, genetic effects specific to each 
phenotype. The common genetic factor exhibited sex differences, in that the factor loaded 
positively on all traits in females, but in males it loaded positively on impulsivity and 
BMI but negatively on depression symptoms. In addition, a significant environmental 
factor was found to load on impulsivity and BMI in females and on impulsivity and 
depression symptoms in males, further demonstrating sex differences in the nature of 
these traits.  
 The proportion of variance in BMI accounted for by ADE components is 
displayed in Figure 28. In females, 77% of the variance in BMI was due to additive 
genetic effects, of which 3.8% was due to shared effects with impulsivity and depression 
 
 
 
 
117  
symptoms, 66.7% was specific to BMI, and 29.5% was female specific effects and 23% 
of the variance was due to environmental components, of which only 0.5% was due to 
effects shared with impulsivity. In males, 75% of the variance in BMI was due to additive 
genetic effects, of which 16% was due to shared effects with impulsivity and depression 
symptoms and 84% was specific to BMI. The remainder of the phenotypic variance was 
due to a BMI specific environmental component (25%). 
  The ADE variance decomposition for depression symptoms is shown in Figure 
29. In females, 35% of the variance was due to genetic effects, of which 2% was due to 
an effect shared with BMI and impulsivity, and 65% of the variance was due to 
environmental factors specific to depression symptoms. In males, the proportion of 
variance due to genetic factors was 38%, of which, 1.5% was an effect shared with BMI 
and impulsivity, 36% was accounted for by effects due to dominance, and 62.5% was an 
effect specific to depression symptoms. The environment accounted for 62% of the 
variance, of which, 0.5% was due to environmental effects in common with impulsivity. 
The proportion of variance in impulsivity symptoms accounted for by ADE 
components is depicted in Figure 30. In females, 32% of the variance was due to genetic 
effects, of which 14% was from the common genetic factor, 15% from a specific additive 
genetic component, and 71% due to specific dominance. The environment accounted for 
68% of the variance, of which, 62% was due to the shared factor with BMI and the 
remainder (38%) was an environmental component specific to impulsivity. In males, 32% 
of the variance was due to genetic effects, of which, 12% was from the common genetic 
factor and 88% from an impulsivity specific additive genetic component. The 
environment accounted for 68% of the variance, of which, 56% was due to the shared 
factor with depression symptoms and the remainder of the variance from an 
environmental component specific to impulsivity (44%). 
 
DISCUSSION 
 
The purpose of this research was to examine phenotypic associations between BMI, 
depression symptoms and impulsivity and to test for shared genetic and environmental 
liability between these traits in a population-based sample of twins. As expected, our 
results indicated that women had significantly greater depression symptoms and lower 
impulsivity than men, and significant positive correlations between BMI and impulsivity, 
and between depression symptoms and impulsivity were observed. However, rates of 
obesity in the VA30k sample (12%) were lower than expected given current national 
estimates (33%). According to national health reports, obesity rates doubled among 
American adults between 1980 and 2000, which may explain, in part, the lower obesity 
rate in the VA30k sample, as it was collected during this timeframe.  
Reported associations between body weight and depression have been conflicted, 
with reports of positive, negative and no association between them. Our results indicated 
a curvilinear relationship between BMI and depression symptoms, signifying that those 
with the highest and the lowest relative body weight were more likely to endorse 
depression items. These findings are in agreement with a population-based study from the 
Netherlands which found a robust U-shaped association between BMI and depression 
symptoms. It is possible that the mixed findings on the nature of the BMI-depression 
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relationship may be due, in part, to the assumption that there is a linear association 
between these traits when indeed it may be curvilinear. Furthermore, examination of 
depression symptom profiles by weight category indicated similar endorsement of 
specific depression items for the underweight and obese groups. These findings suggest 
that there may not be differences in depression profiles by BMI group but rather that 
those with the highest and the lowest BMIs tend to endorse more symptoms overall. 
Since both women and those with the highest and lowest BMI’s were more likely to have 
increased depression scores, these groups might be targeted for prevention and 
intervention efforts. 
 We applied multivariate twin methods to test for shared genetic and/or 
environmental liability between these traits. The bivariate twin modeling results did not 
indicate a significant genetic or environmental correlation between BMI and depression 
symptoms. Our results are in agreement with a Dutch family study by Choy et al. which 
did not find a significant genetic correlation between BMI and depression symptoms 
(363). However, Afari et al. reported a significant genetic correlation between obesity 
and self-report endorsement of clinical depression in a sample of female twin from the 
USA, with this correlation accounting for 12% of the genetic variance (364). It is 
conceivable that the discrepancies in findings are due in part to different measures of 
depression (symptoms vs. diagnosis). Further research utilizing genetically informative 
designs are needed to determine the genetic and environmental structure of comorbidity 
between body composition and depression and, in particular, whether incorporating 
depression symptoms versus clinical depression and its subtypes will reveal significant 
differences in this architecture.   
The results from our bivariate analyses on BMI and impulsivity indicated a 
significant genetic correlation (rG =0.115) between these traits with 8.3% and 13% of the 
genetic variance in impulsivity due to effects shared with BMI in females and males, 
respectively. Additionally, a significant environmental correlation (rE=0.046) was also 
found between these traits indicating ~2.5% of the environmental variance in impulsivity 
was due to effects shared with BMI. Furthermore, when examining depression symptoms 
and impulsivity a significant genetic correlation (rG=0.075) was observed, indicating 4% 
and 6.5% of the genetic variance in impulsivity was due to effects shared with depression 
symptoms in females and males, respectively. To our knowledge, this is the first twin 
study to report on shared liability between BMI and impulsivity and between depression 
symptoms and impulsivity. 
The findings from our trivariate twin modeling indicated a significant common 
genetic factor influencing all three traits. However, we observed significant sex 
differences, as a positive association was found for all traits for females, but in males this 
genetic factor was positively associated with BMI and impulsivity but negatively 
associated with depression symptoms. This suggests that for females, a genetic 
component exists which is associated with greater impulsivity, BMI and depression 
symptoms, while in males this genetic component is associated with greater impulsivity 
and BMI but with decreased depression symptoms. This common genetic factor 
accounted for different proportions of the genetic variance in each trait as well as some 
sex differences were observed. The proportion of the genetic variance accounted for by 
this genetic factor was for BMI 3.8% in females and 16% males; for depression 
symptoms ~2.5%; and for impulsivity 12-14%. In females, an environmental factor 
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common to BMI and impulsivity accounted for 0.5% of the environmental variance in 
BMI and 62% in impulsivity. In males, an environmental factor common to depression 
symptoms and impulsivity was observed, accounting for 0.5% of the environmental 
variance in depression symptoms and 56% in impulsivity. Our multivariate twin 
modeling results suggest that there are shared genetic and environmental factors between 
BMI, depression symptoms and impulsivity. Further research is warranted to confirm 
these results in other cohorts as well as to examine how shared genetic and environmental 
liability may impact gene identification efforts. 
A number of extensions to this work should be applied to future research. First, 
phenotypic associations in this sample indicated a significant quadratic effect of age on 
BMI as well as significant negative associations with depression symptoms and 
impulsivity. Future studies should incorporate these effects into modeling, in order to 
potentially detect differences in genetic and environmental liability by age. Furthermore, 
BMI and depression symptom scores were also found to have a curvilinear association. 
There are known limitations of structural equation modeling for the handling of nonlinear 
relationships. Additional research is needed to determine the effect of nonlinear 
relationships on variance decomposition methodology and parameter estimates. In 
addition, since classical twin designs may not model C and D components 
simultaneously, future models might utilize the extended twin design to determine the 
effect of each of these sources of variance on the covariance of these traits. Indeed, there 
are alternative models that may be applied, including models incorporating moderating 
effects of the environment as well as models of comorbidity (253, 365). For example, 
longitudinal phenotypic studies have found a reciprocal association between obesity and 
depression, suggesting that elevated BMI may increase depression and vice versa (91, 
92). Therefore, future research should apply models of comorbidity and test direction of 
causation in a genetically informative sample. To the best of our knowledge, this is the 
first multivariate twin study to report on the genetic and environmental architecture of 
BMI, depression symptoms and impulsivity. Our results indicate shared genetic and 
environmental risk between these traits. Future research is warranted to confirm our 
findings in additional cohorts and examine how shared genetic risk may impact gene 
identification efforts. 
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TABLES AND FIGURES 
 
Figure 14: Percent of sample by age and sex 
 
 
Figure 15: Percent of sample by weight category and sex 
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Figure 16: BMI by age and sex 
Figure 17: Depression score by age and sex  
Figure 18: Impulsivity score by age and sex 
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Figure 19: Depression symptoms by weight category and sex  
 
 
Figure 20: Impulsivity score by weight category and sex  
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Figure 21: Depression symptoms and impulsivity score by weight category   
 
 
 
 
124  
Figure 22: Depression symptom profile by weight category 
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Table 31: Means and variances by twin group for BMI in VA30k 
 
Group 
(pairs/singletons) 
Mean T1 
(Variance) 
Mean T2 
(Variance) Covariance Correlation 
 
      
MZ female 
(1894/84) 
31.51 
(3.07) 
31.51 
(3.00) 
2.33 0.772  
      
DZ female 
(1206/67) 
31.61 
(3.10) 
31.57 
(3.05) 
1.20 0.392  
      
MZ male 
(795/18) 
32.12 
(1.64) 
32.08 
(1.58) 
1.16 0.725  
      
DZ male 
(590/20) 
32.15 
(1.80) 
32.15 
(1.96) 
0.70 0.382  
      
DZ opposite sex 
(1354/43) 
32.13 
(2.00) 
31.38 
(2.97) 
0.77 0.318  
      
 
 
 
 
Table 32: Testing model assumptions for BMI VA30k 
 
Model EP -2LL Df AIC Diff LL Diff df p-value 
        
Saturated 25 42190.8 11885 18420.8 - - - 
Mean order 21 42193.2 11889 18415.2 2.4 4 0.66 
Variance order 17 42194.8 11893 18408.8 3.96 8 0.86 
Zyg same sex 13 42205.5 11897 18411.5 14.73 12 0.26 
Within sex 9 42213.3 11901 18411.3 22.52 16 0.13 
Across sex 7 42769.7 11903 18963.7 578.9 18 <0.01 
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Table 33: Univariate ACE Sex Limitation BMI VA30k  
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Table 34: Univariate ADE Sex Limitation BMI   
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Table 35: Means and variances of depression symptoms by twin group 
Group 
(pairs/singletons) 
Mean T1 
(Variance) 
Mean T2 
(Variance) Covariance Correlation 
     
MZ female 
(1910/67) 
0.527 
(0.12) 
0.521 
(0.12) 
0.042 0.325 
DZ female 
(1203/69) 
0.511 
(0.12) 
0.538 
(0.13) 
0.029 0.220 
MZ male 
(805/8) 
0.397 
(0.09) 
0.404 
(0.10) 
0.033 0.345 
DZ male 
(590/20) 
0.431 
(0.11) 
0.423 
(0.10) 
0.019 0.159 
DZ opposite sex 
(1362/35) 
0.430 
(0.11) 
0.541 
(0.12) 
0.019 0.154 
     
 
 
Table 36: Testing model assumptions (SCL-90) 
Model EP -2LL df AIC Diff LL Diff df p-value 
        
Saturated 25 7546.5 11914 -16281.5 - - - 
Mean order 21 7552.2 11918 -16283.8 5.75 4 0.22 
Variance order 17 7559.6 11922 -16284.5 13.06 8 0.11 
Zyg same sex 13 7567.5 11926 -16284.5 20.98 12 0.05 
Within sex 9 7577.2 11930 -16282.8 30.69 16 0.01 
Across sex 7 7844.8 11932 -16019.2 298.28 18 <0.01 
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Table 37: Univariate ACE Sex Limitation Depression Symptoms (SCL-90) VA30k 
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Table 38: Univariate ADE Sex Limitation Depression Symptoms (SCL-90) VA30k 
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Table 39: Means and variances of impulsivity (EPQ) by twin group VA30k 
Group 
(pairs/singletons) 
Mean T1 
(Variance) 
Mean T2 
(Variance) Covariance Correlation 
     
MZ female 
(1929/49) 
0.373 
(0.061) 
0.379 
(0.057) 
0.019 0.323 
DZ female 
(1226/45) 
0.380 
(0.064) 
0.373 
(0.058) 
0.007 0.113 
MZ male 
(803/7) 
0.412 
(0.059) 
0.400 
(0.056) 
0.018 0.313 
DZ male 
(588/19) 
0.426 
(0.057) 
0.410 
(0.063) 
0.012 0.189 
DZ opposite sex 
(1380/17) 
0.396 
(0.059) 
0.375 
(0.059) 
0.004 0.072 
     
 
 
Table 40: Testing model assumptions for impulsivity (EPQ) 
 
Model EP -2LL df AIC Diff LL Diff df p-value 
        
Saturated 25 -193.3 11964 -24121.3 - - - 
Mean order 21 -188.9 11968 -24124.9 4.42 4 0.35 
Variance order 17 -182.4 11972 -24126.4 10.90 8 0.21 
Zyg same sex 13 -180.2 11976 -24132.2 13.09 12 0.36 
Within sex 9 -176.8 11980 -24136.8 16.58 16 0.41 
Across sex 7 -141.7 11982 -24105.8 51.56 18 <0.001 
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Table 41: ADE models impulsivity (EPQ) VA30k 
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Figure 23: Proportion of variance in BMI and depression symptoms due to ACE 
components (Bivariate) 
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Figure 24: Proportion of variance in BMI and impulsivity symptoms due to ADE 
components (Bivariate) 
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Figure 25: Proportion of variance in depression symptoms and impulsivity due to ADE 
components (Bivariate) 
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Table 42: Bivariate models of BMI, depression & impulsivity 
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Figure 26: Trivariate independent pathway sex limitation model  
a. Females 
 
b. Males 
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Figure 27: Best fitting model 
a. Females 
 
b. Males 
 
 
 
 
 
  
 
 
1
21.0
1.7
bmiimp
0.20
1
Ac1
0.23
dep
Ec1
1
3.1
0.09 0.030.71
0.53
0.24
1
Ds1
1
As1
0.56
1
Es1
0.83
1
As2 0.55
0.55
1
Afs2
1
Es2
0.70
1
As3
0.96
1
Es3
1
21.4
1.8
bmiimp
0.32
1
Ac1
0.21
dep
0.06
Ec1
1
2.7
-0.07 0.67
0.58
1
As1
0.54
1
Es1
0.73
1
As2
0.45
1
Es2
-0.38
0.50
1
Ds3
1
As3
0.81
1
Es3
 
 
 
 
141  
Figure 28: Proportion of variance in BMI accounted for by ADE components (Trivariate) 
 
 
Figure 29: Proportion of variance in depression symptoms accounted for by ADE 
components (Trivariate) 
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Figure 30: Proportion of variance in impulsivity symptoms accounted for by ADE 
components (Trivariate) 
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Chapter 8:  Evidence of shared genetic risk between body 
composition and smoking behaviors 
 
Adapted from:  
1) On the genetic and environmental relationship of body mass index, smoking initiation 
and nicotine dependence in a population-based sample of twins. Roseann E. Peterson, 
Lindon J. Eaves, Hermine H. Maes. Presentation. XIX World Congress of Psychiatric 
Genetics, September 13th, 2011. Washington, D.C., USA.  
2) Evidence of Shared Polygenic Risk Among Smoking Behaviors and Body Composition. 
Roseann E. Peterson, Xiangning (Sam) Chen, Jingchun Chen, Bradley T. Webb, Hermine 
H. Maes. Presentation. 4th International Conference on Quantitative Genetics, June 21, 
2012. Edinburgh, Scotland, UK. 
 
ABSTRACT 
 
Obesity and nicotine dependence (ND) are complex, heterogeneous diseases, which pose 
a significant burden to public health, affecting 33 and 20 percent of Americans, 
respectively. Cross-sectional studies of ND are generally supportive of a negative 
relationship between smoking and body mass index (BMI), but a positive association is 
supported by the observation that within smoking cohorts, heavy smokers tend to be of 
increased body weight compared to light smokers. Genetic factors have consistently been 
demonstrated to influence individual differences in body mass index (BMI) and nicotine 
dependence (ND), with twin and family studies estimating heritabilities in the order of 
0.70 and 0.60 respectively. A growing body of evidence demonstrates the utility of 
genome-wide association studies (GWAS) for identifying single nucleotide 
polymorphisms (SNP) that contribute to disease risk. The GWAS approach has been 
applied to BMI and smoking behaviors (SB) using sample sizes in the tens of thousands, 
yielding several putative risk variants of small effects on individual traits. However, most 
studies do not examine common versus specific genetic effects, despite many complex 
traits demonstrating comorbidity. Moreover, without consideration of genetically-
correlated traits, the power of genome-wide studies of complex disease to detect 
etiologically relevant variation may be limited. Therefore, the purpose of this study was 
to investigate whether genetic variants affecting BMI or SB were common to multiple 
behaviors or were trait-specific. In total, 75 BMI and 54 SB associated SNPs were 
catalogued from large-scale GWAS meta-analyses and tested for association in n=2,802 
(41% African-American) older adults (68-80 years old) from the Health Aging and Body 
Composition study (Heath ABC). Results indicated current smokers had significantly 
lower BMI and abdominal visceral fat than never or former smokers in both sexes. We 
observed three BMI-associated SNPs also nominally associated with smoking traits: 
rs1900273 in STK33, rs2145270 near BMP2 and rs12127438 in the 1q42.2 locus. 
Additionally, three SB-associated SNPs were found to be nominally associated with body 
composition variables: rs11072774 in CHRNB4, rs2640732 in SCARA3 and rs6945244 in 
PDE1C. These findings are suggestive of partially shared genetic risk between smoking 
and body composition. Future research should confirm these associations and address 
putative mechanisms underlying this overlapping genetic architecture. 
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INTRODUCTION 
 
Obesity and nicotine dependence (ND) represent complex heterogeneous diseases 
affecting 33 and 20 percent of Americans, respectively (106, 127, 129). Both are 
associated with numerous medical conditions including cancer, cardiovascular disease 
and major depressive disorder (12, 127, 128, 366, 367). Phenotypic associations between 
smoking and body composition suggest a complex relationship and the causes of these 
associations remain incompletely understood. Cross-sectional studies of smoking 
behavior are typically supportive of a negative relationship between current smoking and 
body mass index (BMI) (109-111) which may be due in part to effects of nicotine on 
energy homeostasis including a reduction of energy intake (112-116) and enhanced 
capacity for energy expenditure (113, 368-370). Furthermore, the metabolic effects of 
nicotine might partially explain why smoking cessation is often followed by weight-gain 
(113, 117, 118). In contrast, however, a positive association is supported by the 
observation that within smoking cohorts, heavy smokers tend to be of increased body 
weight compared to light smokers (119-121). This may reflect a clustering of risky 
behaviors in addition to smoking- increased alcohol consumption, poor diet and reduced 
physical activity (371-374). Additionally, smoking has been associated with 
accumulation of visceral fat and increased waist circumference (122-124), which may be 
the result of nicotine’s effects on sex hormones (375, 376) and cortisol levels (377, 378). 
For these reasons, the elucidation of the genetic and environmental mechanisms 
underlying these associations remains an important public health endeavor. 
Genetic factors have consistently been demonstrated to influence individual 
differences in BMI and smoking behaviors (SB). Although an increase in energy intake 
coupled with reduced physical activity contributes to increases in adiposity, findings from 
twin and family studies have estimated large heritabilities on the order 0.70 for relative 
body weight (35, 36). Similarly, twin and family studies have estimated heritabilities in 
the order of 0.50-0.70 for smoking initiation and 0.60 for ND (379-383). To date, there 
have been no published multivariate twin and family studies on the genetic and 
environmental architecture of relative body weight and smoking behavior. However, our 
group has examined the possibility of shared genetic and environmental liability between 
BMI, smoking initiation and ND in a population-based sample of adult twins from the 
Virginia 30,000 study (n=14,177, 63.9% female). Preliminary results of fitting trivariate 
modified causal-contingent-common pathway models, which account for the contingency 
of ND on smoking initiation, found 1-5% of the variance in smoking initiation and 
nicotine dependence to be accounted for by genetic factors in common with BMI 
(Peterson et al., in preparation). Preliminary results are presented in SUPPLEMENTAL 
MATERIAL section of this chapter. 
Genome-wide association studies (GWAS) have successfully identified 
polymorphisms that contribute to disease risk for numerous complex traits and diseases 
(72). As applied to BMI and smoking behaviors (SB), GWAS have yielded several 
putative risk variants of small effects on individual traits using sample sizes in the tens of 
thousands. The first common single nucleotide polymorphisms (SNPs) associated with 
BMI and common obesity were in the fat mass and obesity-associated (FTO) gene and 
near melanocortin 4 receptor (MC4R) and have since been widely replicated (66, 130-
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135). Additionally, two large-scale BMI meta-analyses by Thorleifsson et al. (2009) and 
Willer et al. (2009) yielded 13 genetic loci reaching genome-wide significance, including 
the previously implicated variants in and near FTO and MC4R. A recent mega-analysis, 
performed on 249,796 individuals from 46 studies has confirmed 32 BMI-associated 
SNPs. Although highly significant, the identified genetic variants had modest effects, 
corresponding to a 0.06-0.4 kg/m2 change in BMI per allele, and modest odds ratios for 
obesity (BMI>30 kg/m2) ranging between 1.03 and 1.3.  
Similarly, large-scale GWAS for smoking traits have yielded putative risk 
variants of individually small effect. Three large meta-analyses of smoking initiation, 
consumption and cessation from Oxford-GlaxoSmithKline (Ox-GSK), the Tobacco and 
Genetics Consortium (TAG) and ENGAGE consortia were published as a series that 
included a combined analysis of over 140,000 individuals of European descent from 45 
studies (384-386). Findings from these studies revealed one region associated with 
smoking initiation on 11p14.1, which includes the brain-derived neurotrophic factor 
(BDNF) (385). Additionally, the combined analysis of all three studies yielded five loci 
associated with smoking quantity, including the previously identified 15q25 locus which 
harbors three genes encoding neuronal nicotinic acetylcholine receptor subunits 
(NAChR), CHRNA5, CHRNA3 and CHRNA4 (384-386); a second locus encoding 
NAChRs on 8p11 in and near CHRNB3 and CHRNA6 (386); variants on 19q13 in and 
near CYP2A6 and CYP2B6 that code nicotine metabolizing enzymes (385, 386); SNPs on 
7p14 in an intergenic region and variants on 10q25 in LOC100188997, a gene for non-
coding RNA (385). A single variant near the DBH locus (9q34) was found to be 
associated with smoking cessation; this gene encodes dopamine β-hydroxylase, which 
catalyzes the conversion of dopamine to norepinephrine. As in the aforementioned 
studies of body composition, smoking variants were highly significant but had modest 
effect on behavior, with odds ratios ranging from 1.06 to 1.12 (384-386).  
The causes of the observed associations between body composition and smoking 
behavior remain incompletely understood.  It is possible that these traits share a common 
liability influenced by genetic and environmental factors. For example, genetic variants 
in BDNF have been associated with increased body mass and also with smoking initiation 
(63-65, 385). However, despite many complex traits demonstrating comorbidity, most 
studies do not examine common versus specific effects. Therefore, the purpose of this 
study was to investigate whether genetic variants affecting BMI or smoking behavior 
were common to multiple behaviors or were trait specific in n=2,802 (41% African-
American) older community-dwelling adults (68-80 years old) from the Health Aging 
and Body Composition study (Health ABC). To the best of our knowledge, this is the 
first study to test BMI and SB variants in the same cohort across multiple traits.  
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METHODS 
 
Participants 
  
Participants were from the Health ABC study, a prospective community based sample of 
body composition changes over time in elderly American adults. Participants were 
recruited from 1997-1998 from Pittsburgh, PA, and Memphis, TN metropolitan area 
residents who were Medicare eligible and between the ages of 69 and 80 years old. 
Participants were excluded if they reported difficulty walking a quarter of a mile or 
climbing 10 stairs without resting. All participants gave written informed consent and 
both study sites approved the protocol. There were 1663 white and 1139 black 
participants included in the present study. 
 
Phenotypes  
 
BMI was calculated from laboratory measured height and weight during initial 
evaluation. To test various BMI thresholds, BMI was partitioned into clinical categories 
with BMI ranges of underweight <18, normal 18-25, overweight 25-30 and obese 30+ 
kg/m2. Physical activity (PhyAct) was estimated from a structured interview of 27 
questions and summarized as kcal/kg/week. Computerized tomography was used to 
determine abdominal visceral adiposity density (AbVFat). Smoking habits and race were 
self-reported via telephone interview. Smoking status (smoke) was defined as never, 
current or former smoker. Smoking status was further partitioned into ever smoker 
(EvSmo), former versus current smoker (cessation) and current smoker (CurSmo).  
Smoking duration was measured as pack years (PkYrs) and was calculated as the number 
of packs of cigarettes smoked per day multiplied by years as a smoker. 
 
Genotyping 
   
Genotyping in the Health ABC was performed by the Center for Inherited Disease 
Research using the Illumina Human 1M-Duo BeadChip system. Analysis was restricted 
to SNPs with minor allele frequency greater than or equal to 1%, call rate greater than or 
equal to 98% and Hardy-Weinberg Equilibrium p-value greater than 10-5. There were 8 
samples removed for genotypic sex mismatch. 
 
Selection of SNPs 
 
Preliminary SNP selection identified 78 variants meeting criteria for genome-wide or 
suggestive significance in either of two large meta-analyses of BMI; 43 from 
Thorleifsson et al. (2009) and 35 from Willer et al. (64, 65). Thorleifsson and colleagues 
report genome-wide significant (p < 1.6-7) associations with 29 SNPs in 11 chromosomal 
regions, using a discovery sample of n=34,416 and replication sample of n=5,586. The 
Willer et al. meta-analysis detected 8 genome-wide significant (p<5.0-8) SNPs in first- 
and second-stage samples of n=32,387 and n=54,316, respectively.  The only variants 
found to be genome-wide significant in both meta-analyses were in and near FTO and 
MC4R. The remaining genetic loci were suggestive in the opposing meta-analyses 
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(p<0.05), except rs7138803 on 12q13 (p=0.14). Significance level for one SNP, 
rs10938397 on 4p12, could not be compared between meta-analyses because there was 
no corresponding proxy SNP. Of the 78 BMI variants catalogued, 57 had matching SNPs 
on the Illumina Human 1M-Duo array. For the 20 SNPs not present, proxies (16 with 
r2>0.8; 2 with r2>0.7) were identified using SNP Annotation and Proxy Search (SNAP) 
V2.1 (147).  Following removal of 2 variants from Willer et al. for which no proxies 
were available (r2>0.7), a total of 75 SNPs remained.  
SNP selection for smoking traits were catalogued from three large meta-analyses 
on smoking initiation, consumption and cessation from Ox-GSK, TAG and ENGAGE 
consortia which included a combined analysis of over 140,000 individuals from 45 
studies (384-386). There were 510 SNPs reported in Ox-GSK associated with EvSmo, 
smoking quantity and cessation of which 157 remained significant (p<10-5) in the 
combined sample with TAG and ENGAGE. The TAG consortium reported 5 SNPs 
associated with consumption, 8 with EvSmo and 1 with cessation (p<10-8) in the 
combined sample. There were 921 SNPs reported by ENGAGE associated (p<0.05) with 
cigarette consumption and EvSmo of which 437 remained significant (p<10-5) in the 
combined sample with TAG and Ox-GSK. There were a total of 595 SNPs catalogued 
from the three large meta-analyses that were significant at the p<10-5 level in the 
combined analysis of which 179 appeared on the Health ABC Illumina Human 1M-Duo 
array. HapMap phase 2 (CEU, release 23, 90 individuals, 3.96 million SNPs) was used to 
determine independence of the 595 SNPs catalogued (70). SNP pruning at 0.7 level 
indicated 69 independent SNPs of which 54 appeared on the Health ABC Illumina 
Human 1M-Duo array. There were 15 SNPs catalogued from Ox-GSK from fine 
mapping of the 15q25 locus that did not have corresponding proxies on the Illumina 
array.  
Haploview version 4.10 was used to determine phase and corresponding proxy 
alleles (148, 149). In order to avoid bias due to correlated effects, SNP pruning (r2>0.7) 
was performed using PLINK v. 1.07p (150).  In summary, there were 75 BMI and 54 SB 
SNPs used for association in this study. Although our SNP selection threshold was 
more liberal than the traditional genome-wide significance threshold, it was more 
conservative than other models of complex disease risk prediction (151, 152).  
 
Association Analyses 
 
Linear and logistic regression was used to incorporate effects of covariates on outcome 
variables of body composition and smoking traits. Given there are phenotypic and SNP 
allele frequency differences found in European and African ancestries, analyses were run 
separately for self-identified race, white and black. To reduce spurious associations due 
to population stratification, principal component (PC) scores reflecting ancestral 
population sub-structure of each subject were computed (192, 387, 388). Eigensoft (192, 
193) was used to generate 10 PCs from 336,680 independent SNPs (linkage 
disequilibrium <0.5) in the European-American and 578,446 SNPs in the African-
American sample. There were 12 participants removed from analyses due to outlying PC 
scores. PCs 1, 2 and 5 were associated with study variables and were therefore included 
as covariates in subsequent regression analyses along with gender and age. PLINK v. 
1.07p was used for association and meta-analyses (150). 
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RESULTS 
 
Phenotypic 
 
Descriptive statistics for study variables are presented in Table 45. Analysis of variance 
indicated that males had significantly greater AbVFat (F(1,2694)=88.88, p=8.71x10-21) 
and longer duration of tobacco exposure as assessed by PkYrs (F(1,2758)=185.22, 
p=7.11x10-41) than females. There were no statistical differences on PhyAct by gender. 
Pearson’s Chi-Square and subsequent post hoc analyses indicated that males were more 
likely to be former smokers and females more likely to have never smoked (chi-
squ=236.5, p=4.0x10-52). Additionally, females were more likely to be obese (chi-
squ=24.2, p=8.2x10-7). As depicted in Figure 31, current smokers had significantly lower 
BMI than never or former smokers in males (F(2,1362)=18.9, p=7.83x10-9) and in 
females (F(2,1430)=13.15, p= 2.17x10-6). Similarly, current smokers had significantly 
lower AbVFat than never or former smokers in males (F(2,1309)=20.60, p=1.54x10-9) 
and females (F(2,1377)=10.01, p=4.8x10-5)(Figure 32). As shown in Figure 33, there 
were no significant differences in PkYrs across BMI categories in males 
(F(3,1342)=1.45, p=0.330). However, in females the underweight group had significantly 
greater PkYrs than the normal, overweight and obese groups (F(3,1410)=5.75, p=0.001). 
 
BMI SNPs 
 
Among genetic variants previously implicated in BMI, 23 were associated (p<0.05) with 
either BMI, AbVFat, BMICat or obesity (Table 48). Twelve of which were in the same 
direction for both racial groups. Table 46 lists association results suggestive for multiple 
traits. There were three BMI SNPs nominally associated with both body composition 
variables and smoking traits. The top associated SNP was rs1900273 on chromosome 11 
in STK33 for association with BMI (p=0.001). This SNP was also associated with 
AbVFat and PkYrs in both samples (p<0.023). SNP rs2145270 near BMP2 on 
chromosome 20 was associated with obesity (p=0.014), smoking status (p=0.007) and 
EvSmo (p=0.016). Finally, rs12127438 in the 1q42.2 locus was associated with BMI and 
BMICat in both ethnicity-based cohorts (p<0.033) and PkYrs in the European-American 
group (p=0.036). 
 
Smoking SNPs 
 
Among genetic variants previously implicated in SB, 13 were associated (p<0.05) with 
either Smoke, PkYrs, EvSmo, cessation or CurSmo (Table 49). Seven of which were in 
the same direction for both racial groups. The top associated SB SNP was rs9633423 on 
chromosome 1 with smoking cessation (p=0.008). Table 47 lists association results 
suggestive in multiple traits for previously implicated SB SNPs. There were three SB 
SNPs associated with both body composition variables and smoking traits. SNP 
rs11072774 on chromosome 15 in CHRNB4 was associated with BMI (p=0.037), obesity 
(p=0.003) and CurSmo(p=0.020) in both racial groups. In the white group, rs2640732 on 
chromosome 8 in SCARA3 was significantly associated with cessation, CurSmo and 
obesity (p<0.033). SNP rs6945244 on chromosome 7 in PDE1C was associated with 
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Smoke, EvSmo and PhyAct in both groups and additionally with obesity in the white 
group (p<0.037). 
 
DISCUSSION 
 
The purpose of this work was to examine phenotypic associations between body 
composition and smoking behavior in an elderly cohort and to test if genetic variants 
shown previously to be associated with either body composition or smoking behavior 
were associated with multiple traits in the Health ABC study. Since studies report 
significant phenotypic associations between body composition and smoking behavior, the 
work presented here investigated whether the association of these traits was due in part to 
shared genetic liability. Phenotypic results from the Health ABC study indicated there 
were body composition differences between smoking status groups. Specifically, current 
smokers tended to have lower BMI and abdominal visceral fat than former or non-
smokers. These results are in agreement with other cross-sectional studies of smoking 
behavior, which are supportive of lower body weight in smokers (109-111).  
To examine shared genetic liability, 75 BMI and 54 SB variants catalogued from 
large-scale GWAS meta-analyses were tested for association with body composition and 
smoking behavior variables. Among genetic variants previously implicated in BMI, 23 
were nominally associated (p<0.05) in this sample with BMI, abdominal visceral fat or 
obesity in the expected direction, which included SNPs in or near FTO and MC4R. 
Among these, there were three variants that were also nominally associated with smoking 
traits in the Health ABC study. The first SNP was in the 1q42.2 locus between the 
TSNAX and DISC1 genes and was negatively associated with BMI and pack years. This 
suggests that a BMI-decreasing allele is also associated with decreased smoking duration. 
However, a SNP in the STK33 gene (11p15.4), was found to be negatively associated 
with abdominal visceral fat and BMI but positively associated with pack years, 
suggesting that this allele is associated with lower body weight but with increased 
smoking duration. A third variant, on chromosome 20p12.3, was associated with a 
decrease in obesity but an increase in ever smoking with the closest gene bone 
morphogenetic protein 2 (BMP2). 
Among genetic variants previously implicated in smoking behavior, 13 were 
nominally associated (p<0.05) with smoking variables in the Health ABC study. Of these, 
three were also nominally associated with body composition variables. The first variant, 
on chromosome 7 located within the gene PDE1C, was associated with never smoking, 
decreased obesity and increase in physical activity. A second SNP, on chromosome 8 in 
the gene SCARA3, was associated with cessation, non-smoking and an increase in 
obesity. The third variant, located at the 15q25 locus, resides near a cluster of genes 
encoding nicotinic acetylcholine receptors and found to be associated with increased BMI 
and obesity, as well as with former and non-smoking. The genetic associations found in 
the Health ABC study reflect the complex phenotypic associations found between these 
traits. Although SNPs in and near BDNF were previously associated with body 
composition and smoking behaviors (64, 65, 385), there was no evidence of association 
in the Health ABC sample. However, despite their preliminary nature, these results merit 
future research and, in particular, follow-up in additional replication cohorts.  
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It is important to consider that genetic variants selected for association in this 
study, although significant in the meta-analyses from which they were catalogued, 
demonstrated relatively modest effects on their respective traits. As a result, replication 
attempts will have limited power to achieve genome-wide significance (125).  Issues 
related to multiple testing further complicate this. The likelihood of observing a false 
positive finding increases with the number of tests performed and significance values 
reported here were not corrected for multiple testing. However, the results from Health 
ABC are preliminary, and several additional studies will be incorporated into the final 
analyses, with significance evaluated by appropriate measures including Bonferroni 
correction and empirical significance derived by permutation procedures. 
Interpretation of these results should consider several limitations. First, this study 
was conducted using a selected sample. That is, participants were eligible if they were 
both elderly and in relatively good physical health. It is possible that this ascertainment 
strategy influenced the results and limits the ability to generalize the findings across the 
lifespan. Additionally, sex differences on the genetic analyses of these traits were not 
assessed. Further studies are warranted to determine effects of age and gender on the 
genetics of body composition, smoking behaviors and the causes of correlation between 
these traits. 
Preliminary results were suggestive of partially shared genetic risk between 
smoking and body composition. Without consideration of genetically-correlated traits, 
genome-wide studies of complex disease may be limited in their power to detect 
etiologically relevant variation. Future research needs to address mechanisms underlying 
the associations between these traits and moderating effects of the environment to aid 
both obesity and nicotine dependence prevention and treatment efforts. 
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TABLES AND FIGURES 
 
Figure 31: BMI by smoking status in males and females from the HABC study 
 
 
Note: BMI = body mass index, kg = kilograms, m = meter. 
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Figure 32: Mean abdominal visceral fat density by smoking status in males and females  
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Figure 33: Mean pack years by BMI category in males and females 
 
Note: BMI = body mass index, kg = kilograms, m = meter. 
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Table 45: Descriptive statistics for HABC study variables by gender 
  Overall  Males  Females 
 
N 
(%) 
 2802  1367 
(48.8%) 
 1435 
(51.2%) 
Race       
     White  1663  879  784 
     Black  1139  488  651 
Age (yrs) mean  73.6  73.8  73.5 
BMI (kg/m2) mean  27.4  27.1  27.7 
AbVFat mean  144  156.3  132.3 
PhyAct (kcal/kg/wk) mean  82.8  81.7  83.9 
Obese N 
     (%) 
 715 
(25.5%) 
 292  423 
Smoke N       
     Never 
     (%) 
 1206 
(43%) 
 393  813 
     Current 
     (%) 
 293 
(10.5%) 
 150  143 
     Former 
     (%) 
 1299 
(46.4%) 
 822  477 
Pack Years mean 
(median) 
 19.2 
4 
 26.5 
17 
 12.4 
0 
       
Note: BMI = body mass index, kg = kilograms, m = meter, kcal = kilocalories, wk = 
week, AbVFat = abdominal visceral fat, PhyAct = physical activity.  
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Table 46: Association results for SNPs previously implicated in BMI suggestive for 
multiple traits 
 
    
 
White 
 
 
Black 
 
Meta-Analysis 
 
Chr SNP A1 Trait β/OR SE P β/OR SE P β/OR P 
1 rs12127438 G BMI -0.034 0.02 0.160 -0.048 0.03 0.101 -0.040 0.033 
   BMICat -0.056 0.03 0.033 -0.030 0.04 0.460 -0.048 0.029 
   PkYrs -0.051 0.02 0.036 0.046 0.03 0.112 -0.004 0.942 
            
11 rs1900273 C AbVFat -0.041 0.02 0.091 -0.052 0.03 0.088 -0.045 0.017 
   BMI -0.057 0.02 0.020 -0.062 0.03 0.031 -0.059 0.001 
   BMICat -0.038 0.02 0.120 -0.066 0.03 0.056 -0.048 0.017 
   PkYrs 0.056 0.02 0.021 0.023 0.03 0.425 0.043 0.023 
            
20 rs2145270 C EvSmo 1.171 0.08 0.038 1.121 0.09 0.201 1.150 0.016 
   Obesity 0.851 0.09 0.085 0.852 0.09 0.080 0.851 0.014 
            
 
 
 
Table 47: Association results for SNPs previously implicated in smoking behaviors 
suggestive for multiple traits 
 
   
 
 
White 
 
 
Black 
 
Meta-Analysis 
 
Chr SNP A1 Trait β/OR SE P β/OR SE P β/OR P 
7 rs6945244 T EvSmo 0.882 0.08 0.094 0.883 0.10 0.191 0.882 0.034 
   Obesity 0.821 0.09 0.033 0.986 0.10 0.885 0.897 0.238 
   PhyAct 0.024 0.02 0.323 0.062 0.03 0.037 0.040 0.037 
            
8 rs2640732 G Cessation 0.714 0.16 0.033 1.306 0.15 0.080 0.967 0.911 
   CurSmo 0.716 0.15 0.028 1.216 0.14 0.155 0.937 0.805 
   Obesity 1.228 0.09 0.025 0.930 0.11 0.516 1.077 0.595 
            
15 rs11072774 T BMI 0.024 0.02 0.315 0.059 0.03 0.041 0.039 0.037 
   Cessation 0.589 0.22 0.018 0.870 0.18 0.426 0.733 0.109 
   CurSmo 0.641 0.22 0.041 0.799 0.16 0.168 0.739 0.020 
   Obesity 1.207 0.12 0.102 1.353 0.12 0.011 1.276 0.003 
            
 
Note: Chr = chromosome, A1 = allele tested, β = beta estimate for linear regression, OR 
= odds ratio for logistic regression, SE = standard error of the estimate, SNP = single 
nucleotide polymorphism, BMI = body mass index, AbVFat = abdominal visceral fat, 
PhyAct = physical activity, BMICat = clinical BMI category (under, normal, overweight, 
obese), Smoke = smoking status (never, current, former), PkYrs = pack years, EvSmo = 
ever vs never smoked, Cessation = former vs current smoker, CurSmo = current smoker. 
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Table 48: Association results for SNPs previously implicated in BMI  
 
 
    
 
White 
 
 
Black 
 
Meta-Analysis 
 
Chr SNP A1 Trait β/OR SE P β/OR SE P β/OR P 
 
1 rs3766431 T AbVFat 0.017 0.02 0.477 -0.062 0.03 0.040 -0.020 0.608 
1 rs9424977 C PhyAct 0.018 0.02 0.458 0.077 0.03 0.010 -0.028 0.559 
1 rs3101336 A Cessation 0.718 0.17 0.045 0.971 0.12 0.811 0.851 0.281 
   CurSmo 0.713 0.16 0.033 0.969 0.11 0.783 0.848 0.277 
   PhyAct 0.036 0.03 0.153 -0.062 0.03 0.037 -0.012 0.810 
1 rs2568958 G Cessation 0.715 0.17 0.043 0.970 0.12 0.808 0.849 0.281 
   CurSmo 0.711 0.16 0.032 0.969 0.11 0.786 0.847 0.279 
   PhyAct 0.035 0.02 0.159 -0.062 0.03 0.037 -0.012 0.804 
1 rs2815752 C Cessation 0.716 0.17 0.044 0.970 0.12 0.808 0.850 0.281 
   CurSmo 0.711 0.16 0.032 0.969 0.11 0.786 0.847 0.279 
   PhyAct 0.036 0.02 0.153 -0.062 0.03 0.037 -0.012 0.810 
1 rs1973993 T AbVFat -0.047 0.02 0.053 0.063 0.03 0.041 -0.053 0.005 
1 rs10783050 C AbVFat 0.071 0.02 0.003 0.015 0.03 0.635 0.047 0.097 
   BMI 0.055 0.02 0.024 0.014 0.03 0.642 0.038 0.060 
1 rs10913469 C BMI 0.049 0.02 0.045 -0.013 0.03 0.648 0.020 0.523 
1 rs12127438 G BMI -0.034 0.02 0.160 -0.048 0.03 0.101 -0.040 0.033 
   BMICat -0.056 0.03 0.033 -0.030 0.04 0.460 -0.048 0.029 
   PkYrs -0.051 0.02 0.036 0.046 0.03 0.112 -0.004 0.942 
2 rs2867125 A AbVFat 0.000 0.02 0.993 0.066 0.03 0.029 0.031 0.349 
   Obesity 0.716 0.13 0.009 1.093 0.14 0.520 0.882 0.552 
   PhyAct -0.043 0.02 0.082 0.079 0.03 0.008 0.017 0.785 
2 rs4854344 G Obesity 0.716 0.13 0.010 0.970 0.11 0.774 0.840 0.249 
   PhyAct -0.042 0.02 0.089 0.087 0.03 0.004 0.021 0.743 
2 rs7561317 A Obesity 0.715 0.13 0.009 1.004 0.10 0.973 0.854 0.353 
   PhyAct -0.044 0.02 0.080 0.091 0.03 0.002 0.023 0.738 
2 rs10206343 C BMI -0.056 0.02 0.020 -0.009 0.03 0.763 -0.035 0.139 
3 rs7647305 T BMI -0.034 0.02 0.159 -0.053 0.03 0.066 -0.042 0.024 
   BMICat -0.024 0.03 0.426 -0.078 0.03 0.024 -0.049 0.065 
5 rs467650 C Obesity 0.971 0.09 0.755 0.807 0.09 0.020 0.884 0.182 
6 rs1524097 C EvSmo 0.708 0.11 0.002 0.894 0.12 0.366 0.790 0.042 
   PkYrs -0.051 0.02 0.035 0.016 0.03 0.586 -0.020 0.559 
   Smoke -0.154 0.05 0.001 -0.057 0.05 0.283 -0.109 0.026 
7 rs7810507 A AbVFat 0.044 0.02 0.068 0.055 0.03 0.071 0.048 0.011 
   PkYrs 0.003 0.02 0.896 0.092 0.03 0.002 0.046 0.298 
8 rs17069257 C BMI 0.053 0.02 0.029 -0.018 0.03 0.542 0.019 0.582 
   BMICat 0.069 0.03 0.039 -0.043 0.04 0.289 0.015 0.785 
   Cessation 0.718 0.22 0.133 1.440 0.15 0.015 1.036 0.918 
   Smoke -0.014 0.04 0.738 -0.095 0.05 0.040 -0.053 0.189 
9 rs4742700 A EvSmo 1.234 0.08 0.008 1.040 0.12 0.743 1.161 0.069 
   Smoke 0.082 0.03 0.015 0.020 0.05 0.696 0.063 0.025 
9 rs867559 G Cessation 0.762 0.22 0.211 1.378 0.13 0.016 1.051 0.868 
   Smoke -0.047 0.04 0.268 -0.078 0.04 0.056 -0.063 0.032 
10 rs11255232 G BMICat 0.079 0.03 0.023 -0.006 0.08 0.939 0.066 0.038 
   Obesity 1.405 0.12 0.004 0.985 0.23 0.946 1.239 0.207 
11 rs1900273 C AbVFat -0.041 0.02 0.091 -0.052 0.03 0.088 -0.045 0.017 
   BMI -0.057 0.02 0.020 -0.062 0.03 0.031 -0.059 0.001 
   BMICat -0.038 0.02 0.120 -0.066 0.03 0.056 -0.048 0.017 
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   PkYrs 0.056 0.02 0.021 0.023 0.03 0.425 0.043 0.023 
11 rs7481311 T AbVFat -0.020 0.02 0.424 -0.086 0.03 0.005 -0.051 0.126 
11 rs10835211 A PkYrs -0.007 0.02 0.793 -0.059 0.03 0.043 -0.030 0.243 
11 rs4752856 A Cessation 1.409 0.15 0.027 0.711 0.22 0.126 1.020 0.955 
   Obesity 1.173 0.09 0.089 0.731 0.16 0.049 0.942 0.800 
12 rs7138803 A BMI -0.027 0.02 0.264 0.068 0.03 0.018 0.019 0.685 
13 rs7336332 G Cessation 0.893 0.23 0.630 1.377 0.14 0.018 1.157 0.493 
   CurSmo 0.827 0.23 0.414 1.281 0.12 0.046 1.076 0.734 
15 rs12324805 C AbVFat -0.057 0.02 0.018 0.032 0.03 0.300 -0.015 0.739 
   PhyAct 0.067 0.02 0.007 0.004 0.03 0.903 0.038 0.234 
15 rs8024593 G PhyAct -0.051 0.02 0.040 0.022 0.03 0.477 -0.039 0.040 
16 rs6499640 G BMICat -0.010 0.02 0.699 -0.069 0.03 0.046 -0.034 0.239 
16 rs8050136 A BMI 0.058 0.02 0.017 -0.030 0.03 0.291 0.015 0.730 
   BMICat 0.065 0.03 0.010 -0.016 0.03 0.642 0.028 0.490 
   Obesity 1.232 0.09 0.023 0.910 0.09 0.303 1.059 0.707 
16 rs3751812 T BMI 0.055 0.02 0.025 -0.036 0.03 0.219 0.011 0.813 
   BMICat 0.062 0.03 0.016 -0.041 0.06 0.476 0.023 0.640 
   Obesity 1.229 0.09 0.025 0.744 0.16 0.069 0.974 0.915 
16 rs11075989 T BMI 0.057 0.02 0.020 -0.012 0.03 0.682 0.024 0.480 
   BMICat 0.063 0.03 0.014 0.003 0.03 0.934 0.037 0.217 
   Obesity 1.229 0.09 0.025 0.949 0.09 0.566 1.080 0.553 
16 rs7190492 A BMI -0.054 0.02 0.029 0.035 0.03 0.225 -0.011 0.812 
16 rs8044769 T BMI -0.048 0.02 0.048 0.034 0.03 0.244 -0.009 0.834 
   BMICat -0.052 0.03 0.040 0.050 0.04 0.189 -0.005 0.927 
18 rs10871777 G BMI 0.041 0.02 0.092 0.045 0.03 0.118 0.043 0.022 
   PhyAct 0.056 0.02 0.024 -0.021 0.03 0.477 0.019 0.619 
18 rs12970134 A BMI 0.049 0.02 0.044 0.052 0.03 0.071 0.050 0.007 
20 rs2145270 C EvSmo 1.171 0.08 0.038 1.121 0.09 0.201 1.150 0.016 
   Obesity 0.851 0.09 0.085 0.852 0.09 0.080 0.851 0.014 
   Smoke 0.071 0.03 0.030 0.061 0.04 0.108 0.067 0.007 
22 rs4823535 A PhyAct -0.019 0.02 0.439 0.085 0.03 0.004 0.032 0.544 
            
 
Note: Chr = chromosome, A1 = allele tested, β = beta estimate for liner regression, OR = 
odds ratio for logistic regression, SE = standard error of the estimate, SNP = single 
nucleotide polymorphism, BMI = body mass index, AbVFat = abdominal visceral fat, 
PhyAct = physical activity, BMICat = clinical BMI category (under, normal, overweight, 
obese), Smoke = smoking status (never, current, former), EvSmo = ever smoked, 
Cessation = former vs current smoker, CurSmo = current smoker. 
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Table 49: Association results for SNPs previously implicated in smoking behaviors 
 
   
 
 
White 
 
 
Black 
 
Meta-Analysis 
 
Chr SNP A1 Trait β/OR SE P β/OR SE P β/OR P 
1 rs839758 G BMI -0.011 0.02 0.659 0.061 0.03 0.035 0.023 0.514 
   BMICat 0.005 0.02 0.839 0.071 0.03 0.029 0.035 0.289 
   Obesity 1.002 0.09 0.980 1.268 0.09 0.008 1.128 0.307 
1 rs2782641 G Cessation 1.078 0.15 0.626 0.748 0.13 0.031 0.891 0.529 
1 rs10888740 A PkYrs -0.012 0.02 0.617 -0.059 0.03 0.044 -0.033 0.159 
1 rs9633423 T Cessation 1.299 0.16 0.092 1.340 0.14 0.043 1.321 0.009 
   CurSmo 1.283 0.15 0.096 1.194 0.13 0.161 1.230 0.032 
   PhyAct -0.018 0.02 0.471 0.067 0.03 0.025 0.023 0.589 
1 rs6683734 A AbVFat -0.015 0.02 0.536 0.074 0.03 0.016 -0.042 0.156 
   PhyAct -0.049 0.02 0.047 0.033 0.03 0.276 -0.010 0.807 
2 rs16824949 G PkYrs 0.036 0.02 0.143 -0.067 0.03 0.025 -0.014 0.782 
7 rs6945244 T EvSmo 0.882 0.08 0.094 0.883 0.10 0.191 0.882 0.034 
   Obesity 0.821 0.09 0.033 0.986 0.10 0.885 0.897 0.238 
   PhyAct 0.024 0.02 0.323 0.062 0.03 0.037 0.040 0.037 
   Smoke -0.057 0.03 0.079 -0.075 0.04 0.065 -0.064 0.011 
7 rs6948856 A Obesity 0.761 0.11 0.012 1.086 0.09 0.384 0.913 0.608 
8 rs2640732 G Cessation 0.714 0.16 0.033 1.306 0.15 0.080 0.967 0.911 
   CurSmo 0.716 0.15 0.028 1.216 0.14 0.155 0.937 0.805 
   Obesity 1.228 0.09 0.025 0.930 0.11 0.516 1.077 0.595 
15 rs2656069 G AbVFat 0.011 0.02 0.653 -0.075 0.03 0.013 -0.030 0.482 
   PhyAct 0.052 0.02 0.037 0.030 0.03 0.313 0.043 0.024 
15 rs3885951 C BMICat 0.082 0.04 0.042 -0.204 0.12 0.079 -0.040 0.776 
   Obesity 1.155 0.14 0.316 0.380 0.37 0.009 0.698 0.516 
15 rs578776 T PhyAct 0.052 0.02 0.036 0.018 0.03 0.557 0.038 0.047 
15 rs12441998 G Cessation 0.667 0.20 0.041 1.228 0.13 0.106 0.922 0.791 
   PkYrs -0.048 0.02 0.049 -0.012 0.03 0.692 -0.033 0.076 
15 rs11072774 T BMI 0.024 0.02 0.315 0.059 0.03 0.041 0.039 0.037 
   Cessation 0.589 0.22 0.018 0.870 0.18 0.426 0.733 0.109 
   CurSmo 0.641 0.22 0.041 0.799 0.16 0.168 0.739 0.020 
   Obesity 1.207 0.12 0.102 1.353 0.12 0.011 1.276 0.003 
15 rs17487514 T Obesity 1.021 0.10 0.837 0.657 0.20 0.037 0.848 0.450 
15 rs16970006 C BMI 0.018 0.02 0.471 0.066 0.03 0.023 0.039 0.102 
   BMICat 0.040 0.05 0.418 0.218 0.10 0.034 0.106 0.217 
   Cessation 0.435 0.40 0.039 1.848 0.39 0.115 0.900 0.884 
   CurSmo 0.437 0.39 0.036 1.365 0.33 0.347 0.788 0.676 
   Obesity 1.249 0.17 0.191 1.952 0.27 0.014 1.484 0.070 
15 rs11072794 T Cessation 0.652 0.18 0.020 1.364 0.15 0.035 0.951 0.891 
   CurSmo 0.701 0.18 0.045 1.318 0.14 0.044 0.971 0.926 
15 rs7177699 C CurSmo 1.336 0.14 0.046 1.005 0.16 0.973 1.167 0.278 
15 rs4380028 A AbVFat 0.038 0.02 0.113 0.051 0.03 0.099 0.043 0.023 
15 rs11072810 T Obesity 0.986 0.09 0.875 0.826 0.09 0.039 0.902 0.243 
16 rs802698 A PhyAct -0.053 0.02 0.033 0.017 0.03 0.563 -0.020 0.572 
19 rs3889806 A Cessation 0.674 0.17 0.021 0.876 0.20 0.500 0.755 0.031 
   CurSmo 0.717 0.16 0.039 0.926 0.19 0.678 0.801 0.080 
   PhyAct -0.019 0.02 0.435 -0.072 0.03 0.016 -0.043 0.103 
19 rs7251950 T Cessation 1.386 0.16 0.038 1.119 0.17 0.520 1.259 0.049 
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SUPPLEMENTARY MATERIAL 
 
Figure 34: Daily cigarette consumption by BMI and sex in the VA30k sample 
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Figure 35: Smoking history by BMI and sex in the VA30k sample  
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Figure 36: Partial modified CCC model path diagram for BMI, smoking initiation and 
nicotine dependence 
 
Figure 37: CCC path estimates for females (VA30k) 
 
Figure 38: CCC path estimates for males (VA30k)  
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Chapter 9:  Global Discussion 
 
 
Obesity is a serious public health crisis and recent estimates of its incidence are the 
highest in United States history, with 35% and 17% of American adults and children 
affected, respectively (2). The clinical definition of adult obesity is operationalized as a 
body mass index (BMI) greater than 30 kg/m2. Although the prevalence of common 
obesity has increased dramatically over the past 30 years–largely thought to be due to 
changes in the environment, such as high calorie diets and sedentary lifestyles—twin and 
family studies have shown consistently that relative body weight is under considerable 
genetic influence in both children and adults, and heritability estimates range from 40% 
to 90% (35, 51-54).  
Given the large heritability estimates reported for BMI, molecular genetic 
approaches represent a useful tool with which to examine underlying mechanisms of and 
genetic susceptibility to obesity. To date, a number of approaches have been utilized to 
identify BMI/obesity-associated genes including candidate gene, linkage and association 
studies. While candidate gene and linkage studies have been useful in detecting genetic 
factors of large effect for rare forms of obesity, they have proven relatively unsuccessful 
for discovering genes of relatively small effect, such as those thought to underlie genetic 
liability to common complex obesity and BMI.  
Genome-wide association studies (GWAS) have successfully identified 
polymorphisms influencing numerous complex traits and diseases (72).  However, this 
approach has been met with important limitations. A number of potential factors have 
been proposed that may reduce the power of this methodology in general, as well as for 
the field of common complex obesity specifically. The survey of limitations presented in 
Chapter 1 highlights the following issues: replication of variants with small effects, utility 
of risk prediction, generalizability to multiple racial groups and across the lifespan and 
affects of comorbidity with other traits and disorders. The research reported herein 
attempts to address many of these issues, towards developing improved methods to 
delineate the genetics of BMI and common complex obesity, along with the 
corresponding associations with depression symptoms and smoking behavior. In the 
subsequent discussion, we first summarize key findings from each of the chapters, 
discuss limitations of this research and propose extensions for future research.   
 
Research findings 
 
This research integrated clinical, twin, and genetic association studies to further our 
understanding of the genetics of BMI and common complex obesity in the context of 
genetic risk sum scores (GRSS), clinical risk prediction, development across adolescence 
into adulthood, and comorbidity with depression symptoms and smoking behavior. A 
summary of the dissertation studies appears in Figure 39. The first three studies (Chapters 
2-4) incorporated GRSS methodology, which effectively summarizes the effects of a 
number of risk alleles into a composite score. In Chapter 2, the MGS-C sample was used 
for proof-of-principle of this methodology, that is, the use of a GRSS as an alternative 
form of replication. The MGS-C had limited power to detect the previously BMI-
associated variants individually but in aggregate, as a count score, was found to be highly 
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associated with BMI (p-value = 3.19x10-6) but explained a limited amount of the variance 
(0.66%). However, estimates of the area under receiver operator criteria curve (AUC) 
indicated that the GRSS and covariates significantly predicted overweight and obesity 
classification with maximum discriminative ability for predicting class III obesity 
(AUC=0.697). An additional finding was that the GRSS was associated in both 
European- and African-Americans, despite the fact that the BMI-associated variants were 
catalogued from meta-analyses of primarily European descent.   
In Chapter 3, we extended this GRSS methodology by constructing scores from 
proxy versus imputed SNPs and count versus weighted methods. The weighted SNP-
GRSS constructed from imputed probabilities of risk alleles performed best and was 
highly associated with BMI (p=4.3x10-16), accounting for 3% of the phenotypic variance. 
In addition to BMI-validated SNPs, common and rare BMI/obesity-associated CNVs 
were identified from the literature and incorporated into a score in the hopes of increasing 
risk prediction. Of the 84 CNVs previously reported, only a 21-kilobase deletion on 
16p12.3 demonstrated evidence of association with BMI (p=0.003, frequency=16.9%) in 
the SAGE sample, with two CNVs showing nominal association with moderate-obesity, 
1p36.1 duplications (OR=3.1, p=0.009, frequency 1.2%) and 5q13.2 deletions (OR=1.5, 
p=0.048, frequency 7.7%). The combined model, which included covariates, SNP-GRSS, 
and 16p12.3 deletion, accounted for 11.5% of phenotypic variance in BMI (p=3.34x10-54) 
and AUC estimates significantly predicted obesity classification with maximum 
discriminative ability for morbid-obesity (AUC = 0.750). These results illustrate how 
prediction algorithms may be improved by incorporating validated effect-sizes and allelic 
probabilities. Furthermore, in agreement with Chapter 2, the GRSS was associated in 
both European- and African-Americans despite the BMI-associated variants being 
catalogued from meta-analyses primarily of European descent. 
Because there has been only limited research on when during development BMI-
associated variants begin to influence BMI, we utilize in Chapter 4 the ABD longitudinal 
twin study in order to assess the effects of adult-validated BMI-SNPs across adolescence 
into adulthood (age 8 to 18). BMI was found to be highly heritable, accounting for 74-
91% of the variance over the course of adolescent development and, furthermore, 
modeling indicated multiple genetic factors that contributed to BMI liability, including a 
genetic factor that loaded across development, a second common genetic factor that 
loaded later in adolescence and time-specific genetic factors important in mid-
adolescence. Additionally, shared environmental effects were found to account for 
significant portions of the phenotypic variance (1-18%) for ages 11-16 in females and 
ages 8-14 in males. A unique environmental factor accounted for 2-13% of the 
phenotypic variance across development. To better understand the importance of adult 
BMI-associated genetic variants across adolescent development, we tested a weighted 
GRSS as an effect on latent genetic factors as well as on mean BMI. Preliminary results 
indicated that the GRSS was best modeled as an effect on mean BMI at each age group, 
suggesting association across development with the magnitude of the effect differing at 
each time point considered and ranged in effect from 0.05 to 2.4 kg/m2 change in BMI. 
The GRSS accounted for 1-2.3% of the phenotypic variance in BMI across adolescence. 
To our knowledge, this is the first study of BMI to incorporate GRSS methodology in the 
context of variance decomposition.  
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In Chapters 5 through 8, BMI and common complex obesity are approached from 
the perspective of comorbidity through phenotypic and genetic associations with binge 
eating disorder (BED), depression symptoms and smoking behavior. In Chapters 5 and 6, 
we used the UofMN study, a clinical sample of overweight and obese women with and 
without BED, to examine the relationship of BED, food intake and internalizing 
symptoms of depression and anxiety. In Chapter 5, energy intake and energy expenditure 
were assessed by multiple methods to potentially identify differences in food intake, 
metabolism and accuracy of self-reported food intake in obese groups with and without 
BED. The results indicated no between group differences in total daily energy 
expenditure (TDEE), basal metabolic rate (BMR) or thermal effect of food (TEF). 
According to dietary recall data, the BED group had significantly higher caloric intake on 
binge eating episode days than non-binge days (3255 vs. 2343 kilocalories (kcal)). No 
difference was observed between BED non-binge day intake and control group intake 
(2233 vs. 2140 kcal). We observed similar results for food log data and laboratory 
measured intake. Our data suggest that increased energy intake reported by BED 
individuals is due to increased food consumption and, critically, not metabolic 
differences. When comparing TDEE to data on dietary recall and food log, both groups 
displayed significant underreporting of caloric intake of similar magnitudes ranging 20-
33%. Furthermore, predicted energy requirements estimated via the Harris-Benedict 
equation underestimated measured TDEE by 23-24%. These results, taken together, 
provide support for under-reporting of food intake by both BED and non-BED obese 
groups. 
In Chapter 6, we used the UofMN sample to examine models by which BED and 
internalizing symptoms of depression and anxiety influence food intake in 
overweight/obese women. The BED group was found to endorse significantly more 
symptoms of depression (10.1 vs. 4.8, p=0.005) and anxiety (8.5 vs. 2.7, p=0.003). Linear 
regression indicated that BED diagnosis and internalizing symptoms accounted for 30% 
of the variance in kcal-intake (F(3,28)=4.0, p=0.017). Results from path analysis 
suggested that BED mediates the influence of internalizing symptoms on total kcal-intake 
(empirical p<0.001). The associations between internalizing symptoms and food intake 
are best described as acting indirectly through a BED diagnosis. This suggests that 
symptoms of depression and anxiety influence whether an individual engages in binge 
eating, which itself influences kcal-intake. Improved understanding of the mechanisms 
underlying the associations between mood, binge eating and food intake will facilitate the 
development of more effective prevention and treatment strategies for both BED and 
obesity. 
In Chapters 7 and 8, associations between BMI, depression symptoms and 
smoking behavior were examined by two different types of genetically informative 
samples: twin studies and GWAS. In Chapter 7, twin study methodology was utilized in 
order to investigate whether shared genetic and/or environmental liability is responsible 
for phenotypic associations found between BMI, depression symptoms, and impulsivity 
in the VA30k sample. A significant quadratic relationship was found between BMI and 
depression symptoms, indicating that those individuals with the highest and the lowest 
BMI were more likely to endorse higher depression scores. Bivariate twin modeling 
results did not indicate a significant genetic or environmental correlation between BMI 
and depression symptoms. However, significant genetic and environmental correlations 
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were found between BMI and impulsivity (rG =0.115, rE=0.046), as well as a significant 
genetic correlation between depression and impulsivity (rG=0.075). Trivariate 
independent pathway twin modeling indicated shared genetic and environmental liability 
between these traits and a common genetic factor accounting for 2-16% of the genetic 
variance in these traits. In females, an environmental factor common to BMI and 
impulsivity accounted for 0.5% of the environmental variance in BMI and 62% in 
impulsivity. In males, an environmental factor common to depression symptoms and 
impulsivity accounted for 0.5% of the environmental variance in depression symptoms 
and 56% in impulsivity.  Our findings suggested partially shared genetic and 
environmental risk between BMI, depression symptoms and impulsivity. 
The purpose of Chapter 8 was to investigate whether genetic variants previously 
identified to be associated with either BMI or smoking behavior were common to 
multiple behaviors or were trait-specific in the HABC study. Phenotypic associations 
indicated current smokers had significantly lower BMI and abdominal visceral fat than 
“never” or former smokers in both sexes. In total, three BMI-associated SNPs 
demonstrated nominally significant associations with smoking traits: rs1900273 in 
STK33, rs2145270 near BMP2 and rs12127438 at the 1q42.2 locus. Additionally, three 
smoking behavior-associated SNPs were found to be nominally associated with body 
composition variables: rs11072774 in CHRNB4, rs2640732 in SCARA3 and rs6945244 in 
PDE1C. Our preliminary findings are suggestive of partially shared genetic risk between 
smoking and body composition in a sample of European- and African-Americans.   
 
Limitations and extensions 
 
The findings reported herein are best interpreted within the context of several limitations. 
First, although SNP-GRSSs were significantly associated with BMI, they only accounted 
for a limited proportion of the phenotypic variance (0.5-3%) and, accordingly, obesity 
risk prediction based on these scores was not found to have clinical utility. Moreover, 
while it was hoped that by including an additional class of genetic variants (i.e., CNVs) 
we would be able to account for more of the phenotypic variance in BMI, all but three of 
the CNVs catalogued from the literature failed to demonstrate evidence of association 
with BMI or obesity, even when tested in aggregate. However, as large-scale exome and 
genome sequencing initiatives identify lower frequency variants and other types of 
variation such as INDELs, the framework we have provided for integrating common and 
rare variation may be applied.  
There are potentially several other extensions to GRSS methodology. For 
example, the GRSS reported here were constructed from variants that met genome-wide 
significance. Alternatively, these scores could be constructed from a wider significance 
threshold to determine the probability level that captures maximal predictive ability. 
Furthermore, an important extension of an integrated model of BMI and obesity is to 
incorporate the moderating effects of the environment. At least two of the BMI-validated 
SNPs exhibit gene by environment interactions. Future research should incorporate 
environmental variables into models of disease and risk prediction, as consideration of 
only genetic effects will surely be of limited potential. 
Several of the reported phenotypic associations indicated a significant quadratic 
association, including age and BMI. Additionally, a quadratic association was found 
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between BMI and depression symptoms. This finding could explain, in part, conflicting 
reported findings on the nature of the association of BMI and depression, and further 
highlights the importance of addressing the possibility of higher order associations 
between variables (i.e., quadratic, cubic). Furthermore, there are known limitations of 
structural equation modeling for the handling of nonlinear relationships. Additional 
research is needed to determine the effect of curvilinear relationships on variance 
decomposition methodology and parameter estimates. 
 Another limitation of this research was the application of only a few of the 
potentially relevant latent variable twin models. Other longitudinal models, which would 
be particularly insightful, are simplex and growth curves, as they allow for the 
assessment of the contributions of variance components and genetic variants on 
innovations, transmissions and rate of change of BMI across time. In addition, since C 
and D components cannot me modeled simultaneously in classical twin designs, future 
models might utilize the extended twin design to determine the effect of each of these 
sources of variance among others such as assortative mating. Of particular interest is the 
application of models of comorbidity to potentially determine the direction of effect, as 
longitudinal phenotypic studies have found a reciprocal association between obesity and 
depression. Future research should apply models of comorbidity and test direction of 
causation in genetically informative samples. Our results suggest that there is partially 
shared genetic risk between BMI, depression symptoms and impulsivity and BMI and 
smoking behavior. More studies are needed to determine how correlated liability affects 
gene-finding efforts.  
 
Closing remarks 
 
 Given the seriousness of the global obesity epidemic among both children and 
adults, research elucidating the genetic and environmental liability to BMI and 
development of obesity is essential. It is well recognized that excess body weight is the 
result of positive energy balance, that is, excess caloric intake relative to energy 
expenditure. Although energy balance appears straightforward, its relationship with 
obesity is quite complex and involves the interplay of genetic, environmental, and 
psychological determinants. Despite twin and family studies consistently demonstrating 
that relative body weight is under considerable genetic influence in both children and 
adults, only a limited number of genetic variants have been identified to date and these 
account for only a fraction of the heritability. The so-called “missing heritability” has 
been speculated to reside in lower frequency and other classes of variants yet to be 
elucidated by the holy grail of molecular genetic studies—whole-genome sequencing. 
Longitudinal twin studies indicate there are multiple genetic and environmental factors 
that persist across time, as well as time-specific factors, that influence relative body 
weight. However, most genetic association studies have been performed on cross-
sectional studies ignoring the potential confounders of development. Furthermore, BMI 
and obesity are associated and comorbid with multiple traits and diseases, and studies 
have demonstrated correlated liability between traits. Nonetheless, most genetic 
association studies do not account for effects of correlated liability beyond the use of a 
few basic covariates. This next era of gene finding efforts by large-scale sequencing will 
certainly identify additional genetic variation and likely shed light on new pathways 
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involved in disease etiology. However, to fully understand common complex obesity we 
need to move beyond the rather simplistic model of performing linear associations 
between genetic variant and “trait” and move towards building integrated models 
incorporating development, comorbidity, and, importantly, effects of the environment. 
 
 
Figure 39: Summary of dissertation studies 
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